Clinical practice guidelines for the management of pregnancy in women with autoimmune rheumatic diseases of the Mexican College of Rheumatology. Part I

array:24 ["pii" => "S2173574315000441" "issn" => "21735743" "doi" => "10.1016/j.reumae.2015.03.002" "estado" => "S300" "fechaPublicacion" => "2015-09-01" "aid" => "739" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2014" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Reumatol Clin. 2015;11:295-304" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2230 "formatos" => array:3 [ "EPUB" => 69 "HTML" => 1608 "PDF" => 553 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S1699258X14002277" "issn" => "1699258X" "doi" => "10.1016/j.reuma.2014.11.005" "estado" => "S300" "fechaPublicacion" => "2015-09-01" "aid" => "739" "copyright" => "Elsevier España, S.L.U." "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Reumatol Clin. 2015;11:295-304" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 14870 "formatos" => array:3 [ "EPUB" => 176 "HTML" => 6950 "PDF" => 7744 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "Original" "titulo" => "Guías de práctica clínica para la atención del embarazo en mujeres con enfermedades reumáticas autoinmunes del Colegio Mexicano de Reumatología. Parte I" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "295" "paginaFinal" => "304" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Clinical practice guidelines for the management of pregnancy in women with autoimmune rheumatic diseases of the Mexican College of Rheumatology. Part I" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1919 "Ancho" => 3173 "Tamanyo" => 187047 ] ] "descripcion" => array:1 [ "es" => "Algoritmo de manejo en pacientes con lupus eritematoso sistémico." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Miguel Ángel Saavedra Salinas, Antonio Barrera Cruz, Antonio Rafael Cabral Castañeda, Luis Javier Jara Quezada, C. Alejandro Arce-Salinas, José Álvarez Nemegyei, Antonio Fraga Mouret, Javier Orozco Alcalá, Mario Salazar Páramo, Claudia Verónica Cruz Reyes, Lilia Andrade Ortega, Olga Lidia Vera Lastra, Claudia Mendoza Pinto, Antonio Sánchez González, Polita del Rocío Cruz Cruz, Sara Morales Hernández, Margarita Portela Hernández, Mario Pérez Cristóbal, Gabriela Medina García, Noé Hernández Romero, María del Carmen Velarde Ochoa, José Eduardo Navarro Zarza, Verónica Portillo Díaz, Angélica Vargas Guerrero, María Victoria Goycochea Robles, José Luis García Figueroa, Eduardo Barreira Mercado, Mary Carmen Amigo Castañeda" "autores" => array:28 [ 0 => array:2 [ "nombre" => "Miguel Ángel" "apellidos" => "Saavedra Salinas" ] 1 => array:2 [ "nombre" => "Antonio" "apellidos" => "Barrera Cruz" ] 2 => array:2 [ "nombre" => "Antonio Rafael" "apellidos" => "Cabral Castañeda" ] 3 => array:2 [ "nombre" => "Luis Javier" "apellidos" => "Jara Quezada" ] 4 => array:2 [ "nombre" => "C. Alejandro" "apellidos" => "Arce-Salinas" ] 5 => array:2 [ "nombre" => "José" "apellidos" => "Álvarez Nemegyei" ] 6 => array:2 [ "nombre" => "Antonio" "apellidos" => "Fraga Mouret" ] 7 => array:2 [ "nombre" => "Javier" "apellidos" => "Orozco Alcalá" ] 8 => array:2 [ "nombre" => "Mario" "apellidos" => "Salazar Páramo" ] 9 => array:2 [ "nombre" => "Claudia Verónica" "apellidos" => "Cruz Reyes" ] 10 => array:2 [ "nombre" => "Lilia" "apellidos" => "Andrade Ortega" ] 11 => array:2 [ "nombre" => "Olga Lidia" "apellidos" => "Vera Lastra" ] 12 => array:2 [ "nombre" => "Claudia" "apellidos" => "Mendoza Pinto" ] 13 => array:2 [ "nombre" => "Antonio" "apellidos" => "Sánchez González" ] 14 => array:2 [ "nombre" => "Polita del Rocío" "apellidos" => "Cruz Cruz" ] 15 => array:2 [ "nombre" => "Sara" "apellidos" => "Morales Hernández" ] 16 => array:2 [ "nombre" => "Margarita" "apellidos" => "Portela Hernández" ] 17 => array:2 [ "nombre" => "Mario" "apellidos" => "Pérez Cristóbal" ] 18 => array:2 [ "nombre" => "Gabriela" "apellidos" => "Medina García" ] 19 => array:2 [ "nombre" => "Noé" "apellidos" => "Hernández Romero" ] 20 => array:2 [ "nombre" => "María del Carmen" "apellidos" => "Velarde Ochoa" ] 21 => array:2 [ "nombre" => "José Eduardo" "apellidos" => "Navarro Zarza" ] 22 => array:2 [ "nombre" => "Verónica" "apellidos" => "Portillo Díaz" ] 23 => array:2 [ "nombre" => "Angélica" "apellidos" => "Vargas Guerrero" ] 24 => array:2 [ "nombre" => "María Victoria" "apellidos" => "Goycochea Robles" ] 25 => array:2 [ "nombre" => "José Luis" "apellidos" => "García Figueroa" ] 26 => array:2 [ "nombre" => "Eduardo" "apellidos" => "Barreira Mercado" ] 27 => array:2 [ "nombre" => "Mary Carmen" "apellidos" => "Amigo Castañeda" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173574315000441" "doi" => "10.1016/j.reumae.2015.03.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574315000441?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X14002277?idApp=UINPBA00004M" "url" => "/1699258X/0000001100000005/v1_201508130103/S1699258X14002277/v1_201508130103/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2173574315000477" "issn" => "21735743" "doi" => "10.1016/j.reumae.2015.03.005" "estado" => "S300" "fechaPublicacion" => "2015-09-01" "aid" => "745" "copyright" => "Elsevier España, S.L.U." "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Reumatol Clin. 2015;11:305-15" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2173 "formatos" => array:3 [ "EPUB" => 56 "HTML" => 1604 "PDF" => 513 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "Original Article" "titulo" => "Clinical Practice Guidelines for the Management of Pregnancy in Women With Autoimmune Rheumatic Diseases of the Mexican College of Rheumatology. Part II" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "305" "paginaFinal" => "315" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Guías de práctica clínica para la atención del embarazo en mujeres con enfermedades reumáticas autoinmunes del Colegio Mexicano de Reumatología. Parte II" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1963 "Ancho" => 1679 "Tamanyo" => 169479 ] ] "descripcion" => array:1 [ "en" => "Management algorithm in patients with rheumatoid arthritis." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Miguel Ángel Saavedra Salinas, Antonio Barrera Cruz, Antonio Rafael Cabral Castañeda, Luis Javier Jara Quezada, C. Alejandro Arce-Salinas, José Álvarez Nemegyei, Antonio Fraga Mouret, Javier Orozco Alcalá, Mario Salazar Páramo, Claudia Verónica Cruz Reyes, Lilia Andrade Ortega, Olga Lidia Vera Lastra, Claudia Mendoza Pinto, Antonio Sánchez González, Polita del Rocío Cruz Cruz, Sara Morales Hernández, Margarita Portela Hernández, Mario Pérez Cristóbal, Gabriela Medina García, Noé Hernández Romero, María del Carmen Velarde Ochoa, José Eduardo Navarro Zarza, Verónica Portillo Díaz, Angélica Vargas Guerrero, María Victoria Goycochea Robles, José Luis García Figueroa, Eduardo Barreira Mercado, Mary Carmen Amigo Castañeda" "autores" => array:28 [ 0 => array:2 [ "nombre" => "Miguel Ángel" "apellidos" => "Saavedra Salinas" ] 1 => array:2 [ "nombre" => "Antonio" "apellidos" => "Barrera Cruz" ] 2 => array:2 [ "nombre" => "Antonio Rafael" "apellidos" => "Cabral Castañeda" ] 3 => array:2 [ "nombre" => "Luis Javier" "apellidos" => "Jara Quezada" ] 4 => array:2 [ "nombre" => "C. Alejandro" "apellidos" => "Arce-Salinas" ] 5 => array:2 [ "nombre" => "José" "apellidos" => "Álvarez Nemegyei" ] 6 => array:2 [ "nombre" => "Antonio" "apellidos" => "Fraga Mouret" ] 7 => array:2 [ "nombre" => "Javier" "apellidos" => "Orozco Alcalá" ] 8 => array:2 [ "nombre" => "Mario" "apellidos" => "Salazar Páramo" ] 9 => array:2 [ "nombre" => "Claudia Verónica" "apellidos" => "Cruz Reyes" ] 10 => array:2 [ "nombre" => "Lilia" "apellidos" => "Andrade Ortega" ] 11 => array:2 [ "nombre" => "Olga Lidia" "apellidos" => "Vera Lastra" ] 12 => array:2 [ "nombre" => "Claudia" "apellidos" => "Mendoza Pinto" ] 13 => array:2 [ "nombre" => "Antonio" "apellidos" => "Sánchez González" ] 14 => array:2 [ "nombre" => "Polita del Rocío" "apellidos" => "Cruz Cruz" ] 15 => array:2 [ "nombre" => "Sara" "apellidos" => "Morales Hernández" ] 16 => array:2 [ "nombre" => "Margarita" "apellidos" => "Portela Hernández" ] 17 => array:2 [ "nombre" => "Mario" "apellidos" => "Pérez Cristóbal" ] 18 => array:2 [ "nombre" => "Gabriela" "apellidos" => "Medina García" ] 19 => array:2 [ "nombre" => "Noé" "apellidos" => "Hernández Romero" ] 20 => array:2 [ "nombre" => "María del Carmen" "apellidos" => "Velarde Ochoa" ] 21 => array:2 [ "nombre" => "José Eduardo" "apellidos" => "Navarro Zarza" ] 22 => array:2 [ "nombre" => "Verónica" "apellidos" => "Portillo Díaz" ] 23 => array:2 [ "nombre" => "Angélica" "apellidos" => "Vargas Guerrero" ] 24 => array:2 [ "nombre" => "María Victoria" "apellidos" => "Goycochea Robles" ] 25 => array:2 [ "nombre" => "José Luis" "apellidos" => "García Figueroa" ] 26 => array:2 [ "nombre" => "Eduardo" "apellidos" => "Barreira Mercado" ] 27 => array:2 [ "nombre" => "Mary Carmen" "apellidos" => "Amigo Castañeda" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1699258X14002575" "doi" => "10.1016/j.reuma.2014.12.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X14002575?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574315000477?idApp=UINPBA00004M" "url" => "/21735743/0000001100000005/v1_201509041903/S2173574315000477/v1_201509041903/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2173574315000878" "issn" => "21735743" "doi" => "10.1016/j.reumae.2015.05.002" "estado" => "S300" "fechaPublicacion" => "2015-09-01" "aid" => "789" "copyright" => "Elsevier España, S.L.U." "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Reumatol Clin. 2015;11:279-94" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1727 "formatos" => array:3 [ "EPUB" => 58 "HTML" => 1099 "PDF" => 570 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "Special Article" "titulo" => "2014 Update of the Consensus Statement of the Spanish Society of Rheumatology on the Use of Biological Therapies in Rheumatoid Arthritis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "279" "paginaFinal" => "294" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Actualización 2014 del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 4005 "Ancho" => 2975 "Tamanyo" => 787916 ] ] "descripcion" => array:1 [ "en" => "Therapeutic algorithm for rheumatoid arthritis." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Raimon Sanmartí, Susana García-Rodríguez, José María Álvaro-Gracia, José Luis Andreu, Alejandro Balsa, Rafael Cáliz, Antonio Fernández-Nebro, Iván Ferraz-Amaro, Juan Jesús Gómez-Reino, Isidoro González-Álvaro, Emilio Martín-Mola, Víctor Manuel Martínez-Taboada, Ana M. Ortiz, Jesús Tornero, Sara Marsal, José Vicente Moreno-Muelas" "autores" => array:16 [ 0 => array:2 [ "nombre" => "Raimon" "apellidos" => "Sanmartí" ] 1 => array:2 [ "nombre" => "Susana" "apellidos" => "García-Rodríguez" ] 2 => array:2 [ "nombre" => "José María" "apellidos" => "Álvaro-Gracia" ] 3 => array:2 [ "nombre" => "José Luis" "apellidos" => "Andreu" ] 4 => array:2 [ "nombre" => "Alejandro" "apellidos" => "Balsa" ] 5 => array:2 [ "nombre" => "Rafael" "apellidos" => "Cáliz" ] 6 => array:2 [ "nombre" => "Antonio" "apellidos" => "Fernández-Nebro" ] 7 => array:2 [ "nombre" => "Iván" "apellidos" => "Ferraz-Amaro" ] 8 => array:2 [ "nombre" => "Juan Jesús" "apellidos" => "Gómez-Reino" ] 9 => array:2 [ "nombre" => "Isidoro" "apellidos" => "González-Álvaro" ] 10 => array:2 [ "nombre" => "Emilio" "apellidos" => "Martín-Mola" ] 11 => array:2 [ "nombre" => "Víctor Manuel" "apellidos" => "Martínez-Taboada" ] 12 => array:2 [ "nombre" => "Ana M." "apellidos" => "Ortiz" ] 13 => array:2 [ "nombre" => "Jesús" "apellidos" => "Tornero" ] 14 => array:2 [ "nombre" => "Sara" "apellidos" => "Marsal" ] 15 => array:2 [ "nombre" => "José Vicente" "apellidos" => "Moreno-Muelas" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1699258X15000753" "doi" => "10.1016/j.reuma.2015.05.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X15000753?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574315000878?idApp=UINPBA00004M" "url" => "/21735743/0000001100000005/v1_201509041903/S2173574315000878/v1_201509041903/en/main.assets" ] "en" => array:20 [ "idiomaDefecto" => true "cabecera" => "Original Article" "titulo" => "Clinical practice guidelines for the management of pregnancy in women with autoimmune rheumatic diseases of the Mexican College of Rheumatology. Part I" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "295" "paginaFinal" => "304" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Miguel Ángel Saavedra Salinas, Antonio Barrera Cruz, Antonio Rafael Cabral Castañeda, Luis Javier Jara Quezada, C. Alejandro Arce-Salinas, José Álvarez Nemegyei, Antonio Fraga Mouret, Javier Orozco Alcalá, Mario Salazar Páramo, Claudia Verónica Cruz Reyes, Lilia Andrade Ortega, Olga Lidia Vera Lastra, Claudia Mendoza Pinto, Antonio Sánchez González, Polita del Rocío Cruz Cruz, Sara Morales Hernández, Margarita Portela Hernández, Mario Pérez Cristóbal, Gabriela Medina García, Noé Hernández Romero, María del Carmen Velarde Ochoa, José Eduardo Navarro Zarza, Verónica Portillo Díaz, Angélica Vargas Guerrero, María Victoria Goycochea Robles, José Luis García Figueroa, Eduardo Barreira Mercado, Mary Carmen Amigo Castañeda" "autores" => array:28 [ 0 => array:4 [ "nombre" => "Miguel Ángel" "apellidos" => "Saavedra Salinas" "email" => array:2 [ 0 => "miansaavsa@gmail.com" 1 => "miansaavsa@hotmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Antonio" "apellidos" => "Barrera Cruz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Antonio Rafael" "apellidos" => "Cabral Castañeda" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "c" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "Luis Javier" "apellidos" => "Jara Quezada" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "d" "identificador" => "aff0020" ] ] ] 4 => array:3 [ "nombre" => "C. Alejandro" "apellidos" => "Arce-Salinas" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "e" "identificador" => "aff0025" ] ] ] 5 => array:3 [ "nombre" => "José" "apellidos" => "Álvarez Nemegyei" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "f" "identificador" => "aff0030" ] ] ] 6 => array:3 [ "nombre" => "Antonio" "apellidos" => "Fraga Mouret" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "g" "identificador" => "aff0035" ] ] ] 7 => array:3 [ "nombre" => "Javier" "apellidos" => "Orozco Alcalá" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "h" "identificador" => "aff0040" ] ] ] 8 => array:3 [ "nombre" => "Mario" "apellidos" => "Salazar Páramo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "i" "identificador" => "aff0045" ] ] ] 9 => array:3 [ "nombre" => "Claudia Verónica" "apellidos" => "Cruz Reyes" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 10 => array:3 [ "nombre" => "Lilia" "apellidos" => "Andrade Ortega" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "j" "identificador" => "aff0050" ] ] ] 11 => array:3 [ "nombre" => "Olga Lidia" "apellidos" => "Vera Lastra" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "k" "identificador" => "aff0055" ] ] ] 12 => array:3 [ "nombre" => "Claudia" "apellidos" => "Mendoza Pinto" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "l" "identificador" => "aff0060" ] ] ] 13 => array:3 [ "nombre" => "Antonio" "apellidos" => "Sánchez González" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 14 => array:3 [ "nombre" => "Polita del Rocío" "apellidos" => "Cruz Cruz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "m" "identificador" => "aff0065" ] ] ] 15 => array:3 [ "nombre" => "Sara" "apellidos" => "Morales Hernández" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "n" "identificador" => "aff0070" ] ] ] 16 => array:3 [ "nombre" => "Margarita" "apellidos" => "Portela Hernández" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "o" "identificador" => "aff0075" ] ] ] 17 => array:3 [ "nombre" => "Mario" "apellidos" => "Pérez Cristóbal" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "o" "identificador" => "aff0075" ] ] ] 18 => array:3 [ "nombre" => "Gabriela" "apellidos" => "Medina García" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "p" "identificador" => "aff0080" ] ] ] 19 => array:3 [ "nombre" => "Noé" "apellidos" => "Hernández Romero" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "q" "identificador" => "aff0085" ] ] ] 20 => array:3 [ "nombre" => "María del Carmen" "apellidos" => "Velarde Ochoa" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "r" "identificador" => "aff0090" ] ] ] 21 => array:3 [ "nombre" => "José Eduardo" "apellidos" => "Navarro Zarza" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "s" "identificador" => "aff0095" ] ] ] 22 => array:3 [ "nombre" => "Verónica" "apellidos" => "Portillo Díaz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "t" "identificador" => "aff0100" ] ] ] 23 => array:3 [ "nombre" => "Angélica" "apellidos" => "Vargas Guerrero" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "u" "identificador" => "aff0105" ] ] ] 24 => array:3 [ "nombre" => "María Victoria" "apellidos" => "Goycochea Robles" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "v" "identificador" => "aff0110" ] ] ] 25 => array:3 [ "nombre" => "José Luis" "apellidos" => "García Figueroa" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "w" "identificador" => "aff0115" ] ] ] 26 => array:3 [ "nombre" => "Eduardo" "apellidos" => "Barreira Mercado" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "x" "identificador" => "aff0120" ] ] ] 27 => array:3 [ "nombre" => "Mary Carmen" "apellidos" => "Amigo Castañeda" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "y" "identificador" => "aff0125" ] ] ] ] "afiliaciones" => array:25 [ 0 => array:3 [ "entidad" => "Departamento de Reumatología, Hospital de Especialidades Dr. Antonio Fraga Mouret, CMN La Raza, IMSS, UNAM, Mexico City, Mexico" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "División de Excelencia Clínica, Área de Desarrollo de Guías de Práctica Clínica, IMSS, Mexico City, Mexico" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Ciencias Médicas F, Departamento de Inmunología y Reumatología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Dirección de Educación e Investigación, Hospital de Especialidades Dr. Antonio Fraga Mouret, CMN La Raza, IMSS, UNAM, Mexico City, Mexico" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "División de Medicina Interna, Hospital Central Sur de Pemex, Mexico City, Mexico" "etiqueta" => "e" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Escuela de Medicina, Universidad Anáhuac-Mayab, Mérida, Yucatán, Mexico" "etiqueta" => "f" "identificador" => "aff0030" ] 6 => array:3 [ "entidad" => "Dirección de Educación e Investigación, Secretaría de Salud del Distrito Federal, UNAM, Mexico City, Mexico" "etiqueta" => "g" "identificador" => "aff0035" ] 7 => array:3 [ "entidad" => "Clínica de Reumatología, Escuela de Medicina, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico" "etiqueta" => "h" "identificador" => "aff0040" ] 8 => array:3 [ "entidad" => "División de Investigación en Salud, UMAE, Hospital de Especialidades, Centro Médico Nacional de Occidente, IMSS, Centro Universitario Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico" "etiqueta" => "i" "identificador" => "aff0045" ] 9 => array:3 [ "entidad" => "Departamento de Reumatología, Centro Médico Nacional 20 de Noviembre, ISSSTE, Reumatología, UNAM, Mexico City, Mexico" "etiqueta" => "j" "identificador" => "aff0050" ] 10 => array:3 [ "entidad" => "Departamento de Medicina Interna, Hospital de Especialidades, CMN La Raza, IMSS, UNAM, Mexico City, Mexico" "etiqueta" => "k" "identificador" => "aff0055" ] 11 => array:3 [ "entidad" => "Unidad de Investigación Enfermedades Autoinmunes Sistémicas, Hospital General Regional n.o 36-CIBIOR, Instituto Mexicano del Seguro Social, Unidad de Posgrado, Facultad de Medicina, Benemérita Universidad Autónoma de Puebla, Puebla, Puebla, Mexico" "etiqueta" => "l" "identificador" => "aff0060" ] 12 => array:3 [ "entidad" => "División de Atención Ginecobstétrica y Perinatal de la Dirección de Prestaciones Médicas del IMSS, Mexico City, Mexico" "etiqueta" => "m" "identificador" => "aff0065" ] 13 => array:3 [ "entidad" => "Departamento de Perinatología, Hospital Gineco-Obstetricia n.o3 Dr. Víctor Manuel Espinosa de los Reyes Sánchez, UMAE, CMN La Raza, IMSS, Mexico City, Mexico" "etiqueta" => "n" "identificador" => "aff0070" ] 14 => array:3 [ "entidad" => "Departamento de Reumatología, Hospital de Especialidades, CMN Siglo XXI, IMSS, Mexico City, Mexico" "etiqueta" => "o" "identificador" => "aff0075" ] 15 => array:3 [ "entidad" => "Hospital de Especialidades, CMN La Raza, IMSS, Mexico City, Mexico" "etiqueta" => "p" "identificador" => "aff0080" ] 16 => array:3 [ "entidad" => "Unidad de Cuidados Intensivos Neonatales, Hospital Gineco-Obstetricia n.o 3 Dr. Víctor Manuel Espinosa de los Reyes Sánchez, UMAE, CMN La Raza, IMSS, Mexico City, Mexico" "etiqueta" => "q" "identificador" => "aff0085" ] 17 => array:3 [ "entidad" => "Departamento de Reumatología e Inmunología Clínica, Hospital General de Zona No. 46, IMSS, Villahermosa, Tabasco, Mexico" "etiqueta" => "r" "identificador" => "aff0090" ] 18 => array:3 [ "entidad" => "Hospital General de Chilpancingo Dr. Raymundo Abarca Alarcón, Chilpancingo, Guerrero, Mexico" "etiqueta" => "s" "identificador" => "aff0095" ] 19 => array:3 [ "entidad" => "Departamento de Medicina Interna, UMAE HGO 4, IMSS, Mexico City, Mexico" "etiqueta" => "t" "identificador" => "aff0100" ] 20 => array:3 [ "entidad" => "Departamento de Reumatología, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico" "etiqueta" => "u" "identificador" => "aff0105" ] 21 => array:3 [ "entidad" => "Unidad de investigación en Epidemiología Clínica, Hospital Regional Dr. Carlos Mcgregor Sánchez Navarro, IMSS, Mexico City, Mexico" "etiqueta" => "v" "identificador" => "aff0110" ] 22 => array:3 [ "entidad" => "Universidad Juárez Autónoma de Tabasco, Villahermosa, Tabasco, Mexico" "etiqueta" => "w" "identificador" => "aff0115" ] 23 => array:3 [ "entidad" => "Reumatología de la Facultad de Medicina, Universidad Autónoma de Querétaro y Universidad del Del Valle de Mexico, Querétaro, Qro., Mexico" "etiqueta" => "x" "identificador" => "aff0120" ] 24 => array:3 [ "entidad" => "Reumatología, Centro Médico ABC, Mexico City, Mexico" "etiqueta" => "y" "identificador" => "aff0125" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Guías de práctica clínica para la atención del embarazo en mujeres con enfermedades reumáticas autoinmunes del Colegio Mexicano de Reumatología. Parte I" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1919 "Ancho" => 3173 "Tamanyo" => 177076 ] ] "descripcion" => array:1 [ "en" => "Algorithm of treatment of patients with systemic lupus erythematosus." ] ] ] "textoCompleto" => "Autoimmune diseases develop more frequently in women in reproductive stage; thus, during pregnancy their development is potentially frequent. Pregnancy requires the interaction of endocrine and immune mechanisms, which facilitate maternal and foetal communication, regulate implantation, foster placental growth and prevent immune rejection of the semialogenic foetus.<a class="elsevierStyleCrossRef" href="#bib0335">1</a> These changes can affect the clinical course of autoimmune diseases and they can in turn have an influence on the maternal and foetal outcome, so these are considered high-risk pregnancies.<a class="elsevierStyleCrossRef" href="#bib0340">2</a> The type and frequency of maternal and foetal complications vary with each autoimmune disease.<a class="elsevierStyleCrossRef" href="#bib0340">2</a> However, in general terms, the risk of an adverse maternal and foetal outcome can be reduced when the pregnancy is planned, especially when the disease is controlled and minimal risk medications can be used during gestation. Thus, a multidisciplinary team that participates in the health care process of this group of patients and contributes to the improvement of the maternal and foetal outcome is required.Pregnancy in women with autoimmune rheumatic disease, especially in women with systemic lupus erythematosus (SLE), means a significant challenge for the physicians in charge of the health care process of this group of patients. Knowledge about the security of medications, the effect of pregnancy on the disease, the effect of the disease on pregnancy, preconception advice and the participation of a multidisciplinary team are cornerstones for the provision of effective and safe medical and obstetrical attention. A planned pregnancy associated to close obstetric surveillance during the entire pregnancy and the puerperium increase the probability of favourable outcomes in the mother-son pairing.The development of a clinical practice guideline (CPG) for pregnancy and autoimmune rheumatic diseases derives from the need to provide recommendations supported by the best scientific evidence available to the health care professional in charge of this group of patients, aiming at minimizing the frequency of maternal and foetal complications. In this first part of the CPG, its development and methodology as well as the recommendations for women with SLE are shown.Extent and Objectives<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005">•To provide recommendations about prenatal control, the most effective treatment and follow-up of pregnant women with SLE, rheumatoid arthritis (RA) and antiphospholipid antibody syndrome (APS).</li><li class="elsevierStyleListItem" id="lsti0010">•To prevent the main maternal and foetal complications in women with autoimmune rheumatic diseases.</li><li class="elsevierStyleListItem" id="lsti0015">•To identify and reduce the risk of foetal adverse reactions and events related to the use of antirheumatic drugs in women with autoimmune rheumatic diseases.</li></ul>Potential UsersThis guideline is targeted to rheumatologists, OB/GYNs, internists and neonatologists.Target PopulationWomen ≥18 years old with an established diagnosis of SLE, RA and APS.Attention LevelSecond and third attention level. The use of this guideline will improve the efficacy, security and quality of the medical attention provided to the target population.MethodologyThe methodology used in the preparation of the document included the establishment of nominal groups of experts, development of formal consensus, search for systematized information, elaboration of clinical questions, elaboration and qualification of recommendations, internal validation phase by pairs and external validation of the final document. During the elaboration of the guideline, the quality criteria of AGREE II<a class="elsevierStyleCrossRef" href="#bib0345">3</a> instrument were considered.Working Group. For the establishment of the working group, 30 rheumatologists who are members of the Colegio Mexicano de Reumatología (Mexican College of Rheumatology) where invited and 2 of them rejected the invitation to participate. The selection process considered the professional background of the experts, their clinical judgement, the geographical diversity (with reasonable representation of the different states of the country), their belonging to the main health institutions in the country, including second and third attention level institutions, knowledge and command of the subject, representation per gender, with a men-women balance in the working tables, as well as training in the development of CPG with evidence-based medicine methodology. Given the importance of creating a multi and interdisciplinary working group, apart from the presence of rheumatologists, the collaboration of other specialists was requested so as to obtain their opinion to help improve the disease treatment or the methodology of recommendations elaboration. Finally, the group was made up of 23 rheumatologists, 2 internists, one paediatric neonatologist and 2 OB/GYNs. Once all the members of the working group were selected, and upon their agreement to participate in the project, a nominal group meeting was convened. In this meeting, a theoretical explanation of the CPG working methodology was carried out and a debate was opened to define the title, extent, objectives and users of the guideline; the leaders of each working table were appointed. In the working group training, the development of the PICO (patient, intervention, comparator and outcome or result) clinical questions, CPG elaboration and adaptation, evidence and recommendations elaboration and qualification as well as search protocol procedures were addressed. The working groups reviewed the following subjects: (1) SLE I (maternal morbidity), (2) SLE II (foetal morbidity), (3) RA, (4) APS, and (5) use of antirheumatic drugs during pregnancy and breastfeeding.Development of RecommendationsThe recommendations developed in this document are general in nature and based on the best scientific evidence available at the moment of their development; they pretend to be a useful tool to accelerate the decision-making during the health care process of the pregnant patient with SLE, RA and APS. In this way, the recommendations established herein do not define a unique course of behaviour in a procedure or treatment; thus, when applied in practice, they could exhibit justified variations based on the clinical judgement of the person using them as reference, as well as on the specific needs and preferences of each patient in particular, the resources available at the time of attention and the regulation established by each institution or practice area.Systematic Search. The systematic search for information was focused on CPG and on primary and secondary studies about SLE, RA, primary APS and antirheumatic drugs during pregnancy and breastfeeding.The CPG search was carried out in web sites belonging to entities in charge of the elaboration and compilation of CPG. Below, there is a table that shows the web sites consulted for the preparation of this guideline (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>).<elsevierMultimedia ident="tbl0005"></elsevierMultimedia>As no CPG addressed clinical questions related to potential pregnancies during the course of the 3 target rheumatic diseases, it was not possible to develop the guideline through the adaptation process. For that reason, we proceeded with the de novo elaboration, and carried out a search for primary and secondary studies in Pubmed, Tripdatabase and the Cochrane library, based on the following inclusion criteria:<ul class="elsevierStyleList" id="lis0010"><li class="elsevierStyleListItem" id="lsti0020">•Documents written in English and Spanish.</li><li class="elsevierStyleListItem" id="lsti0025">•Documents published during the last 5 years (recommended range) or, in case of scarce or null information, documents published during the last 10 years (extended range).</li><li class="elsevierStyleListItem" id="lsti0030">•Documents focused on treatment.</li></ul>The bibliographical search was carried out during June 2013 and the terms MeSH Lupus Erythematosus, Systemic AND pregnancy were employed. The search protocol used was: (“Lupus Erythematosus, Systemic/complications”[Mesh] OR “Lupus Erythematosus, Systemic/congenital”[Mesh] OR “Lupus Erythematosus, Systemic/drug therapy”[Mesh] OR “Lupus Erythematosus, Systemic/mortality”[Mesh] OR “Lupus Erythematosus, Systemic/pharmacology”[Mesh] OR “Lupus Erythematosus, Systemic/prevention and control”[Mesh] OR “Lupus Erythematosus, Systemic/therapy”[Mesh]) AND (“pregnancy”[MeSH Terms] OR “pregnancy”[All Fields]) AND ((Clinical Trial[ptyp] OR Comparative Study[ptyp] OR Consensus Development Conference, NIH[ptyp] OR Controlled Clinical Trial[ptyp] OR Guideline[ptyp] OR Meta-Analysis[ptyp] OR Multicenter Study[ptyp] OR Observational Study[ptyp] OR Practice Guideline[ptyp] OR Randomized Controlled Trial[ptyp] OR Review[ptyp] OR systematic[sb]) AND “2004/04/27”[PDat]: “2013/09/24”[PDat] AND “humans”[MeSH Terms] AND (Spanish[lang] OR English[lang])). 110 results were found.The bibliographical search for RA employed the MeSH terms: Arthritis, Rheumatoid AND pregnancy. The search protocol used was: (“Arthritis, Rheumatoid/complications”[Mesh] OR “Arthritis, Rheumatoid/congenital”[Mesh] OR “Arthritis, Rheumatoid/drug therapy”[Mesh] OR “Arthritis, Rheumatoid/embryology”[Mesh] OR “Arthritis, Rheumatoid/mortality”[Mesh] OR “Arthritis, Rheumatoid/prevention and control”[Mesh] OR “Arthritis, Rheumatoid/therapy”[Mesh]) AND (“pregnancy”[MeSH Terms] OR “pregnancy”[All Fields]) AND ((Clinical Trial[ptyp] OR Comparative Study[ptyp] OR Controlled Clinical Trial[ptyp] OR Guideline[ptyp] OR Multicenter Study[ptyp] OR Observational Study[ptyp] OR Practice Guideline[ptyp] OR Randomized Controlled Trial[ptyp] OR Review[ptyp] OR systematic[sb]) AND “2004/04/27”[PDat]: “2013/09/24”[PDat] AND “humans”[MeSH Terms] AND (English[lang] OR Spanish[lang])). 51 results were found.The bibliographical search for APS used the MeSH terms: Antiphospholipid Syndrome AND pregnancy. The search protocol used was: (“Antiphospholipid Syndrome/complications”[Mesh] OR “Antiphospholipid Syndrome/congenital”[Mesh] OR “Antiphospholipid Syndrome/drug therapy”[Mesh] OR “Antiphospholipid Syndrome/embryology”[Mesh] OR “Antiphospholipid Syndrome/genetics”[Mesh] OR “Antiphospholipid Syndrome/mortality”[Mesh] OR “Antiphospholipid Syndrome/prevention and control”[Mesh] OR “Antiphospholipid Syndrome/therapy”[Mesh]) AND (“pregnancy”[MeSH Terms] OR “pregnancy”[All Fields]) AND ((Clinical Trial[ptyp] OR Comparative Study[ptyp] OR Controlled Clinical Trial[ptyp] OR Guideline[ptyp] OR Meta-Analysis[ptyp] OR Multicenter Study[ptyp] OR Observational Study[ptyp] OR Practice Guideline[ptyp] OR Review[ptyp] OR systematic[sb]) AND “2004/04/27”[PDat]: “2013/09/24”[PDat] AND “humans”[MeSH Terms] AND (English[lang] OR Spanish[lang])). 246 results were found.The search protocol related to antirheumatic drugs security in women with autoimmune rheumatic diseases was as follow: (“antirheumatic agents”[Pharmacological Action] OR “antirheumatic agents”[MeSH Terms] OR (“antirheumatic”[All Fields] AND “agents”[All Fields]) OR “antirheumatic agents”[All Fields] OR (“antirheumatic”[All Fields] AND “drugs”[All Fields]) OR “antirheumatic drugs”[All Fields]) AND (autoimmune[All Fields] AND (“rheumatic diseases”[MeSH Terms] OR (“rheumatic”[All Fields] AND “diseases”[All Fields]) OR “rheumatic diseases”[All Fields])) AND ((Clinical Trial[ptyp] OR Comparative Study[ptyp] OR Controlled Clinical Trial[ptyp] OR Meta-Analysis[ptyp] OR Multicenter Study[ptyp] OR Observational Study[ptyp] OR systematic[sb]) AND “2004/04/27”[PDat]: “2013/09/24”[PDat] AND “humans”[MeSH Terms] AND (English[lang] OR Spanish[lang])). 96 results were found. Out of the 503 articles obtained in the search protocols, 346 articles were excluded based on the reading of their titles and abstracts, as they did not comply with the objectives of the questions raised in this guideline.Upon the search for information, a total of 157 articles were selected for the elaboration of the document. The articles were referred to the experts’ panel for their critical reading and assessment of the evidence degree. For the grading of level of evidence, Shekelle et al.<a class="elsevierStyleCrossRef" href="#bib0350">4</a> Classification System was employed. This classification lets us estimate the strength of the recommendations and assess the evidence quality based on the best design to answer the question (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). The aspects considered significant by the editorial team of the guideline because they make up an area lacking conclusive evidence or because they are specially relevant clinical aspects, were marked with the sign (√) and received the consideration of good practice point (GPP) or opinion based on clinical experience and reached through consensus.<elsevierMultimedia ident="tbl0010"></elsevierMultimedia>Validation method: Clinical pairs.Update period: This guideline shall be updated when there is evidence supporting its update or, if previously scheduled, 3–5 years after its release.Questions IncludedSystemic Lupus Erythematosus<ul class="elsevierStyleList" id="lis0015"><li class="elsevierStyleListItem" id="lsti0035">1.In women with SLE, which are the safest contraceptive options?</li><li class="elsevierStyleListItem" id="lsti0040">2.In women with SLE, what actions shall be implemented during the preconception period?</li><li class="elsevierStyleListItem" id="lsti0045">3.In pregnant women with SLE, what are the frequency and risk factors of disease relapse?</li><li class="elsevierStyleListItem" id="lsti0050">4.In pregnant women with SLE, what are the frequency and risk factors to develop preeclampsia/eclampsia?</li><li class="elsevierStyleListItem" id="lsti0055">5.In pregnant women with SLE, which are the most effective treatment options to prevent and treat disease reactivation?</li><li class="elsevierStyleListItem" id="lsti0060">6.In pregnant women with SLE, what are the frequency and risk factors associated to foetal loss?</li><li class="elsevierStyleListItem" id="lsti0065">7.In pregnant women with SLE, what are the frequency and risk factors associated to preterm birth?</li><li class="elsevierStyleListItem" id="lsti0070">8.In foetus of pregnant women with SLE, what are the frequency and risk factors associated to low birth weight/intrauterine growth restriction/small for gestational age?</li><li class="elsevierStyleListItem" id="lsti0075">9.In women with SLE, how is the follow-up during pregnancy and immediate puerperium carried out?</li><li class="elsevierStyleListItem" id="lsti0080">10.In foetus of women with positive anti-Ro and/or anti-La antibodies, what are the most effective prevention and treatment options for the management of congenital heart block (CHB)?</li></ul>Rheumatoid Arthritis<ul class="elsevierStyleList" id="lis0020"><li class="elsevierStyleListItem" id="lsti0085">11.In women with RA, which is the disease effect and treatment regarding fertility and fecundity?</li><li class="elsevierStyleListItem" id="lsti0090">12.In women with RA, which are the most effective contraceptive options?</li><li class="elsevierStyleListItem" id="lsti0095">13.In women with RA, which are the safest contraceptive options?</li><li class="elsevierStyleListItem" id="lsti0100">14.In women with RA, which is the disease improvement or relapse frequency during pregnancy and puerperium?</li><li class="elsevierStyleListItem" id="lsti0105">15.In women with RA, which are the factors associated with the disease improvement or relapse during pregnancy and puerperium?</li><li class="elsevierStyleListItem" id="lsti0110">16.In pregnant women with RA, which is the best instrument to assess the disease activity?</li><li class="elsevierStyleListItem" id="lsti0115">17.In pregnant women with RA, what is the gestation effect on the clinical instruments of functional assessment?</li><li class="elsevierStyleListItem" id="lsti0120">18.In pregnant women with RA, what is the effect of antibodies (rheumatoid factor and anti-cyclic citrullinated peptide antibodies) on the disease activity?</li><li class="elsevierStyleListItem" id="lsti0125">19.In pregnant women with RA, which is the influence of the disease activity on the foetal outcome?</li><li class="elsevierStyleListItem" id="lsti0130">20.In pregnant women with RA, which are the safest treatment options to manage a reactivation of the disease?</li><li class="elsevierStyleListItem" id="lsti0135">21.In breastfeeding women with RA, which is the effect on the disease activity?</li></ul>Antiphospholipid Antibody Syndrome<ul class="elsevierStyleList" id="lis0025"><li class="elsevierStyleListItem" id="lsti0140">22.In women with APS, which are the safest contraceptive options?</li><li class="elsevierStyleListItem" id="lsti0145">23.In women with APS, which are the actions and procedures that should be implemented during the prenatal control?</li><li class="elsevierStyleListItem" id="lsti0150">24.In pregnant women with APS, what are the risk factors for the development of preeclampsia?</li><li class="elsevierStyleListItem" id="lsti0155">25.In pregnant women with APS, with a history of 3 or more miscarriages (≤10 weeks of gestations [WOG]) and without previous history of thrombosis, what are the most efficient treatment options?</li><li class="elsevierStyleListItem" id="lsti0160">26.In pregnant women with APS, with a history of at least one foetal death (>10WOG) or preterm birth (<34WOG) due to severe preeclampsia or placental insufficiency without previous history of thrombosis, what are the most efficient treatment options?</li><li class="elsevierStyleListItem" id="lsti0165">27.In pregnant women with APS with previous history of thrombosis, regardless of her obstetric history, what are the most efficient treatment options?</li><li class="elsevierStyleListItem" id="lsti0170">28.In pregnant women with APS, what is the influence of antiphospholipid antibodies in the clinical course and in the therapeutic decision?</li><li class="elsevierStyleListItem" id="lsti0175">29.In women with APS, what are the most efficient treatment options during puerperium?</li><li class="elsevierStyleListItem" id="lsti0180">30.In women with APS, which are the safest peripartum or peri-caesarean treatment options?</li><li class="elsevierStyleListItem" id="lsti0185">31.In children of women with APS, which are the actions and procedures that should be implemented during the neonatal follow-up?</li></ul>Antirheumatic Drugs<ul class="elsevierStyleList" id="lis0030"><li class="elsevierStyleListItem" id="lsti0190">32.In pregnant women with autoimmune disease, what is the risk of foetal exposure to non-steroidal anti-inflammatory drugs or analgesics (NSAIDs)?</li><li class="elsevierStyleListItem" id="lsti0195">33.In pregnant women with autoimmune disease, what is the maternal and foetal risk of glucocorticoids exposure for disease treatment?</li><li class="elsevierStyleListItem" id="lsti0200">34.In pregnant women with autoimmune disease, what is the foetal risk of exposure to antimalarial medication, azathioprine, sulfasalazine, cyclosporine A, leflunomide, mycophenolate mofetil, cyclophosphamide and methotrexate?</li><li class="elsevierStyleListItem" id="lsti0205">35.In pregnant women with autoimmune disease, what is the foetal risk of exposure to biological drugs (anti-TNF, rituximab and others)?</li><li class="elsevierStyleListItem" id="lsti0210">36.In pregnant women with autoimmune disease during the breastfeeding period, what are the antirheumatic drugs that can be most safely employed?</li><li class="elsevierStyleListItem" id="lsti0215">37.In pregnant women with autoimmune disease, what is the risk of foetal exposure to oral anticoagulants and heparin?</li></ul>Systemic Lupus ErythematosusSLE is a multisystemic autoimmune disease of unknown cause, characterized by the production of diverse antibodies that affects mainly women in reproductive stage with normally conserved fertility.<a class="elsevierStyleCrossRef" href="#bib0355">5</a>Maternal Morbidity1. In Women With Systemic Lupus Erythematosus, What Are the Safest Contraceptive Options?The use of triphase oral contraceptives (ethinyl estradiol plus norethindrone) is not associated to the reactivation risk (assessed by SELENA-SLEDAI) of SLE and it does not increase the risk of known adverse events associated to its intake in healthy women<a class="elsevierStyleCrossRef" href="#bib0360">6</a> [LOE Ib]. The use of combined oral contraceptives, progestogens alone and non-hormonal intrauterine devices does not increase the risk of aggravating the disease activity (assessed by SLEDAI) in patients with mild to moderate SLE; this has only been assessed in women without previous episodes of thrombosis<a class="elsevierStyleCrossRef" href="#bib0365">7</a> [LOE Ib]. Contraception with cyproterone acetate (50mg) and clormadinone (5mg) is well tolerated and effective as contraceptive method in patients with mild, moderate or severe SLE<a class="elsevierStyleCrossRef" href="#bib0370">8</a> [LOE III]. Triphase oral contraceptives and non-combined progestogens can be used in patients with SLE, as their use does not increase the disease activity or the risk of adverse events, especially episodes of thrombosis<a class="elsevierStyleCrossRefs" href="#bib0360">6,7</a> [GR A]. The use of triphase oral contraceptives and non-combined progestogens is not recommended in patients with previous history of thrombosis and/or pre-existing cardiovascular risk factors, neither is it recommended in patients with SLE with associated antiphospholipid antibodies and/or APS<a class="elsevierStyleCrossRefs" href="#bib0360">6,7</a> [GR A].Contraception with progestogens (through different routes of administration) is safe and effective for all kind of patients with SLE at different activity degrees, and it can be administered in patients with positive antiphospholipid antibodies<a class="elsevierStyleCrossRefs" href="#bib0370">8,9</a> [GR C]. The intrauterine device with progestogens is safe and effective when a long-term (at least 5 years) contraceptive method is desired in women with SLE<a class="elsevierStyleCrossRef" href="#bib0375">9</a> [GR C]. Emergency contraception based on progestogens is safe in women with SLE<a class="elsevierStyleCrossRef" href="#bib0375">9</a> [GR C]. Combined barrier contraceptive methods (condoms and spermicide) can be used in patients with SLE; however, their low efficiency as contraceptive method must be considered.<a class="elsevierStyleCrossRef" href="#bib0375">9</a> The definitive (surgical) contraceptive method is safe and effective; in patients with SLE, its use is recommended in those subjects with satisfied parity<a class="elsevierStyleCrossRef" href="#bib0375">9</a> [GR C].<ul class="elsevierStyleList" id="lis0035"><li class="elsevierStyleListItem" id="lsti0220">•Physicians who provide health care to women with SLE must provide advice on contraception in a personalized way to all fertile women (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>) [GPP].<elsevierMultimedia ident="fig0005"></elsevierMultimedia></li></ul>2. In Women With Systemic Lupus Erythematosus, What Are the Actions to Implement During the Preconception Period?Pregnancy in patients with SLE, compared to the general population, is a high-risk pregnancy due to an elevated complication rate and maternal mortality rate<a class="elsevierStyleCrossRefs" href="#bib0380">10,11</a> [LOE III/IV]. The frequency of maternal and foetal complications during pregnancy of women with SLE is higher in unplanned pregnancies<a class="elsevierStyleCrossRef" href="#bib0390">12</a> [LOE III]. Ideally, pregnancy in patients with SLE must be a planned event and there must be close preconception medical surveillance customized for each patient<a class="elsevierStyleCrossRefs" href="#bib0390">12,13</a> [GR C/D].The primary objective of preconception control in patients with SLE that want to be pregnant is to make the patients achieve disease remission at least 6 months before allowing pregnancy<a class="elsevierStyleCrossRef" href="#bib0395">13</a> [LOE IV]. Pregnancy is not recommended in patients with SLE who have received teratogenic drugs during the last 6 months (depending on each drug and assessing the risk-benefit ratio of its use) [GR D]. It is suggested for women with SLE that plan to become pregnant to have antiphospholipid, anti-DNAdc and anti-SSA/Ro and anti-SSB/La antibodies determinations done as part of the preconception assessment<a class="elsevierStyleCrossRef" href="#bib0400">14</a> [GR D]. Pregnancy in women with SLE must be planned, monitored and considered high-risk in all cases<a class="elsevierStyleCrossRefs" href="#bib0385">11,13</a> [GR D]. Pregnancy in patients with SLE is contraindicated in women with severe pulmonary hypertension, restrictive pulmonary disease, heart failure, chronic renal failure (creatinine >2.8mg/dl), history of severe preeclampsia or HELLP syndrome (microangiopaty characterized by haemolytic anaemia, elevation of hepatic enzymes and thrombocytopenia), brain vascular event within the previous 6 months and severe SLE relapse during the last 6 months [GR D]. All fertile patients with SLE must receive medical advice (including the patient and her family) from the rheumatologist and the OB/GYN during the preconception period.<ul class="elsevierStyleList" id="lis0040"><li class="elsevierStyleListItem" id="lsti0225">•If the patient is pregnant and active when she arrives to the physician's office, the reactivation must be immediately treated and she must be informed about the high risk of developing maternal and foetal complications [GPP].</li></ul>3. In Pregnant Women With Systemic Lupus Erythematosus, What Are the Frequency and Risk Factors of DiseaseIn a prospective study on pregnant women with SLE compared to a control group (non-pregnant women), disease exacerbation was reported in 65% of the pregnant women vs 42% of the control group (P=.015)<a class="elsevierStyleCrossRef" href="#bib0405">15</a> [LOE IIa]. At least 3 prospective studies show that pregnant women with SLE have a higher rate of disease relapse (between 58 and 65%) compared to non-pregnant women with SLE<a class="elsevierStyleCrossRefs" href="#bib0405">15–17</a> [LOE IIa]. At least 4 prospective studies on women with SLE showed a disease relapse rate of 27%–70% and it was not higher when compared to non-pregnant women with SLE<a class="elsevierStyleCrossRefs" href="#bib0420">18–21</a> [LOE IIa/IIb]. A SLE activity rate of 1.2 people/year in pregnant women vs 0.4 people/year in non-pregnant women (P<.0001) has been reported<a class="elsevierStyleCrossRef" href="#bib0440">22</a> [LOE IIb]. A prospective study reported as risk factors of SLE activity during pregnancy: an elevated number of disease relapses before pregnancy (P<.05), the discontinuation of chloroquine during pregnancy (P<.05) and a high SLEDAI rate (>5) before pregnancy.<a class="elsevierStyleCrossRef" href="#bib0440">22</a> In a retrospective study, it was observed that disease reactivation in patients with SLE is more frequent during pregnancy (36.5%±3.3%)<a class="elsevierStyleCrossRef" href="#bib0445">23</a> [LOE III]. In women with SLE, pregnancy increases the risk of thrombotic events (brain vascular disease, brain thromboembolism and deep venous thrombosis), severe infections and thrombocytopenia<a class="elsevierStyleCrossRef" href="#bib0380">10</a> [LOE III]. Pregnancy in patients with pre-existing lupus nephropathy increases the activity of renal disease (assessed by SELENA 2K); 47.5 vs 13.4% (P=.0001)<a class="elsevierStyleCrossRef" href="#bib0450">24</a> [LOE III]. Pregnant patients with previous lupus nephritis have a greater risk of renal activity in any organ, compared to those patients that never had a renal condition (54.2 vs 25%; P=.004 and 45.7 vs 6.6%; P=.00001)<a class="elsevierStyleCrossRef" href="#bib0455">25</a> [LOE III]. The following are risk factors of disease relapse in pregnant patients with SLE: active disease within 6 months before conception, multiple exacerbations before conception, treatment interruption during pregnancy and comorbidities<a class="elsevierStyleCrossRef" href="#bib0460">26</a> [LOE IV]. The most frequent clinical manifestations of activity during pregnancy are: mucocutaneous (25%–90%), haematological (10%–40%), articular (20%) and renal (4%–30%)<a class="elsevierStyleCrossRefs" href="#bib0405">15,16,26</a> [LOE IIa]. Close medical surveillance and communication among a multidisciplinary team is recommended, as there is a high risk of disease relapse during pregnancy and immediate puerperium, especially in patients with previous lupus nephritis [GR C/D].<ul class="elsevierStyleList" id="lis0045"><li class="elsevierStyleListItem" id="lsti0230">•Pregnant women with SLE should not abandon treatment [GPP].</li></ul>4. In Pregnant Women With Systemic Lupus Erythematosus, What Are the Frequency and Risks Factors to Develop Preeclampsia/eclampsia?As reported in a meta-analysis, the frequency of preeclampsia in patients with SLE is 7.6%, and 0.8% in the case of eclampsia. Moreover, the presence of active renal condition during pregnancy is a risk factor for the development of preeclampsia but not of eclampsia<a class="elsevierStyleCrossRef" href="#bib0465">27</a> [LOE Ia]. A multicentre study from the USA reported a frequency of 22.5% of preeclampsia and 0.5% of eclampsia in pregnant patients with SLE (OR: 3 and 4.4 respectively, 95% CI, P<.001)<a class="elsevierStyleCrossRef" href="#bib0380">10</a> [LOE III]. A prevalence study of HELLP syndrome in an open population and in patients with SLE reported a frequency of severe preeclampsia in pregnant patients with SLE of 10%–20% and of HELLP syndrome of 0.5%–0.9%<a class="elsevierStyleCrossRef" href="#bib0470">28</a> [LOE III]. A retrospective study that included pregnant women with SLE (with and without previous renal condition) reported a preeclampsia frequency of 22.8% in patients with previous renal activity vs 13.3% in patients without it (P=0.2)<a class="elsevierStyleCrossRef" href="#bib0455">25</a> [LOE III]. Risk factors for the development of preeclampsia/eclampsia described in pregnant patients with SLE are history of histologic class (WHO) iii and iv lupus nephritis, history of preeclampsia and HELLP syndrome, pre-existing high blood pressure, presence of antiphospholipid antibodies and active SLE<a class="elsevierStyleCrossRef" href="#bib0475">29</a> [LOE IV]. Preeclampsia generally occurs as from 20 weeks of gestation, with increased levels of uric acid, normal C3 and C4, and normal double-chain anti-DNA antibodies. In active lupus nephropathy there is hypocomplementemia, elevated anti-DNAdc, normal or increased levels of uric acid and active urinary sediment, and it occurs at any time during gestation<a class="elsevierStyleCrossRefs" href="#bib0395">13,20</a> [LOE IV]. A differential diagnosis between lupus nephropathy and preeclampsia shall be performed in pregnant patients with SLE [GR D]. It should be considered that pregnant patients with SLE have a high risk of preeclampsia development; thus, minimum blood pressure elevations and fluctuations ranging from normal or low blood pressure to mild elevations can be symptoms of the beginning of preeclampsia. Young women or women over 35 years old, primigravida and with history of lupus and/or active nephropathy at the beginning of pregnancy are patients with the highest risk.<a class="elsevierStyleCrossRef" href="#bib0480">30</a>Two meta-analysis showed that early administration (≤16 WOG) of low daily doses of aspirin (50–150mg) reduces the risk of developing severe preeclampsia (RR: 0.22; 95% CI: 0.08–0.57) or preeclampsia (RR: 0.47; 95% CI: 0.36–0.62) in women at risk of developing it<a class="elsevierStyleCrossRefs" href="#bib0485">31,32</a> [LOE Ia]. If there is no contraindication, the use of low doses of aspirin is recommended for all pregnant women with SLE to reduce the risk of preeclampsia development<a class="elsevierStyleCrossRefs" href="#bib0485">31,32</a> [GR A].5. In Pregnant Women With Systemic Lupus Erythematosus, What Are the Most Efficient Treatment Options to Prevent and Treat Disease Reactivation?A prospective placebo-controlled study that included pregnant patients with SLE showed that hydroxychloroquine reduces the risk of exacerbations but does not have an influence on foetal outcome<a class="elsevierStyleCrossRef" href="#bib0495">33</a> [LOE Ib]. Hydroxychloroquine discontinuation during pregnancy increases the risk of SLE activity, including severe exacerbations such as severe urine protein and thrombocytopenia<a class="elsevierStyleCrossRef" href="#bib0500">34</a> [LOE IIa]. The use of hydroxychloroquine is recommended to prevent SLE relapses during pregnancy<a class="elsevierStyleCrossRef" href="#bib0495">33</a> [GR A].A prospective study in pregnant patients with SLE concluded that the use of low doses of prednisone does not prevent disease relapses<a class="elsevierStyleCrossRef" href="#bib0405">15</a> [LOE IIb]. The use of prednisone at doses higher than 20mg/d in pregnant patients with SLE increases the risk of preeclampsia and gestational diabetes<a class="elsevierStyleCrossRef" href="#bib0505">35</a> [LOE IV]. The use of non-fluorinated glucocorticoids in pregnant patients with SLE is recommended to treat moderate to severe activity<a class="elsevierStyleCrossRef" href="#bib0460">26</a> [GR D].Non-steroidal anti-inflammatory drugs (e.g., naproxene, ibuprofen and indomethacin) can be used during pregnancy for the control of joint manifestations; its use shall be avoided only in the third trimester to prevent foetal complications, especially the early closure of ductus arteriosus<a class="elsevierStyleCrossRef" href="#bib0395">13</a> [GR D]. Azathioprine can be used during pregnancy in patients with SLE, in case of moderate to severe activity before pregnancy (continue the administration if it was administered before pregnancy or start administration during pregnancy, as necessary)<a class="elsevierStyleCrossRef" href="#bib0505">35</a> [GR D]. Treatment with azathioprine should be continued in pregnant patients with SLE that received it before pregnancy, and patients taking mycophenolate mofetil or other immunosuppressant who want to become pregnant should switch to azathioprine administration (before pregnancy)<a class="elsevierStyleCrossRef" href="#bib0505">35</a> [GR D]. The use of methotrexate and leflunomide is completely contraindicated during pregnancy<a class="elsevierStyleCrossRef" href="#bib0460">26</a> [GR D]. In a number of cases of pregnant patients with SLE exposed to cyclophosphamide during the first or second gestation trimester, foetal loss was reported in 100% of the cases<a class="elsevierStyleCrossRef" href="#bib0510">36</a> [LOE IV]. The use of mycophenolate mofetil and cyclophosphamide in pregnant patients with SLE shall be reserved only for severe activity cases that threaten the mother's life. It is essential to report the potential teratogenic effects in the foetus or to consider the pregnancy therapeutic discontinuation<a class="elsevierStyleCrossRef" href="#bib0460">26</a> [GR D]. The use of intravenous (iv) gammaglobulin during the pregnancy of patients with SLE is safe and effective and represents a treatment option for those patients with recurrent foetal losses<a class="elsevierStyleCrossRef" href="#bib0515">37</a> [LOE III]. There are no studies that analyze the security of the use of biological medications in pregnant patients with SLE, and the scarce information available derives from case reports; thus, these medications shall not be used during pregnancy and must be discontinued in case of accidental exposure<a class="elsevierStyleCrossRef" href="#bib0520">38</a> [GR C]. It is advisable for patients with SLE that become pregnant to continue the treatment administered before pregnancy, provided that it does not include completely contraindicated drugs during pregnancy.<a class="elsevierStyleCrossRef" href="#bib0405">15</a> It is necessary to personalize the SLE activity treatment during pregnancy, considering the activity seriousness and the potential adverse events on the foetus<a class="elsevierStyleCrossRefs" href="#bib0505">35,38</a> [GR D].<ul class="elsevierStyleList" id="lis0050"><li class="elsevierStyleListItem" id="lsti0235">•It should be noted that most SLE reactivation cases during pregnancy and the postpartum period are mild to moderate in intensity, so the use of metilprednisolone pulses should be avoided, except in high-risk life-threatening situations [GPP].</li></ul>Foetal Morbidity6. In Pregnant Women With Systemic Lupus Erythematosus, What Are the Frequency and Risk Factors Associated to Foetal Loss?In women with lupus nephritis, a frequency of 16% of spontaneous abortions, 3.6% of deaths and 2.5% of neonatal deaths has been reported<a class="elsevierStyleCrossRef" href="#bib0465">27</a> [LOE Ia]. In a prospective study in pregnant women with SLE, it was found that the frequency of spontaneous abortions was 14% and of foetal death was 12%<a class="elsevierStyleCrossRef" href="#bib0440">22</a> [LOE IIb]. Hypocomplementemia (P<.05), high blood pressure at conception (P>.001) and antiphospholipid antibodies (P<.05) are foetal loss predictors in pregnant women with SLE<a class="elsevierStyleCrossRef" href="#bib0440">22</a> [LOE IIb]. SLE activity within 6 months before conception has been associated to foetal loss in 42% of cases<a class="elsevierStyleCrossRef" href="#bib0510">36</a> [LOE IIb]. The disease clinical activity associated to hypocomplementemia and elevated anti-DNAdc antibodies titles are associated to foetal loss in pregnant women with SLE<a class="elsevierStyleCrossRef" href="#bib0485">31</a> [LOE IIb]. Pregnancy is not recommended in women with active lupus nephritis<a class="elsevierStyleCrossRef" href="#bib0465">27</a> [GR A]. SLE activity during pregnancy must be eventually identified and treated to reduce the risk of adverse foetal outcome (foetal loss, prematurity and intrauterine growth restriction)<a class="elsevierStyleCrossRefs" href="#bib0525">39,40</a> [GR B/C]. Patients with SLE are recommended to have an adequate disease control at least as from 6 months before pregnancy planning<a class="elsevierStyleCrossRef" href="#bib0510">36</a> [GR B].Associated APS is a foetal loss (risk 3.1 times higher) and spontaneous abortion (risk 5 times higher) predictor. Thrombocytopenia during the first trimester is associated to foetal loss (risk 3.3 times higher)<a class="elsevierStyleCrossRef" href="#bib0535">41</a> [LOE IIb]. High blood pressure during the first trimester of gestation is associated to foetal loss (risk 2.4 times higher) and death (risk 3.4 times higher)<a class="elsevierStyleCrossRef" href="#bib0535">41</a> [LOE IIb]. Chronic systemic high blood pressure (before pregnancy or acquired in the first trimester) shall be controlled to reduce the risk of adverse foetal outcome (foetal loss, prematurity and intrauterine growth restriction)<a class="elsevierStyleCrossRefs" href="#bib0440">22,40–42</a> [GR B/C].Hypocomplementemia and urine protein >1g/24h are foetal loss predictors in women with lupus nephritis<a class="elsevierStyleCrossRef" href="#bib0545">43</a> [LOE IIb]. Lupus nephritis (OR: 7.3), anticardiolipine antibodies (OR: 3.9) and disease activity during pregnancy (OR: 1.9) are foetal loss predictors<a class="elsevierStyleCrossRef" href="#bib0530">40</a> [LOE III]. In women with chronic renal disease, pregnancy can accelerate the renal function deterioration and worsen high blood pressure and urine protein, with a higher risk of maternal mortality and foetal complications (such as intrauterine growth delay)<a class="elsevierStyleCrossRef" href="#bib0550">44</a> [LOE IV]. In women with lupus nephritis, pregnancy can be planned if renal function is normal or presents minimal damage (serum creatinine <1.5mg/dl, creatinine clearance ≥60ml/min, urine protein <1g/24h)<a class="elsevierStyleCrossRefs" href="#bib0545">43,45</a> [GR C].7. In Pregnant Women With Systemic Lupus Erythematosus, What Are the Frequency and Risk Factors Associated to Preterm Birth?The reported frequency of prematurity in foetus of pregnant women with lupus nephritis is 39.4% (95% CI: 32.4–46.4%)<a class="elsevierStyleCrossRef" href="#bib0465">27</a> [LOE Ia]. The clinical activity of the disease along with the presence of hypocomplementemia and elevated high anti-DNAdc antibodies titles is associated to prematurity in foetus of women with SLE<a class="elsevierStyleCrossRef" href="#bib0525">39</a> [LOE IIb]. The measurement of serum complement (C3 and C4) and anti-DNadc antibodies is recommended to identify pregnant women with SLE with foetal loss and prematurity risk<a class="elsevierStyleCrossRef" href="#bib0525">39</a> [GR B].High blood pressure during pregnancy and preeclampsia increase the risk of prematurity in foetus of pregnant women with SLE<a class="elsevierStyleCrossRefs" href="#bib0440">22,42</a> [LOE IIb]. Positive antiphospholipid antibodies (OR: 3.6; 95% CI: 1.5–8.7; P=.004) and active disease at conception (OR: 5.5; 95% CI: 2.3–12.8; P<.0001) increase the risk of prematurity in foetus of women with SLE<a class="elsevierStyleCrossRef" href="#bib0560">46</a> [LOE III]. A retrospective analysis of 396 pregnancies determined that the presence of lupus nephritis (OR: 18.8; 95% CI: 1.5–125.9; P=.02), anti-Ro antibodies (OR: 13.9; 95% CI: 1.0–116.4; P=.04) and disease relapses (OR: 2.4; 95% CI: 1.3–4.5; P=.003) was associated to prematurity in pregnant women with SLE<a class="elsevierStyleCrossRef" href="#bib0530">40</a> [LOE III]. High blood pressure and disease activity control is recommended to reduce prematurity risk in pregnant women with SLE<a class="elsevierStyleCrossRefs" href="#bib0440">22,40,42,46</a> [GR B/C].8. In Foetus of Pregnant Women With Systemic Lupus Erythematosus, What Are the Frequency and Risk Factors Associated to Low Birth Weight/intrauterine Growth Restriction/small for Gestational Age?The reported frequency of intrauterine growth restriction in foetus of pregnant women with lupus nephritis is 12.7% (95% CI: 32.4–46.4%)<a class="elsevierStyleCrossRef" href="#bib0465">27</a> [LOE Ia]. The frequency of low birth weight is higher in foetus of women with lupus nephritis compared to women without the disease (46 vs 20%, P=.01)<a class="elsevierStyleCrossRef" href="#bib0450">24</a> [LOE IIb]. In a prospective study of pregnant women with SLE, intrauterine growth restriction was observed in 35% of cases<a class="elsevierStyleCrossRef" href="#bib0440">22</a> [LOE IIb]. Active disease at conception has been associated to intrauterine growth restriction (OR: 3.2; 95% CI: 1.3–7.6; P<.007)<a class="elsevierStyleCrossRef" href="#bib0560">46</a> [LOE IIb]. A prospective study of 29 pregnancies in women with SLE showed that low serum albumin levels, antiphospholipid antibodies, gestational urine protein, high blood pressure and anti-Sm antibodies were associated to low birth weight<a class="elsevierStyleCrossRef" href="#bib0565">47</a> [LOE IIb]. In women with SLE, urine protein has been associated to small foetus for their gestational age<a class="elsevierStyleCrossRef" href="#bib0570">48</a> [LOE III]. A retrospective analysis of 396 pregnancies in women with SLE determined that the presence of anti-La antibodies (OR: 11.4; 95% CI: 1.1–115.1; P=.03), high blood pressure (OR: 37.7; 95% CI: 3.6–189.7; P=.02), Raynaud's phenomenon (OR: 12.2; 95% CI: 2.1–69.7; P=.005) and disease activity (OR: 4.1; 95% CI: 1.3–13.1; P=.01) were associated to intrauterine growth restriction<a class="elsevierStyleCrossRef" href="#bib0530">40</a> [LOE III].9. In Women With Systemic Lupus Erythematosus, How Is the Follow-up During Pregnancy and Immediate Puerperium Carried out?Pregnancy in women with SLE must be considered a high-risk pregnancy<a class="elsevierStyleCrossRef" href="#bib0380">10</a> [LOE III]. The frequency of complications during pregnancy of women with SLE, such as disease relapse, foetal loss, prematurity and neonatal asphyxiation, is greater when pregnancy is unplanned<a class="elsevierStyleCrossRef" href="#bib0390">12</a> [LOE III]. During the pregnancy of a patient with SLE, the patient must be assessed by the rheumatologist every 4–6 weeks and by the OB/GYN every 4 weeks up to week 20 of gestation, every 2 weeks up to week 28 of gestation and weekly until delivery<a class="elsevierStyleCrossRefs" href="#bib0505">35,49–51</a> [GR D]. At the beginning of pregnancy, C3, C4, CH50, anti-Ro, anti-La, anti-Sm, anti-DNAdc antibodies and anticardiolipine, as well as lupus anticoagulant should be determined<a class="elsevierStyleCrossRefs" href="#bib0395">13,52</a> [GR D]. During the pregnancy of women with SLE, it is recommended to perform a monthly complete blood count, blood biochemistry, serum electrolytes, general urine test, creatinine/urine protein rate, C3, C4, CH50 and anti-DNAdc<a class="elsevierStyleCrossRefs" href="#bib0395">13,52</a> [GR D]. During the pregnancy of women with SLE, it is recommended to perform foetal ultrasounds between week 7 and 13 of gestation and monthly after week 16 of gestation to determine foetal anomalies and monitor the growth<a class="elsevierStyleCrossRef" href="#bib0590">52</a> [GR D]. It is recommended to carry out foetal well-being tests weekly as of week 26 of gestation<a class="elsevierStyleCrossRef" href="#bib0590">52</a> [GR D].10. In Foetus of Women Containing Positive Anti-Ro and/or Anti-La Antibodies, What Are the Most Effective Prevention and Treatment Options for the Management of Congenital Heart Block?Cardiac neonatal lupus risk in children of mothers with anti-Ro antibodies is 2% and with anti-La antibodies is 5%<a class="elsevierStyleCrossRefs" href="#bib0595">53–55</a> [LOE IIb]. CHB recurrence rate associated to anti-Ro antibodies is 17%<a class="elsevierStyleCrossRef" href="#bib0610">56</a> [LOE IIb]. Neonatal cardiac lupus mortality rate is around 20%<a class="elsevierStyleCrossRefs" href="#bib0595">53,57</a> [LOE III]. In pregnant women with positive anti-Ro and/or anti-La antibodies, a foetal echocardiography must be performed weekly from week 16 to week 26 of gestation<a class="elsevierStyleCrossRefs" href="#bib0400">14,52,58</a> [GR D].A multicentre, open, with no randomized selection study did not show any benefits derived from the use of dexametasone to revert third degree CHB or the lack of progression from second to third degree CHB<a class="elsevierStyleCrossRef" href="#bib0625">59</a> [LOE IIb]. A retrospective, multinational, multicentre study in 175 patients did not find significant differences in survival of foetus treated or not with fluorinated glucocorticoids, regardless of the dose, CHB degree and/or presence of anti-RO antibodies<a class="elsevierStyleCrossRef" href="#bib0630">60</a> [LOE III]. The use of fluorinated glucocorticoids is not recommended in foetus with third degree CHB<a class="elsevierStyleCrossRefs" href="#bib0625">59,60</a> [GR C].In a sub-analysis of 2 retrospective studies, with foetus belonging to positive anti-Ro/anti-La mothers, a CHB reversion from second degree to sinusal rhythm or first degree block was found in 35% of the cases exposed to dexametasone, compared to 6.25% of cases not exposed (P=.053)<a class="elsevierStyleCrossRefs" href="#bib0615">57,60</a> [LOE III]. The use of fluorinated glucocorticoids is recommended in foetus with second degree CHB<a class="elsevierStyleCrossRefs" href="#bib0615">57,60</a> [GR C].In 2 prospective, multicentre studies in pregnant women of <12WOG, with positive anti-Ro/anti-La antibodies and at least one previous birth with CHB/neonatal lupus, the use of iv gammaglobulin (400mg/kg) every 3 weeks, from week 12 to 24 of gestation, did not prevent the recurrence of CHB<a class="elsevierStyleCrossRefs" href="#bib0635">61,62</a> [LOE IIb]. The use of gammaglobulin iv is not recommended for the prevention of CHB recurrence in pregnant women with anti-Ro/anti-La antibodies<a class="elsevierStyleCrossRefs" href="#bib0635">61,62</a> [GR B].A retrospective study in 20 patients treated with iv gammaglobulin (1g/kg per 1–3 doses), combined with glucocorticoids, showed 80% of live births with established neonatal cardiac lupus (cardiomyopathy)<a class="elsevierStyleCrossRef" href="#bib0645">63</a> [LOE III]. A report of 2 cases showed second to first degree CHB reversion with the combined use of dexamethasone 4mg/d, iv gammaglobulin (1g/kg every 15d) and weekly plasmapheresis until birth<a class="elsevierStyleCrossRef" href="#bib0650">64</a> [LOE IV]. The use of therapy combined with glucocorticoids, iv gammaglobulin and plasmapheresis creates second and third line interventions to revert second degree CHB<a class="elsevierStyleCrossRef" href="#bib0650">64</a> [GR D].A case control study determined that exposure to hydroxychloroquine during pregnancy in women with SLE and positive anti-Ro/anti-La antibodies can reduce the risk of developing neonatal cardiac lupus (OR: 0.46; 95% CI: 0.18–1.18; P=.10)<a class="elsevierStyleCrossRef" href="#bib0655">65</a> [LOE III]. A retrospective study of 3 cohorts determined that the use of hydroxychloroquine during pregnancy in women with SLE and positive anti-Ro/anti-La antibodies reduces the risk of developing recurrent neonatal cardiac lupus (OR: 0.23; 95% CI: 0.06–0.92; P=.037)<a class="elsevierStyleCrossRef" href="#bib0660">66</a> [LOE III]. It is recommended to continue the use of hydroxychloroquine during pregnancy in women with positive anti-Ro/anti-La antibodies to reduce the risk of developing recurrent neonatal cardiac lupus<a class="elsevierStyleCrossRefs" href="#bib0655">65,66</a> [GR C].Ethical ResponsibilitiesProtection of persons and animalsAuthors state that no experiments were performed on human beings or animals as part of this investigation.Data confidentialityAuthors state that this article does not contain patient data.Right to privacy and informed consentAuthors state that this article does not contain patient data.Conflict of InterestThe Mexican College of Rheumatology received unrestricted educational support from the company UCB. The staff working at UCB had no interference with the information vested herein and did not participate in any meetings of the working group." "textoCompletoSecciones" => array:1 [ "secciones" => array:15 [ 0 => array:3 [ "identificador" => "xres548571" "titulo" => "Abstract" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Background" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Objectives" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Methodology" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Results" ] 4 => array:2 [ "identificador" => "abst0025" "titulo" => "Conclusions" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec566354" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres548570" "titulo" => "Resumen" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0030" "titulo" => "Antecedentes" ] 1 => array:2 [ "identificador" => "abst0035" "titulo" => "Objetivos" ] 2 => array:2 [ "identificador" => "abst0040" "titulo" => "Metodología" ] 3 => array:2 [ "identificador" => "abst0045" "titulo" => "Resultados" ] 4 => array:2 [ "identificador" => "abst0050" "titulo" => "Conclusiones" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec566355" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Extent and Objectives" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Potential Users" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "Target Population" ] 7 => array:2 [ "identificador" => "sec0020" "titulo" => "Attention Level" ] 8 => array:2 [ "identificador" => "sec0025" "titulo" => "Methodology" ] 9 => array:2 [ "identificador" => "sec0030" "titulo" => "Development of Recommendations" ] 10 => array:3 [ "identificador" => "sec0035" "titulo" => "Questions Included" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0040" "titulo" => "Systemic Lupus Erythematosus" ] 1 => array:2 [ "identificador" => "sec0045" "titulo" => "Rheumatoid Arthritis" ] 2 => array:2 [ "identificador" => "sec0050" "titulo" => "Antiphospholipid Antibody Syndrome" ] 3 => array:2 [ "identificador" => "sec0055" "titulo" => "Antirheumatic Drugs" ] ] ] 11 => array:3 [ "identificador" => "sec0060" "titulo" => "Systemic Lupus Erythematosus" "secciones" => array:2 [ 0 => array:3 [ "identificador" => "sec0065" "titulo" => "Maternal Morbidity" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0070" "titulo" => "1. In Women With Systemic Lupus Erythematosus, What Are the Safest Contraceptive Options?" ] 1 => array:2 [ "identificador" => "sec0075" "titulo" => "2. In Women With Systemic Lupus Erythematosus, What Are the Actions to Implement During the Preconception Period?" ] 2 => array:2 [ "identificador" => "sec0080" "titulo" => "3. In Pregnant Women With Systemic Lupus Erythematosus, What Are the Frequency and Risk Factors of Disease" ] 3 => array:2 [ "identificador" => "sec0085" "titulo" => "4. In Pregnant Women With Systemic Lupus Erythematosus, What Are the Frequency and Risks Factors to Develop Preeclampsia/eclampsia?" ] 4 => array:2 [ "identificador" => "sec0090" "titulo" => "5. In Pregnant Women With Systemic Lupus Erythematosus, What Are the Most Efficient Treatment Options to Prevent and Treat Disease Reactivation?" ] ] ] 1 => array:3 [ "identificador" => "sec0095" "titulo" => "Foetal Morbidity" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0100" "titulo" => "6. In Pregnant Women With Systemic Lupus Erythematosus, What Are the Frequency and Risk Factors Associated to Foetal Loss?" ] 1 => array:2 [ "identificador" => "sec0105" "titulo" => "7. In Pregnant Women With Systemic Lupus Erythematosus, What Are the Frequency and Risk Factors Associated to Preterm Birth?" ] 2 => array:2 [ "identificador" => "sec0110" "titulo" => "8. In Foetus of Pregnant Women With Systemic Lupus Erythematosus, What Are the Frequency and Risk Factors Associated to Low Birth Weight/intrauterine Growth Restriction/small for Gestational Age?" ] 3 => array:2 [ "identificador" => "sec0115" "titulo" => "9. In Women With Systemic Lupus Erythematosus, How Is the Follow-up During Pregnancy and Immediate Puerperium Carried out?" ] 4 => array:2 [ "identificador" => "sec0120" "titulo" => "10. In Foetus of Women Containing Positive Anti-Ro and/or Anti-La Antibodies, What Are the Most Effective Prevention and Treatment Options for the Management of Congenital Heart Block?" ] ] ] ] ] 12 => array:3 [ "identificador" => "sec0125" "titulo" => "Ethical Responsibilities" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0130" "titulo" => "Protection of persons and animals" ] 1 => array:2 [ "identificador" => "sec0135" "titulo" => "Data confidentiality" ] 2 => array:2 [ "identificador" => "sec0140" "titulo" => "Right to privacy and informed consent" ] ] ] 13 => array:2 [ "identificador" => "sec0145" "titulo" => "Conflict of Interest" ] 14 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2014-06-10" "fechaAceptado" => "2014-11-08" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec566354" "palabras" => array:4 [ 0 => "Clinical practice guidelines" 1 => "Pregnancy" 2 => "Systemic lupus erythematosus" 3 => "Antirheumatic drugs" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec566355" "palabras" => array:4 [ 0 => "Guías de práctica clínica" 1 => "Embarazo" 2 => "Lupus eritematoso sistémico" 3 => "Fármacos antirreumáticos" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "BackgroundPregnancy in women with autoimmune rheumatic diseases is associated with several maternal and foetal complications. The development of clinical practice guidelines with the best available scientific evidence may help standardize the care of these patients. ObjectivesTo provide recommendations regarding prenatal care, treatment, and a more effective monitoring of pregnancy in women with lupus erythematosus (SLE), rheumatoid arthritis (RA) and antiphospholipid antibody syndrome (APS). MethodologyNominal panels were formed for consensus, systematic search of information, development of clinical questions, processing and grading of recommendations, internal validation by peers, and external validation of the final document. The quality criteria of the AGREE II instrument were followed. ResultsThe various panels answered the 37 questions related to maternal and foetal care in SLE, RA, and APS, as well as to the use of antirheumatic drugs during pregnancy and lactation. The recommendations were discussed and integrated into a final manuscript. Finally, the corresponding algorithms were developed. We present the recommendations for pregnant women with SLE in this first part. ConclusionsWe believe that the Mexican clinical practice guidelines for the management of pregnancy in women with SLE integrate the best available evidence for the treatment and follow-up of patients with these conditions." "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Background" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Objectives" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Methodology" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Results" ] 4 => array:2 [ "identificador" => "abst0025" "titulo" => "Conclusions" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "AntecedentesEl embarazo en mujeres con enfermedades reumáticas autoinmunes se asocia a diversas complicaciones maternofetales. El desarrollo de guías de práctica clínica con la mejor evidencia científica disponible puede ayudar a homogeneizar la atención en estas pacientes. ObjetivosProporcionar recomendaciones respecto al control prenatal, el tratamiento y el seguimiento más efectivo de la mujer embarazada con lupus eritematoso (LES), artritis reumatoide (AR) y síndrome por anticuerpos antifosfolípidos (SAF). MetodologíaPara la elaboración de las recomendaciones se conformaron grupos nominales de expertos y se realizaron consensos formales, búsqueda sistematizada de la información, elaboración de preguntas clínicas, elaboración y calificación de las recomendaciones, fase de validación interna por pares y validación externa del documento final teniendo en cuenta los criterios de calidad del instrumento AGREE II. ResultadosLos grupos de trabajo contestaron las 37 preguntas relacionadas con la atención maternofetal en LES, AR y SAF, así como de fármacos antirreumáticos durante el embarazo y la lactancia. Las recomendaciones fueron discutidas e integradas en un manuscrito final y se elaboraron los algoritmos correspondientes. En esta primera parte se presentan las recomendaciones para mujeres embarazadas con LES. ConclusionesLa guía mexicana de práctica clínica para la atención del embarazo en mujeres con LES proporciona recomendaciones e integra la mejor evidencia disponible para el tratamiento y el seguimiento de estas pacientes." "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0030" "titulo" => "Antecedentes" ] 1 => array:2 [ "identificador" => "abst0035" "titulo" => "Objetivos" ] 2 => array:2 [ "identificador" => "abst0040" "titulo" => "Metodología" ] 3 => array:2 [ "identificador" => "abst0045" "titulo" => "Resultados" ] 4 => array:2 [ "identificador" => "abst0050" "titulo" => "Conclusiones" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "Please cite this article as: Saavedra Salinas MÁ, Barrera Cruz A, Cabral Castañeda AR, Jara Quezada LJ, Arce-Salinas CA, Álvarez Nemegyei J, et al. Guías de práctica clínica para la atención del embarazo en mujeres con enfermedades reumáticas autoinmunes del Colegio Mexicano de Reumatología. Parte I. Reumatol Clin. 2015;11:295–304." ] ] "multimedia" => array:3 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1919 "Ancho" => 3173 "Tamanyo" => 177076 ] ] "descripcion" => array:1 [ "en" => "Algorithm of treatment of patients with systemic lupus erythematosus." ] ] 1 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Websites \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">No. of results obtained \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">No. of documents used \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">National Institute for Health and Clinical Excellence (NICE) – England \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Scottish Intercollegiate Guidelines Network (SIGN) – Scotland \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">New Zealand Guidelines Group (NZGG) – New Zealand \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">National Health and Medical Research Council (NHMRC) – Australia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Institute for Clinical Systems Improvement (ICSI) health care guidelines – USA \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">National Guideline Clearinghouse \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Guidelines International Network (G-I-N) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">15 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Total \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">32 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab886170.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Websites Consulted for the Elaboration of This CPG Guideline." ] ] 2 => array:7 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "It classifies evidence per levels (categories) and indicates the source of the issued recommendations based on the soundness degree. To establish the evidence category, it uses Roman numbers from i to iv and letters a and b (lower case). In soundness of recommendation, upper case letters from A to D are used.Source: Modified from Shekelle et al.<a class="elsevierStyleCrossRef" href="#bib0350">4</a>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Evidence category \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Recommendation soundness \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Ia. Evidence for meta-analysis of the randomized clinical studies \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">A. Directly based on category I evidence \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Ib. Evidence from at least one randomized controlled clinical study \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">IIa. Evidence from at least one controlled study without randomization \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">B. Directly based on category II evidence or recommendations extrapolated from evidence I \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">IIb. At least other kind of quasi-experimental study or studies of cohort \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">III. Evidence of a descriptive, non-experimental study, such as comparative studies, correlation studies, cases and controls and clinical reviews \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">C. Directly based on category III evidence or recommendations extrapolated from category I or II evidences \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">IV. Evidence from expert's committees, reports, opinions or clinical experience from authorities regulating the subject or both \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">D. Directly based on category IV evidence or recommendations extrapolated from category IIor III evidences \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab886169.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Shekelle et al. Modified Scale." ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:66 [ 0 => array:3 [ "identificador" => "bib0335" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interaction of pregnancy and autoimmune rheumatic disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.autrev.2011.11.013" "Revista" => array:6 [ "tituloSerie" => "Autoimmun Rev" "fecha" => "2012" "volumen" => "11" "paginaInicial" => "A437" "paginaFinal" => "A446" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0340" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancy and reproduction in autoimmune rheumatic diseases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rheumatology (Oxford)" "fecha" => "2011" "volumen" => "50" "paginaInicial" => "657" "paginaFinal" => "664" "itemHostRev" => array:3 [ "pii" => "S0266613813003379" "estado" => "S300" "issn" => "02666138" ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0345" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "AGREE II: advancing guideline development, reporting and evaluation in health care" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "CMAJ" "fecha" => "2010" "volumen" => "182" "paginaInicial" => "839" "paginaFinal" => "842" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0350" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical guidelines. Developing guidelines" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "BMJ" "fecha" => "1999" "volumen" => "3" "paginaInicial" => "593" "paginaFinal" => "599" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0355" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mechanisms of disease: systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMra1100359" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2011" "volumen" => "365" "paginaInicial" => "2110" "paginaFinal" => "2121" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0360" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Combined oral contraceptives in women with systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa051135" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2005" "volumen" => "353" "paginaInicial" => "2550" "paginaFinal" => "2558" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0365" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A trial of contraceptive methods in women with systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa050817" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2005" "volumen" => "353" "paginaInicial" => "2539" "paginaFinal" => "2549" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0370" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnane progestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.contraception.2010.08.012" "Revista" => array:6 [ "tituloSerie" => "Contraception" "fecha" => "2011" "volumen" => "83" "paginaInicial" => "229" "paginaFinal" => "237" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0375" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Managing contraception and pregnancy in the rheumatologic diseases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.berh.2009.12.004" "Revista" => array:6 [ "tituloSerie" => "Best Pract Res Clin Rheumatol" "fecha" => "2010" "volumen" => "24" "paginaInicial" => "373" "paginaFinal" => "385" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0380" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A national study of the complications of lupus in pregnancy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ajog.2008.10.006" "Revista" => array:6 [ "tituloSerie" => "Am J Obstet Gynecol" "fecha" => "2008" "volumen" => "199" "paginaInicial" => "e1" "paginaFinal" => "e6" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0385" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lupus and pregnancy: ten questions and some answers" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203308090027" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2008" "volumen" => "17" "paginaInicial" => "416" "paginaFinal" => "420" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0390" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancy complicating systemic lupus erythematosus: a series of 86 cases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00404-010-1786-5" "Revista" => array:6 [ "tituloSerie" => "Arch Gynecol Obstet" "fecha" => "2011" "volumen" => "284" "paginaInicial" => "1067" "paginaFinal" => "1071" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0395" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lupus and pregnancy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/OGX.0b013e318239e1ee" "Revista" => array:6 [ "tituloSerie" => "Obstet Gynecol Surv" "fecha" => "2011" "volumen" => "66" "paginaInicial" => "639" "paginaFinal" => "653" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0400" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lupus and pregnancy: integrating clues from the bench and bedside" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2362.2010.02443.x" "Revista" => array:6 [ "tituloSerie" => "Eur J Clin Invest" "fecha" => "2011" "volumen" => "41" "paginaInicial" => "672" "paginaFinal" => "678" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0405" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Br J Rheumatol" "fecha" => "1996" "volumen" => "35" "paginaInicial" => "133" "paginaFinal" => "138" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0410" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "1991" "volumen" => "34" "paginaInicial" => "1538" "paginaFinal" => "1545" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0415" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Intern Med" "fecha" => "1991" "volumen" => "151" "paginaInicial" => "269" "paginaFinal" => "273" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0420" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lupus pregnancy. Case–control prospective study demonstrating absence of lupus exacerbation during or after pregnancy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Med" "fecha" => "1984" "volumen" => "77" "paginaInicial" => "893" "paginaFinal" => "898" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0425" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lupus and pregnancy studies" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "1993" "volumen" => "36" "paginaInicial" => "1392" "paginaFinal" => "1397" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0430" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The effect of pregnancy on lupus nephritis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/art.20638" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "2004" "volumen" => "50" "paginaInicial" => "3941" "paginaFinal" => "3946" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0435" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Rheumatol" "fecha" => "1986" "volumen" => "13" "paginaInicial" => "732" "paginaFinal" => "739" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0440" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rheumatology (Oxford)" "fecha" => "2002" "volumen" => "41" "paginaInicial" => "643" "paginaFinal" => "650" ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0445" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancy outcome in systemic lupus erythematosus (SLE) is improving: results from a case control study and literature review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2174/1874312900802010089" "Revista" => array:6 [ "tituloSerie" => "Open Rheumatol J" "fecha" => "2008" "volumen" => "2" "paginaInicial" => "89" "paginaFinal" => "98" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0450" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3899/jrheum.090872" "Revista" => array:6 [ "tituloSerie" => "J Rheumatol" "fecha" => "2010" "volumen" => "37" "paginaInicial" => "754" "paginaFinal" => "758" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0455" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10067-012-1941-4" "Revista" => array:6 [ "tituloSerie" => "Clin Rheumatol" "fecha" => "2012" "volumen" => "31" "paginaInicial" => "813" "paginaFinal" => "819" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0460" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lupus activity in pregnancy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rheum Dis Clin N Am" "fecha" => "2007" "volumen" => "33" "paginaInicial" => "237" "paginaFinal" => "252" ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0465" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2215/CJN.00240110" "Revista" => array:6 [ "tituloSerie" => "Clin J Am Soc Nephrol" "fecha" => "2010" "volumen" => "5" "paginaInicial" => "2060" "paginaFinal" => "2068" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0470" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Obstet Gynecol" "fecha" => "1993" "volumen" => "169" "paginaInicial" => "1000" "paginaFinal" => "1006" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0475" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Obstetric management of the high-risk lupus pregnancy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rheum Dis Clin N Am" "fecha" => "1997" "volumen" => "23" "paginaInicial" => "119" "paginaFinal" => "132" ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0480" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The challenge of pregnancy for patients with SLE" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203313504637" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2013" "volumen" => "22" "paginaInicial" => "1295" "paginaFinal" => "1308" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0485" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1055/s-0032-1310527" "Revista" => array:6 [ "tituloSerie" => "Am J Perinatol" "fecha" => "2012" "volumen" => "29" "paginaInicial" => "551" "paginaFinal" => "556" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0490" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/uog.12421" "Revista" => array:6 [ "tituloSerie" => "Ultrasound Obstet Gynecol" "fecha" => "2013" "volumen" => "41" "paginaInicial" => "491" "paginaFinal" => "499" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0495" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2001" "volumen" => "10" "paginaInicial" => "401" "paginaFinal" => "404" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0500" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hydroxychloroquine in lupus pregnancy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/art.22159" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "2006" "volumen" => "54" "paginaInicial" => "3640" "paginaFinal" => "3647" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0505" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The Hopkins Lupus Pregnancy Center: ten key issues in management" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rheum Dis Clin N Am" "fecha" => "2007" "volumen" => "33" "paginaInicial" => "227" "paginaFinal" => "235" ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0510" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The impact of increased lupus activity on obstetric outcomes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/art.20864" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "2005" "volumen" => "52" "paginaInicial" => "514" "paginaFinal" => "521" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0515" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rheumatology (Oxford)" "fecha" => "2008" "volumen" => "47" "paginaInicial" => "646" "paginaFinal" => "651" ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0520" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1586/eci.12.36" "Revista" => array:6 [ "tituloSerie" => "Expert Rev Clin Immunol" "fecha" => "2012" "volumen" => "8" "paginaInicial" => "439" "paginaFinal" => "453" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0525" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3899/jrheum.100746" "Revista" => array:6 [ "tituloSerie" => "J Rheumatol" "fecha" => "2011" "volumen" => "38" "paginaInicial" => "1012" "paginaFinal" => "1016" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0530" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203310378669" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2010" "volumen" => "19" "paginaInicial" => "1665" "paginaFinal" => "1673" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib0535" "etiqueta" => "41" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Early risk factors for pregnancy loss in lupus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.AOG.0000194205.95870.86" "Revista" => array:6 [ "tituloSerie" => "Obstet Gynecol" "fecha" => "2006" "volumen" => "107" "paginaInicial" => "293" "paginaFinal" => "299" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib0540" "etiqueta" => "42" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Obstetrical outcome of pregnancy in patients with systemic lupus erythematosus. A study of 60 cases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Eur J Obstet Gynecol Reprod Biol" "fecha" => "1999" "volumen" => "83" "paginaInicial" => "137" "paginaFinal" => "142" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib0545" "etiqueta" => "43" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ndt/gfn348" "Revista" => array:6 [ "tituloSerie" => "Nephrol Dial Transplant" "fecha" => "2009" "volumen" => "24" "paginaInicial" => "519" "paginaFinal" => "525" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib0550" "etiqueta" => "44" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lupus nephritis and renal disease in pregnancy lupus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2006" "volumen" => "15" "paginaInicial" => "148" "paginaFinal" => "155" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib0555" "etiqueta" => "45" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Rheum Dis" "fecha" => "2001" "volumen" => "60" "paginaInicial" => "599" "paginaFinal" => "604" "link" => array:1 [ …1] ] ] ] ] ] ] 45 => array:3 [ "identificador" => "bib0560" "etiqueta" => "46" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancy outcomes and appropriate timing of pregnancy in 183 pregnancies in Korean patients with SLE" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Int J Med Sci" "fecha" => "2011" "volumen" => "8" "paginaInicial" => "577" "paginaFinal" => "583" "link" => array:1 [ …1] ] ] ] ] ] ] 46 => array:3 [ "identificador" => "bib0565" "etiqueta" => "47" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Maternal and fetal outcome of lupus pregnancy: a prospective study of 29 pregnancies" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2005" "volumen" => "14" "paginaInicial" => "145" "paginaFinal" => "151" "link" => array:1 [ …1] ] ] ] ] ] ] 47 => array:3 [ "identificador" => "bib0570" "etiqueta" => "48" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3899/jrheum.100997" "Revista" => array:7 [ "tituloSerie" => "J Rheumatol" "fecha" => "2011" "volumen" => "38" "paginaInicial" => "1906" "paginaFinal" => "1913" "link" => array:1 [ …1] "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 48 => array:3 [ "identificador" => "bib0575" "etiqueta" => "49" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systemic lupus erythematosus and pregnancy" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.berh.2006.04.003" "Revista" => array:6 [ "tituloSerie" => "Best Pract Res Clin Rheumatol" "fecha" => "2006" "volumen" => "20" "paginaInicial" => "685" "paginaFinal" => "694" "link" => array:1 [ …1] ] ] ] ] ] ] 49 => array:3 [ "identificador" => "bib0580" "etiqueta" => "50" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Management of the high-risk lupus pregnant patient" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rheum Dis Clin N Am" "fecha" => "2007" "volumen" => "33" "paginaInicial" => "253" "paginaFinal" => "265" ] ] ] ] ] ] 50 => array:3 [ "identificador" => "bib0585" "etiqueta" => "51" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Managing lupus patients during pregnancy" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.berh.2009.04.004" "Revista" => array:6 [ "tituloSerie" => "Best Pract Res Clin Rheumatol" "fecha" => "2009" "volumen" => "23" "paginaInicial" => "575" "paginaFinal" => "582" "link" => array:1 [ …1] ] ] ] ] ] ] 51 => array:3 [ "identificador" => "bib0590" "etiqueta" => "52" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Management of pregnancy in systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nrrheum.2012.133" "Revista" => array:6 [ "tituloSerie" => "Nat Rev Rheumatol" "fecha" => "2012" "volumen" => "8" "paginaInicial" => "710" "paginaFinal" => "718" "link" => array:1 [ …1] ] ] ] ] ] ] 52 => array:3 [ "identificador" => "bib0595" "etiqueta" => "53" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "2001" "volumen" => "44" "paginaInicial" => "1832" "paginaFinal" => "1835" "link" => array:1 [ …1] ] ] ] ] ] ] 53 => array:3 [ "identificador" => "bib0600" "etiqueta" => "54" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR interval and dexamethasone evaluation (PRIDE) prospective study" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIRCULATIONAHA.107.707661" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2008" "volumen" => "117" "paginaInicial" => "485" "paginaFinal" => "493" "link" => array:1 [ …1] ] ] ] ] ] ] 54 => array:3 [ "identificador" => "bib0605" "etiqueta" => "55" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anti-52kDa Ro, anti-60kDa Ro, and anti-La antibody profiles in neonatal lupus" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Rheumatol" "fecha" => "2004" "volumen" => "31" "paginaInicial" => "2480" "paginaFinal" => "2487" "link" => array:1 [ …1] ] ] ] ] ] ] 55 => array:3 [ "identificador" => "bib0610" "etiqueta" => "56" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/art.24768" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "2009" "volumen" => "60" "paginaInicial" => "3091" "paginaFinal" => "3097" "link" => array:1 [ …1] ] ] ] ] ] ] 56 => array:3 [ "identificador" => "bib0615" "etiqueta" => "57" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIRCULATIONAHA.111.033894" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2011" "volumen" => "124" "paginaInicial" => "1927" "paginaFinal" => "1935" "link" => array:1 [ …1] ] ] ] ] ] ] 57 => array:3 [ "identificador" => "bib0620" "etiqueta" => "58" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevention of congenital heart block in children of SSA-positive mothers" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rheumatology (Oxford)" "fecha" => "2008" "volumen" => "47" "paginaInicial" => "i35" "paginaFinal" => "i37" ] ] ] ] ] ] 58 => array:3 [ "identificador" => "bib0625" "etiqueta" => "59" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjcard.2008.12.027" "Revista" => array:6 [ "tituloSerie" => "Am J Cardiol" "fecha" => "2009" "volumen" => "103" "paginaInicial" => "1102" "paginaFinal" => "1106" "link" => array:1 [ …1] ] ] ] ] ] ] 59 => array:3 [ "identificador" => "bib0630" "etiqueta" => "60" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIRCULATIONAHA.111.041970" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2011" "volumen" => "124" "paginaInicial" => "1919" "paginaFinal" => "1926" "link" => array:1 [ …1] ] ] ] ] ] ] 60 => array:3 [ "identificador" => "bib0635" "etiqueta" => "61" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/art.27308" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "2010" "volumen" => "62" "paginaInicial" => "1138" "paginaFinal" => "1146" "link" => array:1 [ …1] ] ] ] ] ] ] 61 => array:3 [ "identificador" => "bib0640" "etiqueta" => "62" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/art.27350" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "2010" "volumen" => "62" "paginaInicial" => "1147" "paginaFinal" => "1152" "link" => array:1 [ …1] ] ] ] ] ] ] 62 => array:3 [ "identificador" => "bib0645" "etiqueta" => "63" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jacc.2010.09.044" "Revista" => array:6 [ "tituloSerie" => "J Am Coll Cardiol" "fecha" => "2011" "volumen" => "57" "paginaInicial" => "715" "paginaFinal" => "723" "link" => array:1 [ …1] ] ] ] ] ] ] 63 => array:3 [ "identificador" => "bib0650" "etiqueta" => "64" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A combination therapy to treat second-degree anti-Ro/La-related congenital heart block: a strategy to avoid stable third-degree heart block" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203311430969" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2011" "volumen" => "21" "paginaInicial" => "666" "paginaFinal" => "671" "link" => array:1 [ …1] ] ] ] ] ] ] 64 => array:3 [ "identificador" => "bib0655" "etiqueta" => "65" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/ard.2009.119263" "Revista" => array:6 [ "tituloSerie" => "Ann Rheum Dis" "fecha" => "2010" "volumen" => "69" "paginaInicial" => "1827" "paginaFinal" => "1830" "link" => array:1 [ …1] ] ] ] ] ] ] 65 => array:3 [ "identificador" => "bib0660" "etiqueta" => "66" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIRCULATIONAHA.111.089268" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2012" "volumen" => "126" "paginaInicial" => "76" "paginaFinal" => "82" "link" => array:1 [ …1] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735743/0000001100000005/v1_201509041903/S2173574315000441/v1_201509041903/en/main.assets" "Apartado" => array:4 [ "identificador" => "43294" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Original articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735743/0000001100000005/v1_201509041903/S2173574315000441/v1_201509041903/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574315000441?idApp=UINPBA00004M"]

Statistics

Original Article

Clinical practice guidelines for the management of pregnancy in women with autoimmune rheumatic diseases of the Mexican College of Rheumatology. Part I

Guías de práctica clínica para la atención del embarazo en mujeres con enfermedades reumáticas autoinmunes del Colegio Mexicano de Reumatología. Parte I

Miguel Ángel Saavedra Salinasa,

Corresponding author

miansaavsa@gmail.com
miansaavsa@hotmail.com

Corresponding author.

, Antonio Barrera Cruzb, Antonio Rafael Cabral Castañedac, Luis Javier Jara Quezadad, C. Alejandro Arce-Salinase, José Álvarez Nemegyeif, Antonio Fraga Mouretg, Javier Orozco Alcaláh, Mario Salazar Páramoi, Claudia Verónica Cruz Reyesa, Lilia Andrade Ortegaj, Olga Lidia Vera Lastrak, Claudia Mendoza Pintol, Antonio Sánchez Gonzáleza, Polita del Rocío Cruz Cruzm, Sara Morales Hernándezn, Margarita Portela Hernándezo, Mario Pérez Cristóbalo, Gabriela Medina Garcíap, Noé Hernández Romeroq..., María del Carmen Velarde Ochoar, José Eduardo Navarro Zarzas, Verónica Portillo Díazt, Angélica Vargas Guerrerou, María Victoria Goycochea Roblesv, José Luis García Figueroaw, Eduardo Barreira Mercadox, Mary Carmen Amigo CastañedayVer más

a Departamento de Reumatología, Hospital de Especialidades Dr. Antonio Fraga Mouret, CMN La Raza, IMSS, UNAM, Mexico City, Mexico

b División de Excelencia Clínica, Área de Desarrollo de Guías de Práctica Clínica, IMSS, Mexico City, Mexico

c Ciencias Médicas F, Departamento de Inmunología y Reumatología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

d Dirección de Educación e Investigación, Hospital de Especialidades Dr. Antonio Fraga Mouret, CMN La Raza, IMSS, UNAM, Mexico City, Mexico

e División de Medicina Interna, Hospital Central Sur de Pemex, Mexico City, Mexico

f Escuela de Medicina, Universidad Anáhuac-Mayab, Mérida, Yucatán, Mexico

g Dirección de Educación e Investigación, Secretaría de Salud del Distrito Federal, UNAM, Mexico City, Mexico

h Clínica de Reumatología, Escuela de Medicina, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

i División de Investigación en Salud, UMAE, Hospital de Especialidades, Centro Médico Nacional de Occidente, IMSS, Centro Universitario Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

j Departamento de Reumatología, Centro Médico Nacional 20 de Noviembre, ISSSTE, Reumatología, UNAM, Mexico City, Mexico

k Departamento de Medicina Interna, Hospital de Especialidades, CMN La Raza, IMSS, UNAM, Mexico City, Mexico

l Unidad de Investigación Enfermedades Autoinmunes Sistémicas, Hospital General Regional n.o 36-CIBIOR, Instituto Mexicano del Seguro Social, Unidad de Posgrado, Facultad de Medicina, Benemérita Universidad Autónoma de Puebla, Puebla, Puebla, Mexico

m División de Atención Ginecobstétrica y Perinatal de la Dirección de Prestaciones Médicas del IMSS, Mexico City, Mexico

n Departamento de Perinatología, Hospital Gineco-Obstetricia n.o3 Dr. Víctor Manuel Espinosa de los Reyes Sánchez, UMAE, CMN La Raza, IMSS, Mexico City, Mexico

o Departamento de Reumatología, Hospital de Especialidades, CMN Siglo XXI, IMSS, Mexico City, Mexico

p Hospital de Especialidades, CMN La Raza, IMSS, Mexico City, Mexico

q Unidad de Cuidados Intensivos Neonatales, Hospital Gineco-Obstetricia n.o 3 Dr. Víctor Manuel Espinosa de los Reyes Sánchez, UMAE, CMN La Raza, IMSS, Mexico City, Mexico

r Departamento de Reumatología e Inmunología Clínica, Hospital General de Zona No. 46, IMSS, Villahermosa, Tabasco, Mexico

s Hospital General de Chilpancingo Dr. Raymundo Abarca Alarcón, Chilpancingo, Guerrero, Mexico

t Departamento de Medicina Interna, UMAE HGO 4, IMSS, Mexico City, Mexico

u Departamento de Reumatología, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico

v Unidad de investigación en Epidemiología Clínica, Hospital Regional Dr. Carlos Mcgregor Sánchez Navarro, IMSS, Mexico City, Mexico

w Universidad Juárez Autónoma de Tabasco, Villahermosa, Tabasco, Mexico

x Reumatología de la Facultad de Medicina, Universidad Autónoma de Querétaro y Universidad del Del Valle de Mexico, Querétaro, Qro., Mexico

y Reumatología, Centro Médico ABC, Mexico City, Mexico

Read

10501

Times
was read the article

3454

Total PDF

7047

Total HTML

Share statistics

 array:24 [
  "pii" => "S2173574315000441"
  "issn" => "21735743"
  "doi" => "10.1016/j.reumae.2015.03.002"
  "estado" => "S300"
  "fechaPublicacion" => "2015-09-01"
  "aid" => "739"
  "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46;. All rights reserved"
  "copyrightAnyo" => "2014"
  "documento" => "article"
  "crossmark" => 1
  "subdocumento" => "fla"
  "cita" => "Reumatol Clin. 2015;11:295-304"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:2 [
    "total" => 2230
    "formatos" => array:3 [
      "EPUB" => 69
      "HTML" => 1608
      "PDF" => 553
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S1699258X14002277"
      "issn" => "1699258X"
      "doi" => "10.1016/j.reuma.2014.11.005"
      "estado" => "S300"
      "fechaPublicacion" => "2015-09-01"
      "aid" => "739"
      "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46;"
      "documento" => "article"
      "crossmark" => 1
      "subdocumento" => "fla"
      "cita" => "Reumatol Clin. 2015;11:295-304"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 14870
        "formatos" => array:3 [
          "EPUB" => 176
          "HTML" => 6950
          "PDF" => 7744
        ]
      ]
      "es" => array:13 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
        "titulo" => "Gu&#237;as de pr&#225;ctica cl&#237;nica para la atenci&#243;n del embarazo en mujeres con enfermedades reum&#225;ticas autoinmunes del Colegio Mexicano de Reumatolog&#237;a&#46; Parte I"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "295"
            "paginaFinal" => "304"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Clinical practice guidelines for the management of pregnancy in women with autoimmune rheumatic diseases of the Mexican College of Rheumatology&#46; Part I"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0005"
            "etiqueta" => "Figura 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 1919
                "Ancho" => 3173
                "Tamanyo" => 187047
              ]
            ]
            "descripcion" => array:1 [
              "es" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Algoritmo de manejo en pacientes con lupus eritematoso sist&#233;mico&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Miguel &#193;ngel Saavedra Salinas, Antonio Barrera Cruz, Antonio Rafael Cabral Casta&#241;eda, Luis Javier Jara Quezada, C&#46; Alejandro Arce-Salinas, Jos&#233; &#193;lvarez Nemegyei, Antonio Fraga Mouret, Javier Orozco Alcal&#225;, Mario Salazar P&#225;ramo, Claudia Ver&#243;nica Cruz Reyes, Lilia Andrade Ortega, Olga Lidia Vera Lastra, Claudia Mendoza Pinto, Antonio S&#225;nchez Gonz&#225;lez, Polita del Roc&#237;o Cruz Cruz, Sara Morales Hern&#225;ndez, Margarita Portela Hern&#225;ndez, Mario P&#233;rez Crist&#243;bal, Gabriela Medina Garc&#237;a, No&#233; Hern&#225;ndez Romero, Mar&#237;a del Carmen Velarde Ochoa, Jos&#233; Eduardo Navarro Zarza, Ver&#243;nica Portillo D&#237;az, Ang&#233;lica Vargas Guerrero, Mar&#237;a Victoria Goycochea Robles, Jos&#233; Luis Garc&#237;a Figueroa, Eduardo Barreira Mercado, Mary Carmen Amigo Casta&#241;eda"
            "autores" => array:28 [
              0 => array:2 [
                "nombre" => "Miguel &#193;ngel"
                "apellidos" => "Saavedra Salinas"
              ]
              1 => array:2 [
                "nombre" => "Antonio"
                "apellidos" => "Barrera Cruz"
              ]
              2 => array:2 [
                "nombre" => "Antonio Rafael"
                "apellidos" => "Cabral Casta&#241;eda"
              ]
              3 => array:2 [
                "nombre" => "Luis Javier"
                "apellidos" => "Jara Quezada"
              ]
              4 => array:2 [
                "nombre" => "C&#46; Alejandro"
                "apellidos" => "Arce-Salinas"
              ]
              5 => array:2 [
                "nombre" => "Jos&#233;"
                "apellidos" => "&#193;lvarez Nemegyei"
              ]
              6 => array:2 [
                "nombre" => "Antonio"
                "apellidos" => "Fraga Mouret"
              ]
              7 => array:2 [
                "nombre" => "Javier"
                "apellidos" => "Orozco Alcal&#225;"
              ]
              8 => array:2 [
                "nombre" => "Mario"
                "apellidos" => "Salazar P&#225;ramo"
              ]
              9 => array:2 [
                "nombre" => "Claudia Ver&#243;nica"
                "apellidos" => "Cruz Reyes"
              ]
              10 => array:2 [
                "nombre" => "Lilia"
                "apellidos" => "Andrade Ortega"
              ]
              11 => array:2 [
                "nombre" => "Olga Lidia"
                "apellidos" => "Vera Lastra"
              ]
              12 => array:2 [
                "nombre" => "Claudia"
                "apellidos" => "Mendoza Pinto"
              ]
              13 => array:2 [
                "nombre" => "Antonio"
                "apellidos" => "S&#225;nchez Gonz&#225;lez"
              ]
              14 => array:2 [
                "nombre" => "Polita del Roc&#237;o"
                "apellidos" => "Cruz Cruz"
              ]
              15 => array:2 [
                "nombre" => "Sara"
                "apellidos" => "Morales Hern&#225;ndez"
              ]
              16 => array:2 [
                "nombre" => "Margarita"
                "apellidos" => "Portela Hern&#225;ndez"
              ]
              17 => array:2 [
                "nombre" => "Mario"
                "apellidos" => "P&#233;rez Crist&#243;bal"
              ]
              18 => array:2 [
                "nombre" => "Gabriela"
                "apellidos" => "Medina Garc&#237;a"
              ]
              19 => array:2 [
                "nombre" => "No&#233;"
                "apellidos" => "Hern&#225;ndez Romero"
              ]
              20 => array:2 [
                "nombre" => "Mar&#237;a del Carmen"
                "apellidos" => "Velarde Ochoa"
              ]
              21 => array:2 [
                "nombre" => "Jos&#233; Eduardo"
                "apellidos" => "Navarro Zarza"
              ]
              22 => array:2 [
                "nombre" => "Ver&#243;nica"
                "apellidos" => "Portillo D&#237;az"
              ]
              23 => array:2 [
                "nombre" => "Ang&#233;lica"
                "apellidos" => "Vargas Guerrero"
              ]
              24 => array:2 [
                "nombre" => "Mar&#237;a Victoria"
                "apellidos" => "Goycochea Robles"
              ]
              25 => array:2 [
                "nombre" => "Jos&#233; Luis"
                "apellidos" => "Garc&#237;a Figueroa"
              ]
              26 => array:2 [
                "nombre" => "Eduardo"
                "apellidos" => "Barreira Mercado"
              ]
              27 => array:2 [
                "nombre" => "Mary Carmen"
                "apellidos" => "Amigo Casta&#241;eda"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2173574315000441"
          "doi" => "10.1016/j.reumae.2015.03.002"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574315000441?idApp=UINPBA00004M"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X14002277?idApp=UINPBA00004M"
      "url" => "/1699258X/0000001100000005/v1_201508130103/S1699258X14002277/v1_201508130103/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S2173574315000477"
    "issn" => "21735743"
    "doi" => "10.1016/j.reumae.2015.03.005"
    "estado" => "S300"
    "fechaPublicacion" => "2015-09-01"
    "aid" => "745"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46;"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Reumatol Clin. 2015;11:305-15"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 2173
      "formatos" => array:3 [
        "EPUB" => 56
        "HTML" => 1604
        "PDF" => 513
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
      "titulo" => "Clinical Practice Guidelines for the Management of Pregnancy in Women With Autoimmune Rheumatic Diseases of the Mexican College of Rheumatology&#46; Part <span class="elsevierStyleSmallCaps">II</span>"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "305"
          "paginaFinal" => "315"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Gu&#237;as de pr&#225;ctica cl&#237;nica para la atenci&#243;n del embarazo en mujeres con enfermedades reum&#225;ticas autoinmunes del Colegio Mexicano de Reumatolog&#237;a&#46; Parte <span class="elsevierStyleSmallCaps">II</span>"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1963
              "Ancho" => 1679
              "Tamanyo" => 169479
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Management algorithm in patients with rheumatoid arthritis&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Miguel &#193;ngel Saavedra Salinas, Antonio Barrera Cruz, Antonio Rafael Cabral Casta&#241;eda, Luis Javier Jara Quezada, C&#46; Alejandro Arce-Salinas, Jos&#233; &#193;lvarez Nemegyei, Antonio Fraga Mouret, Javier Orozco Alcal&#225;, Mario Salazar P&#225;ramo, Claudia Ver&#243;nica Cruz Reyes, Lilia Andrade Ortega, Olga Lidia Vera Lastra, Claudia Mendoza Pinto, Antonio S&#225;nchez Gonz&#225;lez, Polita del Roc&#237;o Cruz Cruz, Sara Morales Hern&#225;ndez, Margarita Portela Hern&#225;ndez, Mario P&#233;rez Crist&#243;bal, Gabriela Medina Garc&#237;a, No&#233; Hern&#225;ndez Romero, Mar&#237;a del Carmen Velarde Ochoa, Jos&#233; Eduardo Navarro Zarza, Ver&#243;nica Portillo D&#237;az, Ang&#233;lica Vargas Guerrero, Mar&#237;a Victoria Goycochea Robles, Jos&#233; Luis Garc&#237;a Figueroa, Eduardo Barreira Mercado, Mary Carmen Amigo Casta&#241;eda"
          "autores" => array:28 [
            0 => array:2 [
              "nombre" => "Miguel &#193;ngel"
              "apellidos" => "Saavedra Salinas"
            ]
            1 => array:2 [
              "nombre" => "Antonio"
              "apellidos" => "Barrera Cruz"
            ]
            2 => array:2 [
              "nombre" => "Antonio Rafael"
              "apellidos" => "Cabral Casta&#241;eda"
            ]
            3 => array:2 [
              "nombre" => "Luis Javier"
              "apellidos" => "Jara Quezada"
            ]
            4 => array:2 [
              "nombre" => "C&#46; Alejandro"
              "apellidos" => "Arce-Salinas"
            ]
            5 => array:2 [
              "nombre" => "Jos&#233;"
              "apellidos" => "&#193;lvarez Nemegyei"
            ]
            6 => array:2 [
              "nombre" => "Antonio"
              "apellidos" => "Fraga Mouret"
            ]
            7 => array:2 [
              "nombre" => "Javier"
              "apellidos" => "Orozco Alcal&#225;"
            ]
            8 => array:2 [
              "nombre" => "Mario"
              "apellidos" => "Salazar P&#225;ramo"
            ]
            9 => array:2 [
              "nombre" => "Claudia Ver&#243;nica"
              "apellidos" => "Cruz Reyes"
            ]
            10 => array:2 [
              "nombre" => "Lilia"
              "apellidos" => "Andrade Ortega"
            ]
            11 => array:2 [
              "nombre" => "Olga Lidia"
              "apellidos" => "Vera Lastra"
            ]
            12 => array:2 [
              "nombre" => "Claudia"
              "apellidos" => "Mendoza Pinto"
            ]
            13 => array:2 [
              "nombre" => "Antonio"
              "apellidos" => "S&#225;nchez Gonz&#225;lez"
            ]
            14 => array:2 [
              "nombre" => "Polita del Roc&#237;o"
              "apellidos" => "Cruz Cruz"
            ]
            15 => array:2 [
              "nombre" => "Sara"
              "apellidos" => "Morales Hern&#225;ndez"
            ]
            16 => array:2 [
              "nombre" => "Margarita"
              "apellidos" => "Portela Hern&#225;ndez"
            ]
            17 => array:2 [
              "nombre" => "Mario"
              "apellidos" => "P&#233;rez Crist&#243;bal"
            ]
            18 => array:2 [
              "nombre" => "Gabriela"
              "apellidos" => "Medina Garc&#237;a"
            ]
            19 => array:2 [
              "nombre" => "No&#233;"
              "apellidos" => "Hern&#225;ndez Romero"
            ]
            20 => array:2 [
              "nombre" => "Mar&#237;a del Carmen"
              "apellidos" => "Velarde Ochoa"
            ]
            21 => array:2 [
              "nombre" => "Jos&#233; Eduardo"
              "apellidos" => "Navarro Zarza"
            ]
            22 => array:2 [
              "nombre" => "Ver&#243;nica"
              "apellidos" => "Portillo D&#237;az"
            ]
            23 => array:2 [
              "nombre" => "Ang&#233;lica"
              "apellidos" => "Vargas Guerrero"
            ]
            24 => array:2 [
              "nombre" => "Mar&#237;a Victoria"
              "apellidos" => "Goycochea Robles"
            ]
            25 => array:2 [
              "nombre" => "Jos&#233; Luis"
              "apellidos" => "Garc&#237;a Figueroa"
            ]
            26 => array:2 [
              "nombre" => "Eduardo"
              "apellidos" => "Barreira Mercado"
            ]
            27 => array:2 [
              "nombre" => "Mary Carmen"
              "apellidos" => "Amigo Casta&#241;eda"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S1699258X14002575"
        "doi" => "10.1016/j.reuma.2014.12.004"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X14002575?idApp=UINPBA00004M"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574315000477?idApp=UINPBA00004M"
    "url" => "/21735743/0000001100000005/v1_201509041903/S2173574315000477/v1_201509041903/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2173574315000878"
    "issn" => "21735743"
    "doi" => "10.1016/j.reumae.2015.05.002"
    "estado" => "S300"
    "fechaPublicacion" => "2015-09-01"
    "aid" => "789"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46;"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Reumatol Clin. 2015;11:279-94"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 1727
      "formatos" => array:3 [
        "EPUB" => 58
        "HTML" => 1099
        "PDF" => 570
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Special Article</span>"
      "titulo" => "2014 Update of the Consensus Statement of the Spanish Society of Rheumatology on the Use of Biological Therapies in Rheumatoid Arthritis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "279"
          "paginaFinal" => "294"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Actualizaci&#243;n 2014 del Documento de Consenso de la Sociedad Espa&#241;ola de Reumatolog&#237;a sobre el uso de terapias biol&#243;gicas en la artritis reumatoide"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 4005
              "Ancho" => 2975
              "Tamanyo" => 787916
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Therapeutic algorithm for rheumatoid arthritis&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Raimon Sanmart&#237;, Susana Garc&#237;a-Rodr&#237;guez, Jos&#233; Mar&#237;a &#193;lvaro-Gracia, Jos&#233; Luis Andreu, Alejandro Balsa, Rafael C&#225;liz, Antonio Fern&#225;ndez-Nebro, Iv&#225;n Ferraz-Amaro, Juan Jes&#250;s G&#243;mez-Reino, Isidoro Gonz&#225;lez-&#193;lvaro, Emilio Mart&#237;n-Mola, V&#237;ctor Manuel Mart&#237;nez-Taboada, Ana M&#46; Ortiz, Jes&#250;s Tornero, Sara Marsal, Jos&#233; Vicente Moreno-Muelas"
          "autores" => array:16 [
            0 => array:2 [
              "nombre" => "Raimon"
              "apellidos" => "Sanmart&#237;"
            ]
            1 => array:2 [
              "nombre" => "Susana"
              "apellidos" => "Garc&#237;a-Rodr&#237;guez"
            ]
            2 => array:2 [
              "nombre" => "Jos&#233; Mar&#237;a"
              "apellidos" => "&#193;lvaro-Gracia"
            ]
            3 => array:2 [
              "nombre" => "Jos&#233; Luis"
              "apellidos" => "Andreu"
            ]
            4 => array:2 [
              "nombre" => "Alejandro"
              "apellidos" => "Balsa"
            ]
            5 => array:2 [
              "nombre" => "Rafael"
              "apellidos" => "C&#225;liz"
            ]
            6 => array:2 [
              "nombre" => "Antonio"
              "apellidos" => "Fern&#225;ndez-Nebro"
            ]
            7 => array:2 [
              "nombre" => "Iv&#225;n"
              "apellidos" => "Ferraz-Amaro"
            ]
            8 => array:2 [
              "nombre" => "Juan Jes&#250;s"
              "apellidos" => "G&#243;mez-Reino"
            ]
            9 => array:2 [
              "nombre" => "Isidoro"
              "apellidos" => "Gonz&#225;lez-&#193;lvaro"
            ]
            10 => array:2 [
              "nombre" => "Emilio"
              "apellidos" => "Mart&#237;n-Mola"
            ]
            11 => array:2 [
              "nombre" => "V&#237;ctor Manuel"
              "apellidos" => "Mart&#237;nez-Taboada"
            ]
            12 => array:2 [
              "nombre" => "Ana M&#46;"
              "apellidos" => "Ortiz"
            ]
            13 => array:2 [
              "nombre" => "Jes&#250;s"
              "apellidos" => "Tornero"
            ]
            14 => array:2 [
              "nombre" => "Sara"
              "apellidos" => "Marsal"
            ]
            15 => array:2 [
              "nombre" => "Jos&#233; Vicente"
              "apellidos" => "Moreno-Muelas"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S1699258X15000753"
        "doi" => "10.1016/j.reuma.2015.05.001"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X15000753?idApp=UINPBA00004M"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574315000878?idApp=UINPBA00004M"
    "url" => "/21735743/0000001100000005/v1_201509041903/S2173574315000878/v1_201509041903/en/main.assets"
  ]
  "en" => array:20 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
    "titulo" => "Clinical practice guidelines for the management of pregnancy in women with autoimmune rheumatic diseases of the Mexican College of Rheumatology&#46; Part I"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "295"
        "paginaFinal" => "304"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Miguel &#193;ngel Saavedra Salinas, Antonio Barrera Cruz, Antonio Rafael Cabral Casta&#241;eda, Luis Javier Jara Quezada, C&#46; Alejandro Arce-Salinas, Jos&#233; &#193;lvarez Nemegyei, Antonio Fraga Mouret, Javier Orozco Alcal&#225;, Mario Salazar P&#225;ramo, Claudia Ver&#243;nica Cruz Reyes, Lilia Andrade Ortega, Olga Lidia Vera Lastra, Claudia Mendoza Pinto, Antonio S&#225;nchez Gonz&#225;lez, Polita del Roc&#237;o Cruz Cruz, Sara Morales Hern&#225;ndez, Margarita Portela Hern&#225;ndez, Mario P&#233;rez Crist&#243;bal, Gabriela Medina Garc&#237;a, No&#233; Hern&#225;ndez Romero, Mar&#237;a del Carmen Velarde Ochoa, Jos&#233; Eduardo Navarro Zarza, Ver&#243;nica Portillo D&#237;az, Ang&#233;lica Vargas Guerrero, Mar&#237;a Victoria Goycochea Robles, Jos&#233; Luis Garc&#237;a Figueroa, Eduardo Barreira Mercado, Mary Carmen Amigo Casta&#241;eda"
        "autores" => array:28 [
          0 => array:4 [
            "nombre" => "Miguel &#193;ngel"
            "apellidos" => "Saavedra Salinas"
            "email" => array:2 [
              0 => "miansaavsa&#64;gmail&#46;com"
              1 => "miansaavsa&#64;hotmail&#46;com"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Antonio"
            "apellidos" => "Barrera Cruz"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Antonio Rafael"
            "apellidos" => "Cabral Casta&#241;eda"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Luis Javier"
            "apellidos" => "Jara Quezada"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "aff0020"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "C&#46; Alejandro"
            "apellidos" => "Arce-Salinas"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">e</span>"
                "identificador" => "aff0025"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "Jos&#233;"
            "apellidos" => "&#193;lvarez Nemegyei"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">f</span>"
                "identificador" => "aff0030"
              ]
            ]
          ]
          6 => array:3 [
            "nombre" => "Antonio"
            "apellidos" => "Fraga Mouret"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">g</span>"
                "identificador" => "aff0035"
              ]
            ]
          ]
          7 => array:3 [
            "nombre" => "Javier"
            "apellidos" => "Orozco Alcal&#225;"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">h</span>"
                "identificador" => "aff0040"
              ]
            ]
          ]
          8 => array:3 [
            "nombre" => "Mario"
            "apellidos" => "Salazar P&#225;ramo"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">i</span>"
                "identificador" => "aff0045"
              ]
            ]
          ]
          9 => array:3 [
            "nombre" => "Claudia Ver&#243;nica"
            "apellidos" => "Cruz Reyes"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          10 => array:3 [
            "nombre" => "Lilia"
            "apellidos" => "Andrade Ortega"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">j</span>"
                "identificador" => "aff0050"
              ]
            ]
          ]
          11 => array:3 [
            "nombre" => "Olga Lidia"
            "apellidos" => "Vera Lastra"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">k</span>"
                "identificador" => "aff0055"
              ]
            ]
          ]
          12 => array:3 [
            "nombre" => "Claudia"
            "apellidos" => "Mendoza Pinto"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">l</span>"
                "identificador" => "aff0060"
              ]
            ]
          ]
          13 => array:3 [
            "nombre" => "Antonio"
            "apellidos" => "S&#225;nchez Gonz&#225;lez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          14 => array:3 [
            "nombre" => "Polita del Roc&#237;o"
            "apellidos" => "Cruz Cruz"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">m</span>"
                "identificador" => "aff0065"
              ]
            ]
          ]
          15 => array:3 [
            "nombre" => "Sara"
            "apellidos" => "Morales Hern&#225;ndez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">n</span>"
                "identificador" => "aff0070"
              ]
            ]
          ]
          16 => array:3 [
            "nombre" => "Margarita"
            "apellidos" => "Portela Hern&#225;ndez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">o</span>"
                "identificador" => "aff0075"
              ]
            ]
          ]
          17 => array:3 [
            "nombre" => "Mario"
            "apellidos" => "P&#233;rez Crist&#243;bal"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">o</span>"
                "identificador" => "aff0075"
              ]
            ]
          ]
          18 => array:3 [
            "nombre" => "Gabriela"
            "apellidos" => "Medina Garc&#237;a"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">p</span>"
                "identificador" => "aff0080"
              ]
            ]
          ]
          19 => array:3 [
            "nombre" => "No&#233;"
            "apellidos" => "Hern&#225;ndez Romero"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">q</span>"
                "identificador" => "aff0085"
              ]
            ]
          ]
          20 => array:3 [
            "nombre" => "Mar&#237;a del Carmen"
            "apellidos" => "Velarde Ochoa"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">r</span>"
                "identificador" => "aff0090"
              ]
            ]
          ]
          21 => array:3 [
            "nombre" => "Jos&#233; Eduardo"
            "apellidos" => "Navarro Zarza"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">s</span>"
                "identificador" => "aff0095"
              ]
            ]
          ]
          22 => array:3 [
            "nombre" => "Ver&#243;nica"
            "apellidos" => "Portillo D&#237;az"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">t</span>"
                "identificador" => "aff0100"
              ]
            ]
          ]
          23 => array:3 [
            "nombre" => "Ang&#233;lica"
            "apellidos" => "Vargas Guerrero"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">u</span>"
                "identificador" => "aff0105"
              ]
            ]
          ]
          24 => array:3 [
            "nombre" => "Mar&#237;a Victoria"
            "apellidos" => "Goycochea Robles"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">v</span>"
                "identificador" => "aff0110"
              ]
            ]
          ]
          25 => array:3 [
            "nombre" => "Jos&#233; Luis"
            "apellidos" => "Garc&#237;a Figueroa"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">w</span>"
                "identificador" => "aff0115"
              ]
            ]
          ]
          26 => array:3 [
            "nombre" => "Eduardo"
            "apellidos" => "Barreira Mercado"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">x</span>"
                "identificador" => "aff0120"
              ]
            ]
          ]
          27 => array:3 [
            "nombre" => "Mary Carmen"
            "apellidos" => "Amigo Casta&#241;eda"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">y</span>"
                "identificador" => "aff0125"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:25 [
          0 => array:3 [
            "entidad" => "Departamento de Reumatolog&#237;a&#44; Hospital de Especialidades Dr&#46; Antonio Fraga Mouret&#44; CMN La Raza&#44; IMSS&#44; UNAM&#44; Mexico City&#44; Mexico"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Divisi&#243;n de Excelencia Cl&#237;nica&#44; &#193;rea de Desarrollo de Gu&#237;as de Pr&#225;ctica Cl&#237;nica&#44; IMSS&#44; Mexico City&#44; Mexico"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Ciencias M&#233;dicas F&#44; Departamento de Inmunolog&#237;a y Reumatolog&#237;a&#44; Instituto Nacional de Ciencias M&#233;dicas y Nutrici&#243;n Salvador Zubir&#225;n&#44; Mexico City&#44; Mexico"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
          3 => array:3 [
            "entidad" => "Direcci&#243;n de Educaci&#243;n e Investigaci&#243;n&#44; Hospital de Especialidades Dr&#46; Antonio Fraga Mouret&#44; CMN La Raza&#44; IMSS&#44; UNAM&#44; Mexico City&#44; Mexico"
            "etiqueta" => "d"
            "identificador" => "aff0020"
          ]
          4 => array:3 [
            "entidad" => "Divisi&#243;n de Medicina Interna&#44; Hospital Central Sur de Pemex&#44; Mexico City&#44; Mexico"
            "etiqueta" => "e"
            "identificador" => "aff0025"
          ]
          5 => array:3 [
            "entidad" => "Escuela de Medicina&#44; Universidad An&#225;huac-Mayab&#44; M&#233;rida&#44; Yucat&#225;n&#44; Mexico"
            "etiqueta" => "f"
            "identificador" => "aff0030"
          ]
          6 => array:3 [
            "entidad" => "Direcci&#243;n de Educaci&#243;n e Investigaci&#243;n&#44; Secretar&#237;a de Salud del Distrito Federal&#44; UNAM&#44; Mexico City&#44; Mexico"
            "etiqueta" => "g"
            "identificador" => "aff0035"
          ]
          7 => array:3 [
            "entidad" => "Cl&#237;nica de Reumatolog&#237;a&#44; Escuela de Medicina&#44; Universidad de Guadalajara&#44; Guadalajara&#44; Jalisco&#44; Mexico"
            "etiqueta" => "h"
            "identificador" => "aff0040"
          ]
          8 => array:3 [
            "entidad" => "Divisi&#243;n de Investigaci&#243;n en Salud&#44; UMAE&#44; Hospital de Especialidades&#44; Centro M&#233;dico Nacional de Occidente&#44; IMSS&#44; Centro Universitario Ciencias de la Salud&#44; Universidad de Guadalajara&#44; Guadalajara&#44; Jalisco&#44; Mexico"
            "etiqueta" => "i"
            "identificador" => "aff0045"
          ]
          9 => array:3 [
            "entidad" => "Departamento de Reumatolog&#237;a&#44; Centro M&#233;dico Nacional 20 de Noviembre&#44; ISSSTE&#44; Reumatolog&#237;a&#44; UNAM&#44; Mexico City&#44; Mexico"
            "etiqueta" => "j"
            "identificador" => "aff0050"
          ]
          10 => array:3 [
            "entidad" => "Departamento de Medicina Interna&#44; Hospital de Especialidades&#44; CMN La Raza&#44; IMSS&#44; UNAM&#44; Mexico City&#44; Mexico"
            "etiqueta" => "k"
            "identificador" => "aff0055"
          ]
          11 => array:3 [
            "entidad" => "Unidad de Investigaci&#243;n Enfermedades Autoinmunes Sist&#233;micas&#44; Hospital General Regional n&#46;<span class="elsevierStyleSup">o</span> 36-CIBIOR&#44; Instituto Mexicano del Seguro Social&#44; Unidad de Posgrado&#44; Facultad de Medicina&#44; Benem&#233;rita Universidad Aut&#243;noma de Puebla&#44; Puebla&#44; Puebla&#44; Mexico"
            "etiqueta" => "l"
            "identificador" => "aff0060"
          ]
          12 => array:3 [
            "entidad" => "Divisi&#243;n de Atenci&#243;n Ginecobst&#233;trica y Perinatal de la Direcci&#243;n de Prestaciones M&#233;dicas del IMSS&#44; Mexico City&#44; Mexico"
            "etiqueta" => "m"
            "identificador" => "aff0065"
          ]
          13 => array:3 [
            "entidad" => "Departamento de Perinatolog&#237;a&#44; Hospital Gineco-Obstetricia n&#46;<span class="elsevierStyleSup">o</span>3 Dr&#46; V&#237;ctor Manuel Espinosa de los Reyes S&#225;nchez&#44; UMAE&#44; CMN La Raza&#44; IMSS&#44; Mexico City&#44; Mexico"
            "etiqueta" => "n"
            "identificador" => "aff0070"
          ]
          14 => array:3 [
            "entidad" => "Departamento de Reumatolog&#237;a&#44; Hospital de Especialidades&#44; CMN Siglo XXI&#44; IMSS&#44; Mexico City&#44; Mexico"
            "etiqueta" => "o"
            "identificador" => "aff0075"
          ]
          15 => array:3 [
            "entidad" => "Hospital de Especialidades&#44; CMN La Raza&#44; IMSS&#44; Mexico City&#44; Mexico"
            "etiqueta" => "p"
            "identificador" => "aff0080"
          ]
          16 => array:3 [
            "entidad" => "Unidad de Cuidados Intensivos Neonatales&#44; Hospital Gineco-Obstetricia n&#46;<span class="elsevierStyleSup">o</span> 3 Dr&#46; V&#237;ctor Manuel Espinosa de los Reyes S&#225;nchez&#44; UMAE&#44; CMN La Raza&#44; IMSS&#44; Mexico City&#44; Mexico"
            "etiqueta" => "q"
            "identificador" => "aff0085"
          ]
          17 => array:3 [
            "entidad" => "Departamento de Reumatolog&#237;a e Inmunolog&#237;a Cl&#237;nica&#44; Hospital General de Zona No&#46; 46&#44; IMSS&#44; Villahermosa&#44; Tabasco&#44; Mexico"
            "etiqueta" => "r"
            "identificador" => "aff0090"
          ]
          18 => array:3 [
            "entidad" => "Hospital General de Chilpancingo Dr&#46; Raymundo Abarca Alarc&#243;n&#44; Chilpancingo&#44; Guerrero&#44; Mexico"
            "etiqueta" => "s"
            "identificador" => "aff0095"
          ]
          19 => array:3 [
            "entidad" => "Departamento de Medicina Interna&#44; UMAE HGO 4&#44; IMSS&#44; Mexico City&#44; Mexico"
            "etiqueta" => "t"
            "identificador" => "aff0100"
          ]
          20 => array:3 [
            "entidad" => "Departamento de Reumatolog&#237;a&#44; Instituto Nacional de Cardiolog&#237;a Ignacio Ch&#225;vez&#44; Mexico City&#44; Mexico"
            "etiqueta" => "u"
            "identificador" => "aff0105"
          ]
          21 => array:3 [
            "entidad" => "Unidad de investigaci&#243;n en Epidemiolog&#237;a Cl&#237;nica&#44; Hospital Regional Dr&#46; Carlos Mcgregor S&#225;nchez Navarro&#44; IMSS&#44; Mexico City&#44; Mexico"
            "etiqueta" => "v"
            "identificador" => "aff0110"
          ]
          22 => array:3 [
            "entidad" => "Universidad Ju&#225;rez Aut&#243;noma de Tabasco&#44; Villahermosa&#44; Tabasco&#44; Mexico"
            "etiqueta" => "w"
            "identificador" => "aff0115"
          ]
          23 => array:3 [
            "entidad" => "Reumatolog&#237;a de la Facultad de Medicina&#44; Universidad Aut&#243;noma de Quer&#233;taro y Universidad del Del Valle de Mexico&#44; Quer&#233;taro&#44; Qro&#46;&#44; Mexico"
            "etiqueta" => "x"
            "identificador" => "aff0120"
          ]
          24 => array:3 [
            "entidad" => "Reumatolog&#237;a&#44; Centro M&#233;dico ABC&#44; Mexico City&#44; Mexico"
            "etiqueta" => "y"
            "identificador" => "aff0125"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Gu&#237;as de pr&#225;ctica cl&#237;nica para la atenci&#243;n del embarazo en mujeres con enfermedades reum&#225;ticas autoinmunes del Colegio Mexicano de Reumatolog&#237;a&#46; Parte I"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1919
            "Ancho" => 3173
            "Tamanyo" => 177076
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Algorithm of treatment of patients with systemic lupus erythematosus&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Autoimmune diseases develop more frequently in women in reproductive stage&#59; thus&#44; during pregnancy their development is potentially frequent&#46; Pregnancy requires the interaction of endocrine and immune mechanisms&#44; which facilitate maternal and foetal communication&#44; regulate implantation&#44; foster placental growth and prevent immune rejection of the semialogenic foetus&#46;<a class="elsevierStyleCrossRef" href="#bib0335"><span class="elsevierStyleSup">1</span></a> These changes can affect the clinical course of autoimmune diseases and they can in turn have an influence on the maternal and foetal outcome&#44; so these are considered high-risk pregnancies&#46;<a class="elsevierStyleCrossRef" href="#bib0340"><span class="elsevierStyleSup">2</span></a> The type and frequency of maternal and foetal complications vary with each autoimmune disease&#46;<a class="elsevierStyleCrossRef" href="#bib0340"><span class="elsevierStyleSup">2</span></a> However&#44; in general terms&#44; the risk of an adverse maternal and foetal outcome can be reduced when the pregnancy is planned&#44; especially when the disease is controlled and minimal risk medications can be used during gestation&#46; Thus&#44; a multidisciplinary team that participates in the health care process of this group of patients and contributes to the improvement of the maternal and foetal outcome is required&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">Pregnancy in women with autoimmune rheumatic disease&#44; especially in women with systemic lupus erythematosus &#40;SLE&#41;&#44; means a significant challenge for the physicians in charge of the health care process of this group of patients&#46; Knowledge about the security of medications&#44; the effect of pregnancy on the disease&#44; the effect of the disease on pregnancy&#44; preconception advice and the participation of a multidisciplinary team are cornerstones for the provision of effective and safe medical and obstetrical attention&#46; A planned pregnancy associated to close obstetric surveillance during the entire pregnancy and the puerperium increase the probability of favourable outcomes in the mother-son pairing&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">The development of a clinical practice guideline &#40;CPG&#41; for pregnancy and autoimmune rheumatic diseases derives from the need to provide recommendations supported by the best scientific evidence available to the health care professional in charge of this group of patients&#44; aiming at minimizing the frequency of maternal and foetal complications&#46; In this first part of the CPG&#44; its development and methodology as well as the recommendations for women with SLE are shown&#46;</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Extent and Objectives</span><p id="par0020" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">&#8226;</span><p id="par0025" class="elsevierStylePara elsevierViewall">To provide recommendations about prenatal control&#44; the most effective treatment and follow-up of pregnant women with SLE&#44; rheumatoid arthritis &#40;RA&#41; and antiphospholipid antibody syndrome &#40;APS&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">&#8226;</span><p id="par0030" class="elsevierStylePara elsevierViewall">To prevent the main maternal and foetal complications in women with autoimmune rheumatic diseases&#46;</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">&#8226;</span><p id="par0035" class="elsevierStylePara elsevierViewall">To identify and reduce the risk of foetal adverse reactions and events related to the use of antirheumatic drugs in women with autoimmune rheumatic diseases&#46;</p></li></ul></p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Potential Users</span><p id="par0040" class="elsevierStylePara elsevierViewall">This guideline is targeted to rheumatologists&#44; OB&#47;GYNs&#44; internists and neonatologists&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Target Population</span><p id="par0045" class="elsevierStylePara elsevierViewall">Women &#8805;18 years old with an established diagnosis of SLE&#44; RA and APS&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Attention Level</span><p id="par0050" class="elsevierStylePara elsevierViewall">Second and third attention level&#46; The use of this guideline will improve the efficacy&#44; security and quality of the medical attention provided to the target population&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Methodology</span><p id="par0055" class="elsevierStylePara elsevierViewall">The methodology used in the preparation of the document included the establishment of nominal groups of experts&#44; development of formal consensus&#44; search for systematized information&#44; elaboration of clinical questions&#44; elaboration and qualification of recommendations&#44; internal validation phase by pairs and external validation of the final document&#46; During the elaboration of the guideline&#44; the quality criteria of AGREE II<a class="elsevierStyleCrossRef" href="#bib0345"><span class="elsevierStyleSup">3</span></a> instrument were considered&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Working Group</span>&#46; For the establishment of the working group&#44; 30 rheumatologists who are members of the Colegio Mexicano de Reumatolog&#237;a &#40;Mexican College of Rheumatology&#41; where invited and 2 of them rejected the invitation to participate&#46; The selection process considered the professional background of the experts&#44; their clinical judgement&#44; the geographical diversity &#40;with reasonable representation of the different states of the country&#41;&#44; their belonging to the main health institutions in the country&#44; including second and third attention level institutions&#44; knowledge and command of the subject&#44; representation per gender&#44; with a men-women balance in the working tables&#44; as well as training in the development of CPG with evidence-based medicine methodology&#46; Given the importance of creating a multi and interdisciplinary working group&#44; apart from the presence of rheumatologists&#44; the collaboration of other specialists was requested so as to obtain their opinion to help improve the disease treatment or the methodology of recommendations elaboration&#46; Finally&#44; the group was made up of 23 rheumatologists&#44; 2 internists&#44; one paediatric neonatologist and 2 OB&#47;GYNs&#46; Once all the members of the working group were selected&#44; and upon their agreement to participate in the project&#44; a nominal group meeting was convened&#46; In this meeting&#44; a theoretical explanation of the CPG working methodology was carried out and a debate was opened to define the title&#44; extent&#44; objectives and users of the guideline&#59; the leaders of each working table were appointed&#46; In the working group training&#44; the development of the PICO &#40;patient&#44; intervention&#44; comparator and outcome or result&#41; clinical questions&#44; CPG elaboration and adaptation&#44; evidence and recommendations elaboration and qualification as well as search protocol procedures were addressed&#46; The working groups reviewed the following subjects&#58; &#40;1&#41; SLE I &#40;maternal morbidity&#41;&#44; &#40;2&#41; SLE II &#40;foetal morbidity&#41;&#44; &#40;3&#41; RA&#44; &#40;4&#41; APS&#44; and &#40;5&#41; use of antirheumatic drugs during pregnancy and breastfeeding&#46;</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Development of Recommendations</span><p id="par0065" class="elsevierStylePara elsevierViewall">The recommendations developed in this document are general in nature and based on the best scientific evidence available at the moment of their development&#59; they pretend to be a useful tool to accelerate the decision-making during the health care process of the pregnant patient with SLE&#44; RA and APS&#46; In this way&#44; the recommendations established herein do not define a unique course of behaviour in a procedure or treatment&#59; thus&#44; when applied in practice&#44; they could exhibit justified variations based on the clinical judgement of the person using them as reference&#44; as well as on the specific needs and preferences of each patient in particular&#44; the resources available at the time of attention and the regulation established by each institution or practice area&#46;</p><p id="par0070" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Systematic Search</span>&#46; The systematic search for information was focused on CPG and on primary and secondary studies about SLE&#44; RA&#44; primary APS and antirheumatic drugs during pregnancy and breastfeeding&#46;</p><p id="par0075" class="elsevierStylePara elsevierViewall">The CPG search was carried out in web sites belonging to entities in charge of the elaboration and compilation of CPG&#46; Below&#44; there is a table that shows the web sites consulted for the preparation of this guideline &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0080" class="elsevierStylePara elsevierViewall">As no CPG addressed clinical questions related to potential pregnancies during the course of the 3 target rheumatic diseases&#44; it was not possible to develop the guideline through the adaptation process&#46; For that reason&#44; we proceeded with the de novo elaboration&#44; and carried out a search for primary and secondary studies in Pubmed&#44; Tripdatabase and the Cochrane library&#44; based on the following inclusion criteria&#58;<ul class="elsevierStyleList" id="lis0010"><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">&#8226;</span><p id="par0085" class="elsevierStylePara elsevierViewall">Documents written in English and Spanish&#46;</p></li><li class="elsevierStyleListItem" id="lsti0025"><span class="elsevierStyleLabel">&#8226;</span><p id="par0090" class="elsevierStylePara elsevierViewall">Documents published during the last 5 years &#40;recommended range&#41; or&#44; in case of scarce or null information&#44; documents published during the last 10 years &#40;extended range&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0030"><span class="elsevierStyleLabel">&#8226;</span><p id="par0095" class="elsevierStylePara elsevierViewall">Documents focused on treatment&#46;</p></li></ul></p><p id="par0100" class="elsevierStylePara elsevierViewall">The bibliographical search was carried out during June 2013 and the terms MeSH Lupus Erythematosus&#44; Systemic AND pregnancy were employed&#46; The search protocol used was&#58; &#40;&#8220;Lupus Erythematosus&#44; Systemic&#47;complications&#8221;&#91;Mesh&#93; OR &#8220;Lupus Erythematosus&#44; Systemic&#47;congenital&#8221;&#91;Mesh&#93; OR &#8220;Lupus Erythematosus&#44; Systemic&#47;drug therapy&#8221;&#91;Mesh&#93; OR &#8220;Lupus Erythematosus&#44; Systemic&#47;mortality&#8221;&#91;Mesh&#93; OR &#8220;Lupus Erythematosus&#44; Systemic&#47;pharmacology&#8221;&#91;Mesh&#93; OR &#8220;Lupus Erythematosus&#44; Systemic&#47;prevention and control&#8221;&#91;Mesh&#93; OR &#8220;Lupus Erythematosus&#44; Systemic&#47;therapy&#8221;&#91;Mesh&#93;&#41; AND &#40;&#8220;pregnancy&#8221;&#91;MeSH Terms&#93; OR &#8220;pregnancy&#8221;&#91;All Fields&#93;&#41; AND &#40;&#40;Clinical Trial&#91;ptyp&#93; OR Comparative Study&#91;ptyp&#93; OR Consensus Development Conference&#44; NIH&#91;ptyp&#93; OR Controlled Clinical Trial&#91;ptyp&#93; OR Guideline&#91;ptyp&#93; OR Meta-Analysis&#91;ptyp&#93; OR Multicenter Study&#91;ptyp&#93; OR Observational Study&#91;ptyp&#93; OR Practice Guideline&#91;ptyp&#93; OR Randomized Controlled Trial&#91;ptyp&#93; OR Review&#91;ptyp&#93; OR systematic&#91;sb&#93;&#41; AND &#8220;2004&#47;04&#47;27&#8221;&#91;PDat&#93;&#58; &#8220;2013&#47;09&#47;24&#8221;&#91;PDat&#93; AND &#8220;humans&#8221;&#91;MeSH Terms&#93; AND &#40;Spanish&#91;lang&#93; OR English&#91;lang&#93;&#41;&#41;&#46; 110 results were found&#46;</p><p id="par0105" class="elsevierStylePara elsevierViewall">The bibliographical search for RA employed the MeSH terms&#58; Arthritis&#44; Rheumatoid AND pregnancy&#46; The search protocol used was&#58; &#40;&#8220;Arthritis&#44; Rheumatoid&#47;complications&#8221;&#91;Mesh&#93; OR &#8220;Arthritis&#44; Rheumatoid&#47;congenital&#8221;&#91;Mesh&#93; OR &#8220;Arthritis&#44; Rheumatoid&#47;drug therapy&#8221;&#91;Mesh&#93; OR &#8220;Arthritis&#44; Rheumatoid&#47;embryology&#8221;&#91;Mesh&#93; OR &#8220;Arthritis&#44; Rheumatoid&#47;mortality&#8221;&#91;Mesh&#93; OR &#8220;Arthritis&#44; Rheumatoid&#47;prevention and control&#8221;&#91;Mesh&#93; OR &#8220;Arthritis&#44; Rheumatoid&#47;therapy&#8221;&#91;Mesh&#93;&#41; AND &#40;&#8220;pregnancy&#8221;&#91;MeSH Terms&#93; OR &#8220;pregnancy&#8221;&#91;All Fields&#93;&#41; AND &#40;&#40;Clinical Trial&#91;ptyp&#93; OR Comparative Study&#91;ptyp&#93; OR Controlled Clinical Trial&#91;ptyp&#93; OR Guideline&#91;ptyp&#93; OR Multicenter Study&#91;ptyp&#93; OR Observational Study&#91;ptyp&#93; OR Practice Guideline&#91;ptyp&#93; OR Randomized Controlled Trial&#91;ptyp&#93; OR Review&#91;ptyp&#93; OR systematic&#91;sb&#93;&#41; AND &#8220;2004&#47;04&#47;27&#8221;&#91;PDat&#93;&#58; &#8220;2013&#47;09&#47;24&#8221;&#91;PDat&#93; AND &#8220;humans&#8221;&#91;MeSH Terms&#93; AND &#40;English&#91;lang&#93; OR Spanish&#91;lang&#93;&#41;&#41;&#46; 51 results were found&#46;</p><p id="par0110" class="elsevierStylePara elsevierViewall">The bibliographical search for APS used the MeSH terms&#58; Antiphospholipid Syndrome AND pregnancy&#46; The search protocol used was&#58; &#40;&#8220;Antiphospholipid Syndrome&#47;complications&#8221;&#91;Mesh&#93; OR &#8220;Antiphospholipid Syndrome&#47;congenital&#8221;&#91;Mesh&#93; OR &#8220;Antiphospholipid Syndrome&#47;drug therapy&#8221;&#91;Mesh&#93; OR &#8220;Antiphospholipid Syndrome&#47;embryology&#8221;&#91;Mesh&#93; OR &#8220;Antiphospholipid Syndrome&#47;genetics&#8221;&#91;Mesh&#93; OR &#8220;Antiphospholipid Syndrome&#47;mortality&#8221;&#91;Mesh&#93; OR &#8220;Antiphospholipid Syndrome&#47;prevention and control&#8221;&#91;Mesh&#93; OR &#8220;Antiphospholipid Syndrome&#47;therapy&#8221;&#91;Mesh&#93;&#41; AND &#40;&#8220;pregnancy&#8221;&#91;MeSH Terms&#93; OR &#8220;pregnancy&#8221;&#91;All Fields&#93;&#41; AND &#40;&#40;Clinical Trial&#91;ptyp&#93; OR Comparative Study&#91;ptyp&#93; OR Controlled Clinical Trial&#91;ptyp&#93; OR Guideline&#91;ptyp&#93; OR Meta-Analysis&#91;ptyp&#93; OR Multicenter Study&#91;ptyp&#93; OR Observational Study&#91;ptyp&#93; OR Practice Guideline&#91;ptyp&#93; OR Review&#91;ptyp&#93; OR systematic&#91;sb&#93;&#41; AND &#8220;2004&#47;04&#47;27&#8221;&#91;PDat&#93;&#58; &#8220;2013&#47;09&#47;24&#8221;&#91;PDat&#93; AND &#8220;humans&#8221;&#91;MeSH Terms&#93; AND &#40;English&#91;lang&#93; OR Spanish&#91;lang&#93;&#41;&#41;&#46; 246 results were found&#46;</p><p id="par0115" class="elsevierStylePara elsevierViewall">The search protocol related to antirheumatic drugs security in women with autoimmune rheumatic diseases was as follow&#58; &#40;&#8220;antirheumatic agents&#8221;&#91;Pharmacological Action&#93; OR &#8220;antirheumatic agents&#8221;&#91;MeSH Terms&#93; OR &#40;&#8220;antirheumatic&#8221;&#91;All Fields&#93; AND &#8220;agents&#8221;&#91;All Fields&#93;&#41; OR &#8220;antirheumatic agents&#8221;&#91;All Fields&#93; OR &#40;&#8220;antirheumatic&#8221;&#91;All Fields&#93; AND &#8220;drugs&#8221;&#91;All Fields&#93;&#41; OR &#8220;antirheumatic drugs&#8221;&#91;All Fields&#93;&#41; AND &#40;autoimmune&#91;All Fields&#93; AND &#40;&#8220;rheumatic diseases&#8221;&#91;MeSH Terms&#93; OR &#40;&#8220;rheumatic&#8221;&#91;All Fields&#93; AND &#8220;diseases&#8221;&#91;All Fields&#93;&#41; OR &#8220;rheumatic diseases&#8221;&#91;All Fields&#93;&#41;&#41; AND &#40;&#40;Clinical Trial&#91;ptyp&#93; OR Comparative Study&#91;ptyp&#93; OR Controlled Clinical Trial&#91;ptyp&#93; OR Meta-Analysis&#91;ptyp&#93; OR Multicenter Study&#91;ptyp&#93; OR Observational Study&#91;ptyp&#93; OR systematic&#91;sb&#93;&#41; AND &#8220;2004&#47;04&#47;27&#8221;&#91;PDat&#93;&#58; &#8220;2013&#47;09&#47;24&#8221;&#91;PDat&#93; AND &#8220;humans&#8221;&#91;MeSH Terms&#93; AND &#40;English&#91;lang&#93; OR Spanish&#91;lang&#93;&#41;&#41;&#46; 96 results were found&#46; Out of the 503 articles obtained in the search protocols&#44; 346 articles were excluded based on the reading of their titles and abstracts&#44; as they did not comply with the objectives of the questions raised in this guideline&#46;</p><p id="par0120" class="elsevierStylePara elsevierViewall">Upon the search for information&#44; a total of 157 articles were selected for the elaboration of the document&#46; The articles were referred to the experts&#8217; panel for their critical reading and assessment of the evidence degree&#46; For the grading of level of evidence&#44; Shekelle et al&#46;<a class="elsevierStyleCrossRef" href="#bib0350"><span class="elsevierStyleSup">4</span></a> Classification System was employed&#46; This classification lets us estimate the strength of the recommendations and assess the evidence quality based on the best design to answer the question &#40;<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>&#41;&#46; The aspects considered significant by the editorial team of the guideline because they make up an area lacking conclusive evidence or because they are specially relevant clinical aspects&#44; were marked with the sign &#40;&#8730;&#41; and received the consideration of good practice point &#40;GPP&#41; or opinion based on clinical experience and reached through consensus&#46;</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0125" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Validation method</span>&#58; Clinical pairs&#46;</p><p id="par0130" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Update period&#58;</span> This guideline shall be updated when there is evidence supporting its update or&#44; if previously scheduled&#44; 3&#8211;5 years after its release&#46;</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Questions Included</span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Systemic Lupus Erythematosus</span><p id="par0135" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0015"><li class="elsevierStyleListItem" id="lsti0035"><span class="elsevierStyleLabel">1&#46;</span><p id="par0140" class="elsevierStylePara elsevierViewall">In women with SLE&#44; which are the safest contraceptive options&#63;</p></li><li class="elsevierStyleListItem" id="lsti0040"><span class="elsevierStyleLabel">2&#46;</span><p id="par0145" class="elsevierStylePara elsevierViewall">In women with SLE&#44; what actions shall be implemented during the preconception period&#63;</p></li><li class="elsevierStyleListItem" id="lsti0045"><span class="elsevierStyleLabel">3&#46;</span><p id="par0150" class="elsevierStylePara elsevierViewall">In pregnant women with SLE&#44; what are the frequency and risk factors of disease relapse&#63;</p></li><li class="elsevierStyleListItem" id="lsti0050"><span class="elsevierStyleLabel">4&#46;</span><p id="par0155" class="elsevierStylePara elsevierViewall">In pregnant women with SLE&#44; what are the frequency and risk factors to develop preeclampsia&#47;eclampsia&#63;</p></li><li class="elsevierStyleListItem" id="lsti0055"><span class="elsevierStyleLabel">5&#46;</span><p id="par0160" class="elsevierStylePara elsevierViewall">In pregnant women with SLE&#44; which are the most effective treatment options to prevent and treat disease reactivation&#63;</p></li><li class="elsevierStyleListItem" id="lsti0060"><span class="elsevierStyleLabel">6&#46;</span><p id="par0165" class="elsevierStylePara elsevierViewall">In pregnant women with SLE&#44; what are the frequency and risk factors associated to foetal loss&#63;</p></li><li class="elsevierStyleListItem" id="lsti0065"><span class="elsevierStyleLabel">7&#46;</span><p id="par0170" class="elsevierStylePara elsevierViewall">In pregnant women with SLE&#44; what are the frequency and risk factors associated to preterm birth&#63;</p></li><li class="elsevierStyleListItem" id="lsti0070"><span class="elsevierStyleLabel">8&#46;</span><p id="par0175" class="elsevierStylePara elsevierViewall">In foetus of pregnant women with SLE&#44; what are the frequency and risk factors associated to low birth weight&#47;intrauterine growth restriction&#47;small for gestational age&#63;</p></li><li class="elsevierStyleListItem" id="lsti0075"><span class="elsevierStyleLabel">9&#46;</span><p id="par0180" class="elsevierStylePara elsevierViewall">In women with SLE&#44; how is the follow-up during pregnancy and immediate puerperium carried out&#63;</p></li><li class="elsevierStyleListItem" id="lsti0080"><span class="elsevierStyleLabel">10&#46;</span><p id="par0185" class="elsevierStylePara elsevierViewall">In foetus of women with positive anti-Ro and&#47;or anti-La antibodies&#44; what are the most effective prevention and treatment options for the management of congenital heart block &#40;CHB&#41;&#63;</p></li></ul></p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Rheumatoid Arthritis</span><p id="par0190" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0020"><li class="elsevierStyleListItem" id="lsti0085"><span class="elsevierStyleLabel">11&#46;</span><p id="par0195" class="elsevierStylePara elsevierViewall">In women with RA&#44; which is the disease effect and treatment regarding fertility and fecundity&#63;</p></li><li class="elsevierStyleListItem" id="lsti0090"><span class="elsevierStyleLabel">12&#46;</span><p id="par0200" class="elsevierStylePara elsevierViewall">In women with RA&#44; which are the most effective contraceptive options&#63;</p></li><li class="elsevierStyleListItem" id="lsti0095"><span class="elsevierStyleLabel">13&#46;</span><p id="par0205" class="elsevierStylePara elsevierViewall">In women with RA&#44; which are the safest contraceptive options&#63;</p></li><li class="elsevierStyleListItem" id="lsti0100"><span class="elsevierStyleLabel">14&#46;</span><p id="par0210" class="elsevierStylePara elsevierViewall">In women with RA&#44; which is the disease improvement or relapse frequency during pregnancy and puerperium&#63;</p></li><li class="elsevierStyleListItem" id="lsti0105"><span class="elsevierStyleLabel">15&#46;</span><p id="par0215" class="elsevierStylePara elsevierViewall">In women with RA&#44; which are the factors associated with the disease improvement or relapse during pregnancy and puerperium&#63;</p></li><li class="elsevierStyleListItem" id="lsti0110"><span class="elsevierStyleLabel">16&#46;</span><p id="par0220" class="elsevierStylePara elsevierViewall">In pregnant women with RA&#44; which is the best instrument to assess the disease activity&#63;</p></li><li class="elsevierStyleListItem" id="lsti0115"><span class="elsevierStyleLabel">17&#46;</span><p id="par0225" class="elsevierStylePara elsevierViewall">In pregnant women with RA&#44; what is the gestation effect on the clinical instruments of functional assessment&#63;</p></li><li class="elsevierStyleListItem" id="lsti0120"><span class="elsevierStyleLabel">18&#46;</span><p id="par0230" class="elsevierStylePara elsevierViewall">In pregnant women with RA&#44; what is the effect of antibodies &#40;rheumatoid factor and anti-cyclic citrullinated peptide antibodies&#41; on the disease activity&#63;</p></li><li class="elsevierStyleListItem" id="lsti0125"><span class="elsevierStyleLabel">19&#46;</span><p id="par0235" class="elsevierStylePara elsevierViewall">In pregnant women with RA&#44; which is the influence of the disease activity on the foetal outcome&#63;</p></li><li class="elsevierStyleListItem" id="lsti0130"><span class="elsevierStyleLabel">20&#46;</span><p id="par0240" class="elsevierStylePara elsevierViewall">In pregnant women with RA&#44; which are the safest treatment options to manage a reactivation of the disease&#63;</p></li><li class="elsevierStyleListItem" id="lsti0135"><span class="elsevierStyleLabel">21&#46;</span><p id="par0245" class="elsevierStylePara elsevierViewall">In breastfeeding women with RA&#44; which is the effect on the disease activity&#63;</p></li></ul></p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Antiphospholipid Antibody Syndrome</span><p id="par0250" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0025"><li class="elsevierStyleListItem" id="lsti0140"><span class="elsevierStyleLabel">22&#46;</span><p id="par0255" class="elsevierStylePara elsevierViewall">In women with APS&#44; which are the safest contraceptive options&#63;</p></li><li class="elsevierStyleListItem" id="lsti0145"><span class="elsevierStyleLabel">23&#46;</span><p id="par0260" class="elsevierStylePara elsevierViewall">In women with APS&#44; which are the actions and procedures that should be implemented during the prenatal control&#63;</p></li><li class="elsevierStyleListItem" id="lsti0150"><span class="elsevierStyleLabel">24&#46;</span><p id="par0265" class="elsevierStylePara elsevierViewall">In pregnant women with APS&#44; what are the risk factors for the development of preeclampsia&#63;</p></li><li class="elsevierStyleListItem" id="lsti0155"><span class="elsevierStyleLabel">25&#46;</span><p id="par0270" class="elsevierStylePara elsevierViewall">In pregnant women with APS&#44; with a history of 3 or more miscarriages &#40;&#8804;10 weeks of gestations &#91;WOG&#93;&#41; and without previous history of thrombosis&#44; what are the most efficient treatment options&#63;</p></li><li class="elsevierStyleListItem" id="lsti0160"><span class="elsevierStyleLabel">26&#46;</span><p id="par0275" class="elsevierStylePara elsevierViewall">In pregnant women with APS&#44; with a history of at least one foetal death &#40;&#62;10WOG&#41; or preterm birth &#40;&#60;34WOG&#41; due to severe preeclampsia or placental insufficiency without previous history of thrombosis&#44; what are the most efficient treatment options&#63;</p></li><li class="elsevierStyleListItem" id="lsti0165"><span class="elsevierStyleLabel">27&#46;</span><p id="par0280" class="elsevierStylePara elsevierViewall">In pregnant women with APS with previous history of thrombosis&#44; regardless of her obstetric history&#44; what are the most efficient treatment options&#63;</p></li><li class="elsevierStyleListItem" id="lsti0170"><span class="elsevierStyleLabel">28&#46;</span><p id="par0285" class="elsevierStylePara elsevierViewall">In pregnant women with APS&#44; what is the influence of antiphospholipid antibodies in the clinical course and in the therapeutic decision&#63;</p></li><li class="elsevierStyleListItem" id="lsti0175"><span class="elsevierStyleLabel">29&#46;</span><p id="par0290" class="elsevierStylePara elsevierViewall">In women with APS&#44; what are the most efficient treatment options during puerperium&#63;</p></li><li class="elsevierStyleListItem" id="lsti0180"><span class="elsevierStyleLabel">30&#46;</span><p id="par0295" class="elsevierStylePara elsevierViewall">In women with APS&#44; which are the safest peripartum or peri-caesarean treatment options&#63;</p></li><li class="elsevierStyleListItem" id="lsti0185"><span class="elsevierStyleLabel">31&#46;</span><p id="par0300" class="elsevierStylePara elsevierViewall">In children of women with APS&#44; which are the actions and procedures that should be implemented during the neonatal follow-up&#63;</p></li></ul></p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Antirheumatic Drugs</span><p id="par0305" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0030"><li class="elsevierStyleListItem" id="lsti0190"><span class="elsevierStyleLabel">32&#46;</span><p id="par0310" class="elsevierStylePara elsevierViewall">In pregnant women with autoimmune disease&#44; what is the risk of foetal exposure to non-steroidal anti-inflammatory drugs or analgesics &#40;NSAIDs&#41;&#63;</p></li><li class="elsevierStyleListItem" id="lsti0195"><span class="elsevierStyleLabel">33&#46;</span><p id="par0315" class="elsevierStylePara elsevierViewall">In pregnant women with autoimmune disease&#44; what is the maternal and foetal risk of glucocorticoids exposure for disease treatment&#63;</p></li><li class="elsevierStyleListItem" id="lsti0200"><span class="elsevierStyleLabel">34&#46;</span><p id="par0320" class="elsevierStylePara elsevierViewall">In pregnant women with autoimmune disease&#44; what is the foetal risk of exposure to antimalarial medication&#44; azathioprine&#44; sulfasalazine&#44; cyclosporine A&#44; leflunomide&#44; mycophenolate mofetil&#44; cyclophosphamide and methotrexate&#63;</p></li><li class="elsevierStyleListItem" id="lsti0205"><span class="elsevierStyleLabel">35&#46;</span><p id="par0325" class="elsevierStylePara elsevierViewall">In pregnant women with autoimmune disease&#44; what is the foetal risk of exposure to biological drugs &#40;anti-TNF&#44; rituximab and others&#41;&#63;</p></li><li class="elsevierStyleListItem" id="lsti0210"><span class="elsevierStyleLabel">36&#46;</span><p id="par0330" class="elsevierStylePara elsevierViewall">In pregnant women with autoimmune disease during the breastfeeding period&#44; what are the antirheumatic drugs that can be most safely employed&#63;</p></li><li class="elsevierStyleListItem" id="lsti0215"><span class="elsevierStyleLabel">37&#46;</span><p id="par0335" class="elsevierStylePara elsevierViewall">In pregnant women with autoimmune disease&#44; what is the risk of foetal exposure to oral anticoagulants and heparin&#63;</p></li></ul></p></span></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Systemic Lupus Erythematosus</span><p id="par0340" class="elsevierStylePara elsevierViewall">SLE is a multisystemic autoimmune disease of unknown cause&#44; characterized by the production of diverse antibodies that affects mainly women in reproductive stage with normally conserved fertility&#46;<a class="elsevierStyleCrossRef" href="#bib0355"><span class="elsevierStyleSup">5</span></a></p><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0135">Maternal Morbidity</span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0140">1&#46; In Women With Systemic Lupus Erythematosus&#44; What Are the Safest Contraceptive Options&#63;</span><p id="par0345" class="elsevierStylePara elsevierViewall">The use of triphase oral contraceptives &#40;ethinyl estradiol plus norethindrone&#41; is not associated to the reactivation risk &#40;assessed by SELENA-SLEDAI&#41; of SLE and it does not increase the risk of known adverse events associated to its intake in healthy women<a class="elsevierStyleCrossRef" href="#bib0360"><span class="elsevierStyleSup">6</span></a> &#91;LOE Ib&#93;&#46; The use of combined oral contraceptives&#44; progestogens alone and non-hormonal intrauterine devices does not increase the risk of aggravating the disease activity &#40;assessed by SLEDAI&#41; in patients with mild to moderate SLE&#59; this has only been assessed in women without previous episodes of thrombosis<a class="elsevierStyleCrossRef" href="#bib0365"><span class="elsevierStyleSup">7</span></a> &#91;LOE Ib&#93;&#46; Contraception with cyproterone acetate &#40;50<span class="elsevierStyleHsp" style=""></span>mg&#41; and clormadinone &#40;5<span class="elsevierStyleHsp" style=""></span>mg&#41; is well tolerated and effective as contraceptive method in patients with mild&#44; moderate or severe SLE<a class="elsevierStyleCrossRef" href="#bib0370"><span class="elsevierStyleSup">8</span></a> &#91;LOE III&#93;&#46; Triphase oral contraceptives and non-combined progestogens can be used in patients with SLE&#44; as their use does not increase the disease activity or the risk of adverse events&#44; especially episodes of thrombosis<a class="elsevierStyleCrossRefs" href="#bib0360"><span class="elsevierStyleSup">6&#44;7</span></a> &#91;GR A&#93;&#46; The use of triphase oral contraceptives and non-combined progestogens is not recommended in patients with previous history of thrombosis and&#47;or pre-existing cardiovascular risk factors&#44; neither is it recommended in patients with SLE with associated antiphospholipid antibodies and&#47;or APS<a class="elsevierStyleCrossRefs" href="#bib0360"><span class="elsevierStyleSup">6&#44;7</span></a> &#91;GR A&#93;&#46;</p><p id="par0350" class="elsevierStylePara elsevierViewall">Contraception with progestogens &#40;through different routes of administration&#41; is safe and effective for all kind of patients with SLE at different activity degrees&#44; and it can be administered in patients with positive antiphospholipid antibodies<a class="elsevierStyleCrossRefs" href="#bib0370"><span class="elsevierStyleSup">8&#44;9</span></a> &#91;GR C&#93;&#46; The intrauterine device with progestogens is safe and effective when a long-term &#40;at least 5 years&#41; contraceptive method is desired in women with SLE<a class="elsevierStyleCrossRef" href="#bib0375"><span class="elsevierStyleSup">9</span></a> &#91;GR C&#93;&#46; Emergency contraception based on progestogens is safe in women with SLE<a class="elsevierStyleCrossRef" href="#bib0375"><span class="elsevierStyleSup">9</span></a> &#91;GR C&#93;&#46; Combined barrier contraceptive methods &#40;condoms and spermicide&#41; can be used in patients with SLE&#59; however&#44; their low efficiency as contraceptive method must be considered&#46;<a class="elsevierStyleCrossRef" href="#bib0375"><span class="elsevierStyleSup">9</span></a> The definitive &#40;surgical&#41; contraceptive method is safe and effective&#59; in patients with SLE&#44; its use is recommended in those subjects with satisfied parity<a class="elsevierStyleCrossRef" href="#bib0375"><span class="elsevierStyleSup">9</span></a> &#91;GR C&#93;&#46;<ul class="elsevierStyleList" id="lis0035"><li class="elsevierStyleListItem" id="lsti0220"><span class="elsevierStyleLabel">&#8226;</span><p id="par0355" class="elsevierStylePara elsevierViewall">Physicians who provide health care to women with SLE must provide advice on contraception in a personalized way to all fertile women &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41; &#91;GPP&#93;&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia></li></ul></p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0145">2&#46; In Women With Systemic Lupus Erythematosus&#44; What Are the Actions to Implement During the Preconception Period&#63;</span><p id="par0360" class="elsevierStylePara elsevierViewall">Pregnancy in patients with SLE&#44; compared to the general population&#44; is a high-risk pregnancy due to an elevated complication rate and maternal mortality rate<a class="elsevierStyleCrossRefs" href="#bib0380"><span class="elsevierStyleSup">10&#44;11</span></a> &#91;LOE III&#47;IV&#93;&#46; The frequency of maternal and foetal complications during pregnancy of women with SLE is higher in unplanned pregnancies<a class="elsevierStyleCrossRef" href="#bib0390"><span class="elsevierStyleSup">12</span></a> &#91;LOE III&#93;&#46; Ideally&#44; pregnancy in patients with SLE must be a planned event and there must be close preconception medical surveillance customized for each patient<a class="elsevierStyleCrossRefs" href="#bib0390"><span class="elsevierStyleSup">12&#44;13</span></a> &#91;GR C&#47;D&#93;&#46;</p><p id="par0365" class="elsevierStylePara elsevierViewall">The primary objective of preconception control in patients with SLE that want to be pregnant is to make the patients achieve disease remission at least 6 months before allowing pregnancy<a class="elsevierStyleCrossRef" href="#bib0395"><span class="elsevierStyleSup">13</span></a> &#91;LOE IV&#93;&#46; Pregnancy is not recommended in patients with SLE who have received teratogenic drugs during the last 6 months &#40;depending on each drug and assessing the risk-benefit ratio of its use&#41; &#91;GR D&#93;&#46; It is suggested for women with SLE that plan to become pregnant to have antiphospholipid&#44; anti-DNAdc and anti-SSA&#47;Ro and anti-SSB&#47;La antibodies determinations done as part of the preconception assessment<a class="elsevierStyleCrossRef" href="#bib0400"><span class="elsevierStyleSup">14</span></a> &#91;GR D&#93;&#46; Pregnancy in women with SLE must be planned&#44; monitored and considered high-risk in all cases<a class="elsevierStyleCrossRefs" href="#bib0385"><span class="elsevierStyleSup">11&#44;13</span></a> &#91;GR D&#93;&#46; Pregnancy in patients with SLE is contraindicated in women with severe pulmonary hypertension&#44; restrictive pulmonary disease&#44; heart failure&#44; chronic renal failure &#40;creatinine &#62;2&#46;8<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&#41;&#44; history of severe preeclampsia or HELLP syndrome &#40;microangiopaty characterized by haemolytic anaemia&#44; elevation of hepatic enzymes and thrombocytopenia&#41;&#44; brain vascular event within the previous 6 months and severe SLE relapse during the last 6 months &#91;GR D&#93;&#46; All fertile patients with SLE must receive medical advice &#40;including the patient and her family&#41; from the rheumatologist and the OB&#47;GYN during the preconception period&#46;<ul class="elsevierStyleList" id="lis0040"><li class="elsevierStyleListItem" id="lsti0225"><span class="elsevierStyleLabel">&#8226;</span><p id="par0370" class="elsevierStylePara elsevierViewall">If the patient is pregnant and active when she arrives to the physician&#39;s office&#44; the reactivation must be immediately treated and she must be informed about the high risk of developing maternal and foetal complications &#91;GPP&#93;&#46;</p></li></ul></p></span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0150">3&#46; In Pregnant Women With Systemic Lupus Erythematosus&#44; What Are the Frequency and Risk Factors of Disease</span><p id="par0375" class="elsevierStylePara elsevierViewall">In a prospective study on pregnant women with SLE compared to a control group &#40;non-pregnant women&#41;&#44; disease exacerbation was reported in 65&#37; of the pregnant women vs 42&#37; of the control group &#40;<span class="elsevierStyleItalic">P</span>&#61;&#46;015&#41;<a class="elsevierStyleCrossRef" href="#bib0405"><span class="elsevierStyleSup">15</span></a> &#91;LOE IIa&#93;&#46; At least 3 prospective studies show that pregnant women with SLE have a higher rate of disease relapse &#40;between 58 and 65&#37;&#41; compared to non-pregnant women with SLE<a class="elsevierStyleCrossRefs" href="#bib0405"><span class="elsevierStyleSup">15&#8211;17</span></a> &#91;LOE IIa&#93;&#46; At least 4 prospective studies on women with SLE showed a disease relapse rate of 27&#37;&#8211;70&#37; and it was not higher when compared to non-pregnant women with SLE<a class="elsevierStyleCrossRefs" href="#bib0420"><span class="elsevierStyleSup">18&#8211;21</span></a> &#91;LOE IIa&#47;IIb&#93;&#46; A SLE activity rate of 1&#46;2 people&#47;year in pregnant women vs 0&#46;4 people&#47;year in non-pregnant women &#40;<span class="elsevierStyleItalic">P</span>&#60;&#46;0001&#41; has been reported<a class="elsevierStyleCrossRef" href="#bib0440"><span class="elsevierStyleSup">22</span></a> &#91;LOE IIb&#93;&#46; A prospective study reported as risk factors of SLE activity during pregnancy&#58; an elevated number of disease relapses before pregnancy &#40;<span class="elsevierStyleItalic">P</span>&#60;&#46;05&#41;&#44; the discontinuation of chloroquine during pregnancy &#40;<span class="elsevierStyleItalic">P</span>&#60;&#46;05&#41; and a high SLEDAI rate &#40;&#62;5&#41; before pregnancy&#46;<a class="elsevierStyleCrossRef" href="#bib0440"><span class="elsevierStyleSup">22</span></a> In a retrospective study&#44; it was observed that disease reactivation in patients with SLE is more frequent during pregnancy &#40;36&#46;5&#37;<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>3&#46;3&#37;&#41;<a class="elsevierStyleCrossRef" href="#bib0445"><span class="elsevierStyleSup">23</span></a> &#91;LOE III&#93;&#46; In women with SLE&#44; pregnancy increases the risk of thrombotic events &#40;brain vascular disease&#44; brain thromboembolism and deep venous thrombosis&#41;&#44; severe infections and thrombocytopenia<a class="elsevierStyleCrossRef" href="#bib0380"><span class="elsevierStyleSup">10</span></a> &#91;LOE III&#93;&#46; Pregnancy in patients with pre-existing lupus nephropathy increases the activity of renal disease &#40;assessed by SELENA 2<span class="elsevierStyleHsp" style=""></span>K&#41;&#59; 47&#46;5 vs 13&#46;4&#37; &#40;<span class="elsevierStyleItalic">P</span>&#61;&#46;0001&#41;<a class="elsevierStyleCrossRef" href="#bib0450"><span class="elsevierStyleSup">24</span></a> &#91;LOE III&#93;&#46; Pregnant patients with previous lupus nephritis have a greater risk of renal activity in any organ&#44; compared to those patients that never had a renal condition &#40;54&#46;2 vs 25&#37;&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;004 and 45&#46;7 vs 6&#46;6&#37;&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;00001&#41;<a class="elsevierStyleCrossRef" href="#bib0455"><span class="elsevierStyleSup">25</span></a> &#91;LOE III&#93;&#46; The following are risk factors of disease relapse in pregnant patients with SLE&#58; active disease within 6 months before conception&#44; multiple exacerbations before conception&#44; treatment interruption during pregnancy and comorbidities<a class="elsevierStyleCrossRef" href="#bib0460"><span class="elsevierStyleSup">26</span></a> &#91;LOE IV&#93;&#46; The most frequent clinical manifestations of activity during pregnancy are&#58; mucocutaneous &#40;25&#37;&#8211;90&#37;&#41;&#44; haematological &#40;10&#37;&#8211;40&#37;&#41;&#44; articular &#40;20&#37;&#41; and renal &#40;4&#37;&#8211;30&#37;&#41;<a class="elsevierStyleCrossRefs" href="#bib0405"><span class="elsevierStyleSup">15&#44;16&#44;26</span></a> &#91;LOE IIa&#93;&#46; Close medical surveillance and communication among a multidisciplinary team is recommended&#44; as there is a high risk of disease relapse during pregnancy and immediate puerperium&#44; especially in patients with previous lupus nephritis &#91;GR C&#47;D&#93;&#46;<ul class="elsevierStyleList" id="lis0045"><li class="elsevierStyleListItem" id="lsti0230"><span class="elsevierStyleLabel">&#8226;</span><p id="par0380" class="elsevierStylePara elsevierViewall">Pregnant women with SLE should not abandon treatment &#91;GPP&#93;&#46;</p></li></ul></p></span><span id="sec0085" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0155">4&#46; In Pregnant Women With Systemic Lupus Erythematosus&#44; What Are the Frequency and Risks Factors to Develop Preeclampsia&#47;eclampsia&#63;</span><p id="par0385" class="elsevierStylePara elsevierViewall">As reported in a meta-analysis&#44; the frequency of preeclampsia in patients with SLE is 7&#46;6&#37;&#44; and 0&#46;8&#37; in the case of eclampsia&#46; Moreover&#44; the presence of active renal condition during pregnancy is a risk factor for the development of preeclampsia but not of eclampsia<a class="elsevierStyleCrossRef" href="#bib0465"><span class="elsevierStyleSup">27</span></a> &#91;LOE Ia&#93;&#46; A multicentre study from the USA reported a frequency of 22&#46;5&#37; of preeclampsia and 0&#46;5&#37; of eclampsia in pregnant patients with SLE &#40;OR&#58; 3 and 4&#46;4 respectively&#44; 95&#37; CI&#44; <span class="elsevierStyleItalic">P</span>&#60;&#46;001&#41;<a class="elsevierStyleCrossRef" href="#bib0380"><span class="elsevierStyleSup">10</span></a> &#91;LOE III&#93;&#46; A prevalence study of HELLP syndrome in an open population and in patients with SLE reported a frequency of severe preeclampsia in pregnant patients with SLE of 10&#37;&#8211;20&#37; and of HELLP syndrome of 0&#46;5&#37;&#8211;0&#46;9&#37;<a class="elsevierStyleCrossRef" href="#bib0470"><span class="elsevierStyleSup">28</span></a> &#91;LOE III&#93;&#46; A retrospective study that included pregnant women with SLE &#40;with and without previous renal condition&#41; reported a preeclampsia frequency of 22&#46;8&#37; in patients with previous renal activity vs 13&#46;3&#37; in patients without it &#40;<span class="elsevierStyleItalic">P</span>&#61;0&#46;2&#41;<a class="elsevierStyleCrossRef" href="#bib0455"><span class="elsevierStyleSup">25</span></a> &#91;LOE III&#93;&#46; Risk factors for the development of preeclampsia&#47;eclampsia described in pregnant patients with SLE are history of histologic class &#40;WHO&#41; iii and iv lupus nephritis&#44; history of preeclampsia and HELLP syndrome&#44; pre-existing high blood pressure&#44; presence of antiphospholipid antibodies and active SLE<a class="elsevierStyleCrossRef" href="#bib0475"><span class="elsevierStyleSup">29</span></a> &#91;LOE IV&#93;&#46; Preeclampsia generally occurs as from 20 weeks of gestation&#44; with increased levels of uric acid&#44; normal C3 and C4&#44; and normal double-chain anti-DNA antibodies&#46; In active lupus nephropathy there is hypocomplementemia&#44; elevated anti-DNAdc&#44; normal or increased levels of uric acid and active urinary sediment&#44; and it occurs at any time during gestation<a class="elsevierStyleCrossRefs" href="#bib0395"><span class="elsevierStyleSup">13&#44;20</span></a> &#91;LOE IV&#93;&#46; A differential diagnosis between lupus nephropathy and preeclampsia shall be performed in pregnant patients with SLE &#91;GR D&#93;&#46; It should be considered that pregnant patients with SLE have a high risk of preeclampsia development&#59; thus&#44; minimum blood pressure elevations and fluctuations ranging from normal or low blood pressure to mild elevations can be symptoms of the beginning of preeclampsia&#46; Young women or women over 35 years old&#44; primigravida and with history of lupus and&#47;or active nephropathy at the beginning of pregnancy are patients with the highest risk&#46;<a class="elsevierStyleCrossRef" href="#bib0480"><span class="elsevierStyleSup">30</span></a></p><p id="par0390" class="elsevierStylePara elsevierViewall">Two meta-analysis showed that early administration &#40;&#8804;16 WOG&#41; of low daily doses of aspirin &#40;50&#8211;150<span class="elsevierStyleHsp" style=""></span>mg&#41; reduces the risk of developing severe preeclampsia &#40;RR&#58; 0&#46;22&#59; 95&#37; CI&#58; 0&#46;08&#8211;0&#46;57&#41; or preeclampsia &#40;RR&#58; 0&#46;47&#59; 95&#37; CI&#58; 0&#46;36&#8211;0&#46;62&#41; in women at risk of developing it<a class="elsevierStyleCrossRefs" href="#bib0485"><span class="elsevierStyleSup">31&#44;32</span></a> &#91;LOE Ia&#93;&#46; If there is no contraindication&#44; the use of low doses of aspirin is recommended for all pregnant women with SLE to reduce the risk of preeclampsia development<a class="elsevierStyleCrossRefs" href="#bib0485"><span class="elsevierStyleSup">31&#44;32</span></a> &#91;GR A&#93;&#46;</p></span><span id="sec0090" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0160">5&#46; In Pregnant Women With Systemic Lupus Erythematosus&#44; What Are the Most Efficient Treatment Options to Prevent and Treat Disease Reactivation&#63;</span><p id="par0395" class="elsevierStylePara elsevierViewall">A prospective placebo-controlled study that included pregnant patients with SLE showed that hydroxychloroquine reduces the risk of exacerbations but does not have an influence on foetal outcome<a class="elsevierStyleCrossRef" href="#bib0495"><span class="elsevierStyleSup">33</span></a> &#91;LOE Ib&#93;&#46; Hydroxychloroquine discontinuation during pregnancy increases the risk of SLE activity&#44; including severe exacerbations such as severe urine protein and thrombocytopenia<a class="elsevierStyleCrossRef" href="#bib0500"><span class="elsevierStyleSup">34</span></a> &#91;LOE IIa&#93;&#46; The use of hydroxychloroquine is recommended to prevent SLE relapses during pregnancy<a class="elsevierStyleCrossRef" href="#bib0495"><span class="elsevierStyleSup">33</span></a> &#91;GR A&#93;&#46;</p><p id="par0400" class="elsevierStylePara elsevierViewall">A prospective study in pregnant patients with SLE concluded that the use of low doses of prednisone does not prevent disease relapses<a class="elsevierStyleCrossRef" href="#bib0405"><span class="elsevierStyleSup">15</span></a> &#91;LOE IIb&#93;&#46; The use of prednisone at doses higher than 20<span class="elsevierStyleHsp" style=""></span>mg&#47;d in pregnant patients with SLE increases the risk of preeclampsia and gestational diabetes<a class="elsevierStyleCrossRef" href="#bib0505"><span class="elsevierStyleSup">35</span></a> &#91;LOE IV&#93;&#46; The use of non-fluorinated glucocorticoids in pregnant patients with SLE is recommended to treat moderate to severe activity<a class="elsevierStyleCrossRef" href="#bib0460"><span class="elsevierStyleSup">26</span></a> &#91;GR D&#93;&#46;</p><p id="par0405" class="elsevierStylePara elsevierViewall">Non-steroidal anti-inflammatory drugs &#40;e&#46;g&#46;&#44; naproxene&#44; ibuprofen and indomethacin&#41; can be used during pregnancy for the control of joint manifestations&#59; its use shall be avoided only in the third trimester to prevent foetal complications&#44; especially the early closure of ductus arteriosus<a class="elsevierStyleCrossRef" href="#bib0395"><span class="elsevierStyleSup">13</span></a> &#91;GR D&#93;&#46; Azathioprine can be used during pregnancy in patients with SLE&#44; in case of moderate to severe activity before pregnancy &#40;continue the administration if it was administered before pregnancy or start administration during pregnancy&#44; as necessary&#41;<a class="elsevierStyleCrossRef" href="#bib0505"><span class="elsevierStyleSup">35</span></a> &#91;GR D&#93;&#46; Treatment with azathioprine should be continued in pregnant patients with SLE that received it before pregnancy&#44; and patients taking mycophenolate mofetil or other immunosuppressant who want to become pregnant should switch to azathioprine administration &#40;before pregnancy&#41;<a class="elsevierStyleCrossRef" href="#bib0505"><span class="elsevierStyleSup">35</span></a> &#91;GR D&#93;&#46; The use of methotrexate and leflunomide is completely contraindicated during pregnancy<a class="elsevierStyleCrossRef" href="#bib0460"><span class="elsevierStyleSup">26</span></a> &#91;GR D&#93;&#46; In a number of cases of pregnant patients with SLE exposed to cyclophosphamide during the first or second gestation trimester&#44; foetal loss was reported in 100&#37; of the cases<a class="elsevierStyleCrossRef" href="#bib0510"><span class="elsevierStyleSup">36</span></a> &#91;LOE IV&#93;&#46; The use of mycophenolate mofetil and cyclophosphamide in pregnant patients with SLE shall be reserved only for severe activity cases that threaten the mother&#39;s life&#46; It is essential to report the potential teratogenic effects in the foetus or to consider the pregnancy therapeutic discontinuation<a class="elsevierStyleCrossRef" href="#bib0460"><span class="elsevierStyleSup">26</span></a> &#91;GR D&#93;&#46; The use of intravenous &#40;iv&#41; gammaglobulin during the pregnancy of patients with SLE is safe and effective and represents a treatment option for those patients with recurrent foetal losses<a class="elsevierStyleCrossRef" href="#bib0515"><span class="elsevierStyleSup">37</span></a> &#91;LOE III&#93;&#46; There are no studies that analyze the security of the use of biological medications in pregnant patients with SLE&#44; and the scarce information available derives from case reports&#59; thus&#44; these medications shall not be used during pregnancy and must be discontinued in case of accidental exposure<a class="elsevierStyleCrossRef" href="#bib0520"><span class="elsevierStyleSup">38</span></a> &#91;GR C&#93;&#46; It is advisable for patients with SLE that become pregnant to continue the treatment administered before pregnancy&#44; provided that it does not include completely contraindicated drugs during pregnancy&#46;<a class="elsevierStyleCrossRef" href="#bib0405"><span class="elsevierStyleSup">15</span></a> It is necessary to personalize the SLE activity treatment during pregnancy&#44; considering the activity seriousness and the potential adverse events on the foetus<a class="elsevierStyleCrossRefs" href="#bib0505"><span class="elsevierStyleSup">35&#44;38</span></a> &#91;GR D&#93;&#46;<ul class="elsevierStyleList" id="lis0050"><li class="elsevierStyleListItem" id="lsti0235"><span class="elsevierStyleLabel">&#8226;</span><p id="par0410" class="elsevierStylePara elsevierViewall">It should be noted that most SLE reactivation cases during pregnancy and the postpartum period are mild to moderate in intensity&#44; so the use of metilprednisolone pulses should be avoided&#44; except in high-risk life-threatening situations &#91;GPP&#93;&#46;</p></li></ul></p></span></span><span id="sec0095" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0165">Foetal Morbidity</span><span id="sec0100" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0170">6&#46; In Pregnant Women With Systemic Lupus Erythematosus&#44; What Are the Frequency and Risk Factors Associated to Foetal Loss&#63;</span><p id="par0415" class="elsevierStylePara elsevierViewall">In women with lupus nephritis&#44; a frequency of 16&#37; of spontaneous abortions&#44; 3&#46;6&#37; of deaths and 2&#46;5&#37; of neonatal deaths has been reported<a class="elsevierStyleCrossRef" href="#bib0465"><span class="elsevierStyleSup">27</span></a> &#91;LOE Ia&#93;&#46; In a prospective study in pregnant women with SLE&#44; it was found that the frequency of spontaneous abortions was 14&#37; and of foetal death was 12&#37;<a class="elsevierStyleCrossRef" href="#bib0440"><span class="elsevierStyleSup">22</span></a> &#91;LOE IIb&#93;&#46; Hypocomplementemia &#40;<span class="elsevierStyleItalic">P</span>&#60;&#46;05&#41;&#44; high blood pressure at conception &#40;<span class="elsevierStyleItalic">P</span>&#62;&#46;001&#41; and antiphospholipid antibodies &#40;<span class="elsevierStyleItalic">P</span>&#60;&#46;05&#41; are foetal loss predictors in pregnant women with SLE<a class="elsevierStyleCrossRef" href="#bib0440"><span class="elsevierStyleSup">22</span></a> &#91;LOE IIb&#93;&#46; SLE activity within 6 months before conception has been associated to foetal loss in 42&#37; of cases<a class="elsevierStyleCrossRef" href="#bib0510"><span class="elsevierStyleSup">36</span></a> &#91;LOE IIb&#93;&#46; The disease clinical activity associated to hypocomplementemia and elevated anti-DNAdc antibodies titles are associated to foetal loss in pregnant women with SLE<a class="elsevierStyleCrossRef" href="#bib0485"><span class="elsevierStyleSup">31</span></a> &#91;LOE IIb&#93;&#46; Pregnancy is not recommended in women with active lupus nephritis<a class="elsevierStyleCrossRef" href="#bib0465"><span class="elsevierStyleSup">27</span></a> &#91;GR A&#93;&#46; SLE activity during pregnancy must be eventually identified and treated to reduce the risk of adverse foetal outcome &#40;foetal loss&#44; prematurity and intrauterine growth restriction&#41;<a class="elsevierStyleCrossRefs" href="#bib0525"><span class="elsevierStyleSup">39&#44;40</span></a> &#91;GR B&#47;C&#93;&#46; Patients with SLE are recommended to have an adequate disease control at least as from 6 months before pregnancy planning<a class="elsevierStyleCrossRef" href="#bib0510"><span class="elsevierStyleSup">36</span></a> &#91;GR B&#93;&#46;</p><p id="par0420" class="elsevierStylePara elsevierViewall">Associated APS is a foetal loss &#40;risk 3&#46;1 times higher&#41; and spontaneous abortion &#40;risk 5 times higher&#41; predictor&#46; Thrombocytopenia during the first trimester is associated to foetal loss &#40;risk 3&#46;3 times higher&#41;<a class="elsevierStyleCrossRef" href="#bib0535"><span class="elsevierStyleSup">41</span></a> &#91;LOE IIb&#93;&#46; High blood pressure during the first trimester of gestation is associated to foetal loss &#40;risk 2&#46;4 times higher&#41; and death &#40;risk 3&#46;4 times higher&#41;<a class="elsevierStyleCrossRef" href="#bib0535"><span class="elsevierStyleSup">41</span></a> &#91;LOE IIb&#93;&#46; Chronic systemic high blood pressure &#40;before pregnancy or acquired in the first trimester&#41; shall be controlled to reduce the risk of adverse foetal outcome &#40;foetal loss&#44; prematurity and intrauterine growth restriction&#41;<a class="elsevierStyleCrossRefs" href="#bib0440"><span class="elsevierStyleSup">22&#44;40&#8211;42</span></a> &#91;GR B&#47;C&#93;&#46;</p><p id="par0425" class="elsevierStylePara elsevierViewall">Hypocomplementemia and urine protein &#62;1<span class="elsevierStyleHsp" style=""></span>g&#47;24<span class="elsevierStyleHsp" style=""></span>h are foetal loss predictors in women with lupus nephritis<a class="elsevierStyleCrossRef" href="#bib0545"><span class="elsevierStyleSup">43</span></a> &#91;LOE IIb&#93;&#46; Lupus nephritis &#40;OR&#58; 7&#46;3&#41;&#44; anticardiolipine antibodies &#40;OR&#58; 3&#46;9&#41; and disease activity during pregnancy &#40;OR&#58; 1&#46;9&#41; are foetal loss predictors<a class="elsevierStyleCrossRef" href="#bib0530"><span class="elsevierStyleSup">40</span></a> &#91;LOE III&#93;&#46; In women with chronic renal disease&#44; pregnancy can accelerate the renal function deterioration and worsen high blood pressure and urine protein&#44; with a higher risk of maternal mortality and foetal complications &#40;such as intrauterine growth delay&#41;<a class="elsevierStyleCrossRef" href="#bib0550"><span class="elsevierStyleSup">44</span></a> &#91;LOE IV&#93;&#46; In women with lupus nephritis&#44; pregnancy can be planned if renal function is normal or presents minimal damage &#40;serum creatinine &#60;1&#46;5<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&#44; creatinine clearance &#8805;60<span class="elsevierStyleHsp" style=""></span>ml&#47;min&#44; urine protein &#60;1<span class="elsevierStyleHsp" style=""></span>g&#47;24<span class="elsevierStyleHsp" style=""></span>h&#41;<a class="elsevierStyleCrossRefs" href="#bib0545"><span class="elsevierStyleSup">43&#44;45</span></a> &#91;GR C&#93;&#46;</p></span><span id="sec0105" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0175">7&#46; In Pregnant Women With Systemic Lupus Erythematosus&#44; What Are the Frequency and Risk Factors Associated to Preterm Birth&#63;</span><p id="par0430" class="elsevierStylePara elsevierViewall">The reported frequency of prematurity in foetus of pregnant women with lupus nephritis is 39&#46;4&#37; &#40;95&#37; CI&#58; 32&#46;4&#8211;46&#46;4&#37;&#41;<a class="elsevierStyleCrossRef" href="#bib0465"><span class="elsevierStyleSup">27</span></a> &#91;LOE Ia&#93;&#46; The clinical activity of the disease along with the presence of hypocomplementemia and elevated high anti-DNAdc antibodies titles is associated to prematurity in foetus of women with SLE<a class="elsevierStyleCrossRef" href="#bib0525"><span class="elsevierStyleSup">39</span></a> &#91;LOE IIb&#93;&#46; The measurement of serum complement &#40;C3 and C4&#41; and anti-DNadc antibodies is recommended to identify pregnant women with SLE with foetal loss and prematurity risk<a class="elsevierStyleCrossRef" href="#bib0525"><span class="elsevierStyleSup">39</span></a> &#91;GR B&#93;&#46;</p><p id="par0435" class="elsevierStylePara elsevierViewall">High blood pressure during pregnancy and preeclampsia increase the risk of prematurity in foetus of pregnant women with SLE<a class="elsevierStyleCrossRefs" href="#bib0440"><span class="elsevierStyleSup">22&#44;42</span></a> &#91;LOE IIb&#93;&#46; Positive antiphospholipid antibodies &#40;OR&#58; 3&#46;6&#59; 95&#37; CI&#58; 1&#46;5&#8211;8&#46;7&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;004&#41; and active disease at conception &#40;OR&#58; 5&#46;5&#59; 95&#37; CI&#58; 2&#46;3&#8211;12&#46;8&#59; <span class="elsevierStyleItalic">P</span>&#60;&#46;0001&#41; increase the risk of prematurity in foetus of women with SLE<a class="elsevierStyleCrossRef" href="#bib0560"><span class="elsevierStyleSup">46</span></a> &#91;LOE III&#93;&#46; A retrospective analysis of 396 pregnancies determined that the presence of lupus nephritis &#40;OR&#58; 18&#46;8&#59; 95&#37; CI&#58; 1&#46;5&#8211;125&#46;9&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;02&#41;&#44; anti-Ro antibodies &#40;OR&#58; 13&#46;9&#59; 95&#37; CI&#58; 1&#46;0&#8211;116&#46;4&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;04&#41; and disease relapses &#40;OR&#58; 2&#46;4&#59; 95&#37; CI&#58; 1&#46;3&#8211;4&#46;5&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;003&#41; was associated to prematurity in pregnant women with SLE<a class="elsevierStyleCrossRef" href="#bib0530"><span class="elsevierStyleSup">40</span></a> &#91;LOE III&#93;&#46; High blood pressure and disease activity control is recommended to reduce prematurity risk in pregnant women with SLE<a class="elsevierStyleCrossRefs" href="#bib0440"><span class="elsevierStyleSup">22&#44;40&#44;42&#44;46</span></a> &#91;GR B&#47;C&#93;&#46;</p></span><span id="sec0110" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0180">8&#46; In Foetus of Pregnant Women With Systemic Lupus Erythematosus&#44; What Are the Frequency and Risk Factors Associated to Low Birth Weight&#47;intrauterine Growth Restriction&#47;small for Gestational Age&#63;</span><p id="par0440" class="elsevierStylePara elsevierViewall">The reported frequency of intrauterine growth restriction in foetus of pregnant women with lupus nephritis is 12&#46;7&#37; &#40;95&#37; CI&#58; 32&#46;4&#8211;46&#46;4&#37;&#41;<a class="elsevierStyleCrossRef" href="#bib0465"><span class="elsevierStyleSup">27</span></a> &#91;LOE Ia&#93;&#46; The frequency of low birth weight is higher in foetus of women with lupus nephritis compared to women without the disease &#40;46 vs 20&#37;&#44; <span class="elsevierStyleItalic">P</span>&#61;&#46;01&#41;<a class="elsevierStyleCrossRef" href="#bib0450"><span class="elsevierStyleSup">24</span></a> &#91;LOE IIb&#93;&#46; In a prospective study of pregnant women with SLE&#44; intrauterine growth restriction was observed in 35&#37; of cases<a class="elsevierStyleCrossRef" href="#bib0440"><span class="elsevierStyleSup">22</span></a> &#91;LOE IIb&#93;&#46; Active disease at conception has been associated to intrauterine growth restriction &#40;OR&#58; 3&#46;2&#59; 95&#37; CI&#58; 1&#46;3&#8211;7&#46;6&#59; <span class="elsevierStyleItalic">P</span>&#60;&#46;007&#41;<a class="elsevierStyleCrossRef" href="#bib0560"><span class="elsevierStyleSup">46</span></a> &#91;LOE IIb&#93;&#46; A prospective study of 29 pregnancies in women with SLE showed that low serum albumin levels&#44; antiphospholipid antibodies&#44; gestational urine protein&#44; high blood pressure and anti-Sm antibodies were associated to low birth weight<a class="elsevierStyleCrossRef" href="#bib0565"><span class="elsevierStyleSup">47</span></a> &#91;LOE IIb&#93;&#46; In women with SLE&#44; urine protein has been associated to small foetus for their gestational age<a class="elsevierStyleCrossRef" href="#bib0570"><span class="elsevierStyleSup">48</span></a> &#91;LOE III&#93;&#46; A retrospective analysis of 396 pregnancies in women with SLE determined that the presence of anti-La antibodies &#40;OR&#58; 11&#46;4&#59; 95&#37; CI&#58; 1&#46;1&#8211;115&#46;1&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;03&#41;&#44; high blood pressure &#40;OR&#58; 37&#46;7&#59; 95&#37; CI&#58; 3&#46;6&#8211;189&#46;7&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;02&#41;&#44; Raynaud&#39;s phenomenon &#40;OR&#58; 12&#46;2&#59; 95&#37; CI&#58; 2&#46;1&#8211;69&#46;7&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;005&#41; and disease activity &#40;OR&#58; 4&#46;1&#59; 95&#37; CI&#58; 1&#46;3&#8211;13&#46;1&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;01&#41; were associated to intrauterine growth restriction<a class="elsevierStyleCrossRef" href="#bib0530"><span class="elsevierStyleSup">40</span></a> &#91;LOE III&#93;&#46;</p></span><span id="sec0115" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0185">9&#46; In Women With Systemic Lupus Erythematosus&#44; How Is the Follow-up During Pregnancy and Immediate Puerperium Carried out&#63;</span><p id="par0445" class="elsevierStylePara elsevierViewall">Pregnancy in women with SLE must be considered a high-risk pregnancy<a class="elsevierStyleCrossRef" href="#bib0380"><span class="elsevierStyleSup">10</span></a> &#91;LOE III&#93;&#46; The frequency of complications during pregnancy of women with SLE&#44; such as disease relapse&#44; foetal loss&#44; prematurity and neonatal asphyxiation&#44; is greater when pregnancy is unplanned<a class="elsevierStyleCrossRef" href="#bib0390"><span class="elsevierStyleSup">12</span></a> &#91;LOE III&#93;&#46; During the pregnancy of a patient with SLE&#44; the patient must be assessed by the rheumatologist every 4&#8211;6 weeks and by the OB&#47;GYN every 4 weeks up to week 20 of gestation&#44; every 2 weeks up to week 28 of gestation and weekly until delivery<a class="elsevierStyleCrossRefs" href="#bib0505"><span class="elsevierStyleSup">35&#44;49&#8211;51</span></a> &#91;GR D&#93;&#46; At the beginning of pregnancy&#44; C3&#44; C4&#44; CH50&#44; anti-Ro&#44; anti-La&#44; anti-Sm&#44; anti-DNAdc antibodies and anticardiolipine&#44; as well as lupus anticoagulant should be determined<a class="elsevierStyleCrossRefs" href="#bib0395"><span class="elsevierStyleSup">13&#44;52</span></a> &#91;GR D&#93;&#46; During the pregnancy of women with SLE&#44; it is recommended to perform a monthly complete blood count&#44; blood biochemistry&#44; serum electrolytes&#44; general urine test&#44; creatinine&#47;urine protein rate&#44; C3&#44; C4&#44; CH50 and anti-DNAdc<a class="elsevierStyleCrossRefs" href="#bib0395"><span class="elsevierStyleSup">13&#44;52</span></a> &#91;GR D&#93;&#46; During the pregnancy of women with SLE&#44; it is recommended to perform foetal ultrasounds between week 7 and 13 of gestation and monthly after week 16 of gestation to determine foetal anomalies and monitor the growth<a class="elsevierStyleCrossRef" href="#bib0590"><span class="elsevierStyleSup">52</span></a> &#91;GR D&#93;&#46; It is recommended to carry out foetal well-being tests weekly as of week 26 of gestation<a class="elsevierStyleCrossRef" href="#bib0590"><span class="elsevierStyleSup">52</span></a> &#91;GR D&#93;&#46;</p></span><span id="sec0120" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0190">10&#46; In Foetus of Women Containing Positive Anti-Ro and&#47;or Anti-La Antibodies&#44; What Are the Most Effective Prevention and Treatment Options for the Management of Congenital Heart Block&#63;</span><p id="par0450" class="elsevierStylePara elsevierViewall">Cardiac neonatal lupus risk in children of mothers with anti-Ro antibodies is 2&#37; and with anti-La antibodies is 5&#37;<a class="elsevierStyleCrossRefs" href="#bib0595"><span class="elsevierStyleSup">53&#8211;55</span></a> &#91;LOE IIb&#93;&#46; CHB recurrence rate associated to anti-Ro antibodies is 17&#37;<a class="elsevierStyleCrossRef" href="#bib0610"><span class="elsevierStyleSup">56</span></a> &#91;LOE IIb&#93;&#46; Neonatal cardiac lupus mortality rate is around 20&#37;<a class="elsevierStyleCrossRefs" href="#bib0595"><span class="elsevierStyleSup">53&#44;57</span></a> &#91;LOE III&#93;&#46; In pregnant women with positive anti-Ro and&#47;or anti-La antibodies&#44; a foetal echocardiography must be performed weekly from week 16 to week 26 of gestation<a class="elsevierStyleCrossRefs" href="#bib0400"><span class="elsevierStyleSup">14&#44;52&#44;58</span></a> &#91;GR D&#93;&#46;</p><p id="par0455" class="elsevierStylePara elsevierViewall">A multicentre&#44; open&#44; with no randomized selection study did not show any benefits derived from the use of dexametasone to revert third degree CHB or the lack of progression from second to third degree CHB<a class="elsevierStyleCrossRef" href="#bib0625"><span class="elsevierStyleSup">59</span></a> &#91;LOE IIb&#93;&#46; A retrospective&#44; multinational&#44; multicentre study in 175 patients did not find significant differences in survival of foetus treated or not with fluorinated glucocorticoids&#44; regardless of the dose&#44; CHB degree and&#47;or presence of anti-RO antibodies<a class="elsevierStyleCrossRef" href="#bib0630"><span class="elsevierStyleSup">60</span></a> &#91;LOE III&#93;&#46; The use of fluorinated glucocorticoids is not recommended in foetus with third degree CHB<a class="elsevierStyleCrossRefs" href="#bib0625"><span class="elsevierStyleSup">59&#44;60</span></a> &#91;GR C&#93;&#46;</p><p id="par0460" class="elsevierStylePara elsevierViewall">In a sub-analysis of 2 retrospective studies&#44; with foetus belonging to positive anti-Ro&#47;anti-La mothers&#44; a CHB reversion from second degree to sinusal rhythm or first degree block was found in 35&#37; of the cases exposed to dexametasone&#44; compared to 6&#46;25&#37; of cases not exposed &#40;<span class="elsevierStyleItalic">P</span>&#61;&#46;053&#41;<a class="elsevierStyleCrossRefs" href="#bib0615"><span class="elsevierStyleSup">57&#44;60</span></a> &#91;LOE III&#93;&#46; The use of fluorinated glucocorticoids is recommended in foetus with second degree CHB<a class="elsevierStyleCrossRefs" href="#bib0615"><span class="elsevierStyleSup">57&#44;60</span></a> &#91;GR C&#93;&#46;</p><p id="par0465" class="elsevierStylePara elsevierViewall">In 2 prospective&#44; multicentre studies in pregnant women of &#60;12WOG&#44; with positive anti-Ro&#47;anti-La antibodies and at least one previous birth with CHB&#47;neonatal lupus&#44; the use of iv gammaglobulin &#40;400<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#41; every 3 weeks&#44; from week 12 to 24 of gestation&#44; did not prevent the recurrence of CHB<a class="elsevierStyleCrossRefs" href="#bib0635"><span class="elsevierStyleSup">61&#44;62</span></a> &#91;LOE IIb&#93;&#46; The use of gammaglobulin iv is not recommended for the prevention of CHB recurrence in pregnant women with anti-Ro&#47;anti-La antibodies<a class="elsevierStyleCrossRefs" href="#bib0635"><span class="elsevierStyleSup">61&#44;62</span></a> &#91;GR B&#93;&#46;</p><p id="par0470" class="elsevierStylePara elsevierViewall">A retrospective study in 20 patients treated with iv gammaglobulin &#40;1<span class="elsevierStyleHsp" style=""></span>g&#47;kg per 1&#8211;3 doses&#41;&#44; combined with glucocorticoids&#44; showed 80&#37; of live births with established neonatal cardiac lupus &#40;cardiomyopathy&#41;<a class="elsevierStyleCrossRef" href="#bib0645"><span class="elsevierStyleSup">63</span></a> &#91;LOE III&#93;&#46; A report of 2 cases showed second to first degree CHB reversion with the combined use of dexamethasone 4<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#44; iv gammaglobulin &#40;1<span class="elsevierStyleHsp" style=""></span>g&#47;kg every 15<span class="elsevierStyleHsp" style=""></span>d&#41; and weekly plasmapheresis until birth<a class="elsevierStyleCrossRef" href="#bib0650"><span class="elsevierStyleSup">64</span></a> &#91;LOE IV&#93;&#46; The use of therapy combined with glucocorticoids&#44; iv gammaglobulin and plasmapheresis creates second and third line interventions to revert second degree CHB<a class="elsevierStyleCrossRef" href="#bib0650"><span class="elsevierStyleSup">64</span></a> &#91;GR D&#93;&#46;</p><p id="par0475" class="elsevierStylePara elsevierViewall">A case control study determined that exposure to hydroxychloroquine during pregnancy in women with SLE and positive anti-Ro&#47;anti-La antibodies can reduce the risk of developing neonatal cardiac lupus &#40;OR&#58; 0&#46;46&#59; 95&#37; CI&#58; 0&#46;18&#8211;1&#46;18&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;10&#41;<a class="elsevierStyleCrossRef" href="#bib0655"><span class="elsevierStyleSup">65</span></a> &#91;LOE III&#93;&#46; A retrospective study of 3 cohorts determined that the use of hydroxychloroquine during pregnancy in women with SLE and positive anti-Ro&#47;anti-La antibodies reduces the risk of developing recurrent neonatal cardiac lupus &#40;OR&#58; 0&#46;23&#59; 95&#37; CI&#58; 0&#46;06&#8211;0&#46;92&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;037&#41;<a class="elsevierStyleCrossRef" href="#bib0660"><span class="elsevierStyleSup">66</span></a> &#91;LOE III&#93;&#46; It is recommended to continue the use of hydroxychloroquine during pregnancy in women with positive anti-Ro&#47;anti-La antibodies to reduce the risk of developing recurrent neonatal cardiac lupus<a class="elsevierStyleCrossRefs" href="#bib0655"><span class="elsevierStyleSup">65&#44;66</span></a> &#91;GR C&#93;&#46;</p></span></span></span><span id="sec0125" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0195">Ethical Responsibilities</span><span id="sec0130" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0200">Protection of persons and animals</span><p id="par0480" class="elsevierStylePara elsevierViewall">Authors state that no experiments were performed on human beings or animals as part of this investigation&#46;</p></span><span id="sec0135" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0205">Data confidentiality</span><p id="par0485" class="elsevierStylePara elsevierViewall">Authors state that this article does not contain patient data&#46;</p></span><span id="sec0140" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0210">Right to privacy and informed consent</span><p id="par0490" class="elsevierStylePara elsevierViewall">Authors state that this article does not contain patient data&#46;</p></span></span><span id="sec0145" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0215">Conflict of Interest</span><p id="par0495" class="elsevierStylePara elsevierViewall">The Mexican College of Rheumatology received unrestricted educational support from the company UCB&#46; The staff working at UCB had no interference with the information vested herein and did not participate in any meetings of the working group&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:15 [
        0 => array:3 [
          "identificador" => "xres548571"
          "titulo" => "Abstract"
          "secciones" => array:5 [
            0 => array:2 [
              "identificador" => "abst0005"
              "titulo" => "Background"
            ]
            1 => array:2 [
              "identificador" => "abst0010"
              "titulo" => "Objectives"
            ]
            2 => array:2 [
              "identificador" => "abst0015"
              "titulo" => "Methodology"
            ]
            3 => array:2 [
              "identificador" => "abst0020"
              "titulo" => "Results"
            ]
            4 => array:2 [
              "identificador" => "abst0025"
              "titulo" => "Conclusions"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec566354"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres548570"
          "titulo" => "Resumen"
          "secciones" => array:5 [
            0 => array:2 [
              "identificador" => "abst0030"
              "titulo" => "Antecedentes"
            ]
            1 => array:2 [
              "identificador" => "abst0035"
              "titulo" => "Objetivos"
            ]
            2 => array:2 [
              "identificador" => "abst0040"
              "titulo" => "Metodolog&#237;a"
            ]
            3 => array:2 [
              "identificador" => "abst0045"
              "titulo" => "Resultados"
            ]
            4 => array:2 [
              "identificador" => "abst0050"
              "titulo" => "Conclusiones"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec566355"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Extent and Objectives"
        ]
        5 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Potential Users"
        ]
        6 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Target Population"
        ]
        7 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "Attention Level"
        ]
        8 => array:2 [
          "identificador" => "sec0025"
          "titulo" => "Methodology"
        ]
        9 => array:2 [
          "identificador" => "sec0030"
          "titulo" => "Development of Recommendations"
        ]
        10 => array:3 [
          "identificador" => "sec0035"
          "titulo" => "Questions Included"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "sec0040"
              "titulo" => "Systemic Lupus Erythematosus"
            ]
            1 => array:2 [
              "identificador" => "sec0045"
              "titulo" => "Rheumatoid Arthritis"
            ]
            2 => array:2 [
              "identificador" => "sec0050"
              "titulo" => "Antiphospholipid Antibody Syndrome"
            ]
            3 => array:2 [
              "identificador" => "sec0055"
              "titulo" => "Antirheumatic Drugs"
            ]
          ]
        ]
        11 => array:3 [
          "identificador" => "sec0060"
          "titulo" => "Systemic Lupus Erythematosus"
          "secciones" => array:2 [
            0 => array:3 [
              "identificador" => "sec0065"
              "titulo" => "Maternal Morbidity"
              "secciones" => array:5 [
                0 => array:2 [
                  "identificador" => "sec0070"
                  "titulo" => "1&#46; In Women With Systemic Lupus Erythematosus&#44; What Are the Safest Contraceptive Options&#63;"
                ]
                1 => array:2 [
                  "identificador" => "sec0075"
                  "titulo" => "2&#46; In Women With Systemic Lupus Erythematosus&#44; What Are the Actions to Implement During the Preconception Period&#63;"
                ]
                2 => array:2 [
                  "identificador" => "sec0080"
                  "titulo" => "3&#46; In Pregnant Women With Systemic Lupus Erythematosus&#44; What Are the Frequency and Risk Factors of Disease"
                ]
                3 => array:2 [
                  "identificador" => "sec0085"
                  "titulo" => "4&#46; In Pregnant Women With Systemic Lupus Erythematosus&#44; What Are the Frequency and Risks Factors to Develop Preeclampsia&#47;eclampsia&#63;"
                ]
                4 => array:2 [
                  "identificador" => "sec0090"
                  "titulo" => "5&#46; In Pregnant Women With Systemic Lupus Erythematosus&#44; What Are the Most Efficient Treatment Options to Prevent and Treat Disease Reactivation&#63;"
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "sec0095"
              "titulo" => "Foetal Morbidity"
              "secciones" => array:5 [
                0 => array:2 [
                  "identificador" => "sec0100"
                  "titulo" => "6&#46; In Pregnant Women With Systemic Lupus Erythematosus&#44; What Are the Frequency and Risk Factors Associated to Foetal Loss&#63;"
                ]
                1 => array:2 [
                  "identificador" => "sec0105"
                  "titulo" => "7&#46; In Pregnant Women With Systemic Lupus Erythematosus&#44; What Are the Frequency and Risk Factors Associated to Preterm Birth&#63;"
                ]
                2 => array:2 [
                  "identificador" => "sec0110"
                  "titulo" => "8&#46; In Foetus of Pregnant Women With Systemic Lupus Erythematosus&#44; What Are the Frequency and Risk Factors Associated to Low Birth Weight&#47;intrauterine Growth Restriction&#47;small for Gestational Age&#63;"
                ]
                3 => array:2 [
                  "identificador" => "sec0115"
                  "titulo" => "9&#46; In Women With Systemic Lupus Erythematosus&#44; How Is the Follow-up During Pregnancy and Immediate Puerperium Carried out&#63;"
                ]
                4 => array:2 [
                  "identificador" => "sec0120"
                  "titulo" => "10&#46; In Foetus of Women Containing Positive Anti-Ro and&#47;or Anti-La Antibodies&#44; What Are the Most Effective Prevention and Treatment Options for the Management of Congenital Heart Block&#63;"
                ]
              ]
            ]
          ]
        ]
        12 => array:3 [
          "identificador" => "sec0125"
          "titulo" => "Ethical Responsibilities"
          "secciones" => array:3 [
            0 => array:2 [
              "identificador" => "sec0130"
              "titulo" => "Protection of persons and animals"
            ]
            1 => array:2 [
              "identificador" => "sec0135"
              "titulo" => "Data confidentiality"
            ]
            2 => array:2 [
              "identificador" => "sec0140"
              "titulo" => "Right to privacy and informed consent"
            ]
          ]
        ]
        13 => array:2 [
          "identificador" => "sec0145"
          "titulo" => "Conflict of Interest"
        ]
        14 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2014-06-10"
    "fechaAceptado" => "2014-11-08"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec566354"
          "palabras" => array:4 [
            0 => "Clinical practice guidelines"
            1 => "Pregnancy"
            2 => "Systemic lupus erythematosus"
            3 => "Antirheumatic drugs"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec566355"
          "palabras" => array:4 [
            0 => "Gu&#237;as de pr&#225;ctica cl&#237;nica"
            1 => "Embarazo"
            2 => "Lupus eritematoso sist&#233;mico"
            3 => "F&#225;rmacos antirreum&#225;ticos"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:3 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Background</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Pregnancy in women with autoimmune rheumatic diseases is associated with several maternal and foetal complications&#46; The development of clinical practice guidelines with the best available scientific evidence may help standardize the care of these patients&#46;</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Objectives</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">To provide recommendations regarding prenatal care&#44; treatment&#44; and a more effective monitoring of pregnancy in women with lupus erythematosus &#40;SLE&#41;&#44; rheumatoid arthritis &#40;RA&#41; and antiphospholipid antibody syndrome &#40;APS&#41;&#46;</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Methodology</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Nominal panels were formed for consensus&#44; systematic search of information&#44; development of clinical questions&#44; processing and grading of recommendations&#44; internal validation by peers&#44; and external validation of the final document&#46; The quality criteria of the AGREE II instrument were followed&#46;</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Results</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">The various panels answered the 37 questions related to maternal and foetal care in SLE&#44; RA&#44; and APS&#44; as well as to the use of antirheumatic drugs during pregnancy and lactation&#46; The recommendations were discussed and integrated into a final manuscript&#46; Finally&#44; the corresponding algorithms were developed&#46; We present the recommendations for pregnant women with SLE in this first part&#46;</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Conclusions</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">We believe that the Mexican clinical practice guidelines for the management of pregnancy in women with SLE integrate the best available evidence for the treatment and follow-up of patients with these conditions&#46;</p></span>"
        "secciones" => array:5 [
          0 => array:2 [
            "identificador" => "abst0005"
            "titulo" => "Background"
          ]
          1 => array:2 [
            "identificador" => "abst0010"
            "titulo" => "Objectives"
          ]
          2 => array:2 [
            "identificador" => "abst0015"
            "titulo" => "Methodology"
          ]
          3 => array:2 [
            "identificador" => "abst0020"
            "titulo" => "Results"
          ]
          4 => array:2 [
            "identificador" => "abst0025"
            "titulo" => "Conclusions"
          ]
        ]
      ]
      "es" => array:3 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Antecedentes</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">El embarazo en mujeres con enfermedades reum&#225;ticas autoinmunes se asocia a diversas complicaciones maternofetales&#46; El desarrollo de gu&#237;as de pr&#225;ctica cl&#237;nica con la mejor evidencia cient&#237;fica disponible puede ayudar a homogeneizar la atenci&#243;n en estas pacientes&#46;</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Objetivos</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Proporcionar recomendaciones respecto al control prenatal&#44; el tratamiento y el seguimiento m&#225;s efectivo de la mujer embarazada con lupus eritematoso &#40;LES&#41;&#44; artritis reumatoide &#40;AR&#41; y s&#237;ndrome por anticuerpos antifosfol&#237;pidos &#40;SAF&#41;&#46;</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Metodolog&#237;a</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Para la elaboraci&#243;n de las recomendaciones se conformaron grupos nominales de expertos y se realizaron consensos formales&#44; b&#250;squeda sistematizada de la informaci&#243;n&#44; elaboraci&#243;n de preguntas cl&#237;nicas&#44; elaboraci&#243;n y calificaci&#243;n de las recomendaciones&#44; fase de validaci&#243;n interna por pares y validaci&#243;n externa del documento final teniendo en cuenta los criterios de calidad del instrumento AGREE II&#46;</p></span> <span id="abst0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Resultados</span><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Los grupos de trabajo contestaron las 37 preguntas relacionadas con la atenci&#243;n maternofetal en LES&#44; AR y SAF&#44; as&#237; como de f&#225;rmacos antirreum&#225;ticos durante el embarazo y la lactancia&#46; Las recomendaciones fueron discutidas e integradas en un manuscrito final y se elaboraron los algoritmos correspondientes&#46; En esta primera parte se presentan las recomendaciones para mujeres embarazadas con LES&#46;</p></span> <span id="abst0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Conclusiones</span><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">La gu&#237;a mexicana de pr&#225;ctica cl&#237;nica para la atenci&#243;n del embarazo en mujeres con LES proporciona recomendaciones e integra la mejor evidencia disponible para el tratamiento y el seguimiento de estas pacientes&#46;</p></span>"
        "secciones" => array:5 [
          0 => array:2 [
            "identificador" => "abst0030"
            "titulo" => "Antecedentes"
          ]
          1 => array:2 [
            "identificador" => "abst0035"
            "titulo" => "Objetivos"
          ]
          2 => array:2 [
            "identificador" => "abst0040"
            "titulo" => "Metodolog&#237;a"
          ]
          3 => array:2 [
            "identificador" => "abst0045"
            "titulo" => "Resultados"
          ]
          4 => array:2 [
            "identificador" => "abst0050"
            "titulo" => "Conclusiones"
          ]
        ]
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Saavedra Salinas M&#193;&#44; Barrera Cruz A&#44; Cabral Casta&#241;eda AR&#44; Jara Quezada LJ&#44; Arce-Salinas CA&#44; &#193;lvarez Nemegyei J&#44; et al&#46; Gu&#237;as de pr&#225;ctica cl&#237;nica para la atenci&#243;n del embarazo en mujeres con enfermedades reum&#225;ticas autoinmunes del Colegio Mexicano de Reumatolog&#237;a&#46; Parte I&#46; Reumatol Clin&#46; 2015&#59;11&#58;295&#8211;304&#46;</p>"
      ]
    ]
    "multimedia" => array:3 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1919
            "Ancho" => 3173
            "Tamanyo" => 177076
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Algorithm of treatment of patients with systemic lupus erythematosus&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Websites&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">No&#46; of results obtained&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">No&#46; of documents used&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">National Institute for Health and Clinical Excellence &#40;NICE&#41; &#8211; England&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Scottish Intercollegiate Guidelines Network &#40;SIGN&#41; &#8211; Scotland&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">New Zealand Guidelines Group &#40;NZGG&#41; &#8211; New Zealand&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">National Health and Medical Research Council &#40;NHMRC&#41; &#8211; Australia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Institute for Clinical Systems Improvement &#40;ICSI&#41; health care guidelines &#8211; USA&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">National Guideline Clearinghouse&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Guidelines International Network &#40;G-I-N&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">15&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Total&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">32&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab886170.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Websites Consulted for the Elaboration of This CPG Guideline&#46;</p>"
        ]
      ]
      2 => array:7 [
        "identificador" => "tbl0010"
        "etiqueta" => "Table 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">It classifies evidence per levels &#40;categories&#41; and indicates the source of the issued recommendations based on the soundness degree&#46; To establish the evidence category&#44; it uses Roman numbers from i to iv and letters a and b &#40;lower case&#41;&#46; In soundness of recommendation&#44; upper case letters from A to D are used&#46;</p><p id="spar0075" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">Source</span>&#58; Modified from Shekelle et al&#46;<a class="elsevierStyleCrossRef" href="#bib0350"><span class="elsevierStyleSup">4</span></a></p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Evidence category&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Recommendation soundness&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Ia&#46; Evidence for meta-analysis of the randomized clinical studies&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">A&#46; Directly based on category I evidence&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Ib&#46; Evidence from at least one randomized controlled clinical study&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">IIa&#46; Evidence from at least one controlled study without randomization&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">B&#46; Directly based on category <span class="elsevierStyleSmallCaps">II</span> evidence or recommendations extrapolated from evidence <span class="elsevierStyleSmallCaps">I</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">IIb&#46; At least other kind of quasi-experimental study or studies of cohort&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">III&#46; Evidence of a descriptive&#44; non-experimental study&#44; such as comparative studies&#44; correlation studies&#44; cases and controls and clinical reviews&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">C&#46; Directly based on category <span class="elsevierStyleSmallCaps">III</span> evidence or recommendations extrapolated from category <span class="elsevierStyleSmallCaps">I</span> or <span class="elsevierStyleSmallCaps">II</span> evidences&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">IV&#46; Evidence from expert&#39;s committees&#44; reports&#44; opinions or clinical experience from authorities regulating the subject or both&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">D&#46; Directly based on category <span class="elsevierStyleSmallCaps">IV</span> evidence or recommendations extrapolated from category <span class="elsevierStyleSmallCaps">II</span>or <span class="elsevierStyleSmallCaps">III</span> evidences&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab886169.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Shekelle et al&#46; Modified Scale&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:66 [
            0 => array:3 [
              "identificador" => "bib0335"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Interaction of pregnancy and autoimmune rheumatic disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [ …3]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.autrev.2011.11.013"
                      "Revista" => array:6 [
                        "tituloSerie" => "Autoimmun Rev"
                        "fecha" => "2012"
                        "volumen" => "11"
                        "paginaInicial" => "A437"
                        "paginaFinal" => "A446"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0340"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pregnancy and reproduction in autoimmune rheumatic diseases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Rheumatology &#40;Oxford&#41;"
                        "fecha" => "2011"
                        "volumen" => "50"
                        "paginaInicial" => "657"
                        "paginaFinal" => "664"
                        "itemHostRev" => array:3 [
                          "pii" => "S0266613813003379"
                          "estado" => "S300"
                          "issn" => "02666138"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0345"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "AGREE II&#58; advancing guideline development&#44; reporting and evaluation in health care"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "CMAJ"
                        "fecha" => "2010"
                        "volumen" => "182"
                        "paginaInicial" => "839"
                        "paginaFinal" => "842"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0350"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical guidelines&#46; Developing guidelines"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "BMJ"
                        "fecha" => "1999"
                        "volumen" => "3"
                        "paginaInicial" => "593"
                        "paginaFinal" => "599"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0355"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mechanisms of disease&#58; systemic lupus erythematosus"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMra1100359"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2011"
                        "volumen" => "365"
                        "paginaInicial" => "2110"
                        "paginaFinal" => "2121"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0360"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Combined oral contraceptives in women with systemic lupus erythematosus"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa051135"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2005"
                        "volumen" => "353"
                        "paginaInicial" => "2550"
                        "paginaFinal" => "2558"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0365"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A trial of contraceptive methods in women with systemic lupus erythematosus"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa050817"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2005"
                        "volumen" => "353"
                        "paginaInicial" => "2539"
                        "paginaFinal" => "2549"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0370"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pregnane progestin contraception in systemic lupus erythematosus&#58; a longitudinal study of 187 patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.contraception.2010.08.012"
                      "Revista" => array:6 [
                        "tituloSerie" => "Contraception"
                        "fecha" => "2011"
                        "volumen" => "83"
                        "paginaInicial" => "229"
                        "paginaFinal" => "237"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0375"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Managing contraception and pregnancy in the rheumatologic diseases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.berh.2009.12.004"
                      "Revista" => array:6 [
                        "tituloSerie" => "Best Pract Res Clin Rheumatol"
                        "fecha" => "2010"
                        "volumen" => "24"
                        "paginaInicial" => "373"
                        "paginaFinal" => "385"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0380"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A national study of the complications of lupus in pregnancy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.ajog.2008.10.006"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Obstet Gynecol"
                        "fecha" => "2008"
                        "volumen" => "199"
                        "paginaInicial" => "e1"
                        "paginaFinal" => "e6"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0385"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Lupus and pregnancy&#58; ten questions and some answers"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1177/0961203308090027"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lupus"
                        "fecha" => "2008"
                        "volumen" => "17"
                        "paginaInicial" => "416"
                        "paginaFinal" => "420"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0390"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pregnancy complicating systemic lupus erythematosus&#58; a series of 86 cases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s00404-010-1786-5"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Gynecol Obstet"
                        "fecha" => "2011"
                        "volumen" => "284"
                        "paginaInicial" => "1067"
                        "paginaFinal" => "1071"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0395"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Lupus and pregnancy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [ …3]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/OGX.0b013e318239e1ee"
                      "Revista" => array:6 [
                        "tituloSerie" => "Obstet Gynecol Surv"
                        "fecha" => "2011"
                        "volumen" => "66"
                        "paginaInicial" => "639"
                        "paginaFinal" => "653"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0400"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Lupus and pregnancy&#58; integrating clues from the bench and bedside"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-2362.2010.02443.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur J Clin Invest"
                        "fecha" => "2011"
                        "volumen" => "41"
                        "paginaInicial" => "672"
                        "paginaFinal" => "678"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0405"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Increased rate of lupus flare during pregnancy and the puerperium&#58; a prospective study of 78 pregnancies"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Rheumatol"
                        "fecha" => "1996"
                        "volumen" => "35"
                        "paginaInicial" => "133"
                        "paginaFinal" => "138"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0410"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Frequency of lupus flare in pregnancy&#46; The Hopkins Lupus Pregnancy Center experience"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [ …3]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "1991"
                        "volumen" => "34"
                        "paginaInicial" => "1538"
                        "paginaFinal" => "1545"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0415"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Outcome of pregnancy in patients with systemic lupus erythematosus&#46; A prospective study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [ …3]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Intern Med"
                        "fecha" => "1991"
                        "volumen" => "151"
                        "paginaInicial" => "269"
                        "paginaFinal" => "273"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0420"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Lupus pregnancy&#46; Case&#8211;control prospective study demonstrating absence of lupus exacerbation during or after pregnancy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [ …5]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med"
                        "fecha" => "1984"
                        "volumen" => "77"
                        "paginaInicial" => "893"
                        "paginaFinal" => "898"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0425"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Lupus and pregnancy studies"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [ …5]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "1993"
                        "volumen" => "36"
                        "paginaInicial" => "1392"
                        "paginaFinal" => "1397"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0430"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The effect of pregnancy on lupus nephritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.20638"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2004"
                        "volumen" => "50"
                        "paginaInicial" => "3941"
                        "paginaFinal" => "3946"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0435"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prospective study of pregnancy in systemic lupus erythematosus&#46; Results of a multidisciplinary approach"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [ …5]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Rheumatol"
                        "fecha" => "1986"
                        "volumen" => "13"
                        "paginaInicial" => "732"
                        "paginaFinal" => "739"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0440"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus&#58; a prospective study of 103 pregnancies"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Rheumatology &#40;Oxford&#41;"
                        "fecha" => "2002"
                        "volumen" => "41"
                        "paginaInicial" => "643"
                        "paginaFinal" => "650"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0445"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pregnancy outcome in systemic lupus erythematosus &#40;SLE&#41; is improving&#58; results from a case control study and literature review"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2174/1874312900802010089"
                      "Revista" => array:6 [
                        "tituloSerie" => "Open Rheumatol J"
                        "fecha" => "2008"
                        "volumen" => "2"
                        "paginaInicial" => "89"
                        "paginaFinal" => "98"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0450"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3899/jrheum.090872"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Rheumatol"
                        "fecha" => "2010"
                        "volumen" => "37"
                        "paginaInicial" => "754"
                        "paginaFinal" => "758"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0455"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s10067-012-1941-4"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Rheumatol"
                        "fecha" => "2012"
                        "volumen" => "31"
                        "paginaInicial" => "813"
                        "paginaFinal" => "819"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib0460"
              "etiqueta" => "26"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Lupus activity in pregnancy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Rheum Dis Clin N Am"
                        "fecha" => "2007"
                        "volumen" => "33"
                        "paginaInicial" => "237"
                        "paginaFinal" => "252"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib0465"
              "etiqueta" => "27"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2215/CJN.00240110"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin J Am Soc Nephrol"
                        "fecha" => "2010"
                        "volumen" => "5"
                        "paginaInicial" => "2060"
                        "paginaFinal" => "2068"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib0470"
              "etiqueta" => "28"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Maternal morbidity and mortality in 442 pregnancies with hemolysis&#44; elevated liver enzymes&#44; and low platelets &#40;HELLP syndrome&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Obstet Gynecol"
                        "fecha" => "1993"
                        "volumen" => "169"
                        "paginaInicial" => "1000"
                        "paginaFinal" => "1006"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib0475"
              "etiqueta" => "29"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Obstetric management of the high-risk lupus pregnancy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Rheum Dis Clin N Am"
                        "fecha" => "1997"
                        "volumen" => "23"
                        "paginaInicial" => "119"
                        "paginaFinal" => "132"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            29 => array:3 [
              "identificador" => "bib0480"
              "etiqueta" => "30"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The challenge of pregnancy for patients with SLE"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1177/0961203313504637"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lupus"
                        "fecha" => "2013"
                        "volumen" => "22"
                        "paginaInicial" => "1295"
                        "paginaFinal" => "1308"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            30 => array:3 [
              "identificador" => "bib0485"
              "etiqueta" => "31"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia&#58; a systematic review and meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1055/s-0032-1310527"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Perinatol"
                        "fecha" => "2012"
                        "volumen" => "29"
                        "paginaInicial" => "551"
                        "paginaFinal" => "556"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            31 => array:3 [
              "identificador" => "bib0490"
              "etiqueta" => "32"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin&#58; a meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [ …5]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/uog.12421"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ultrasound Obstet Gynecol"
                        "fecha" => "2013"
                        "volumen" => "41"
                        "paginaInicial" => "491"
                        "paginaFinal" => "499"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            32 => array:3 [
              "identificador" => "bib0495"
              "etiqueta" => "33"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Hydroxychloroquine &#40;HCQ&#41; in lupus pregnancy&#58; double-blind and placebo-controlled study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Lupus"
                        "fecha" => "2001"
                        "volumen" => "10"
                        "paginaInicial" => "401"
                        "paginaFinal" => "404"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            33 => array:3 [
              "identificador" => "bib0500"
              "etiqueta" => "34"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Hydroxychloroquine in lupus pregnancy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.22159"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2006"
                        "volumen" => "54"
                        "paginaInicial" => "3640"
                        "paginaFinal" => "3647"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            34 => array:3 [
              "identificador" => "bib0505"
              "etiqueta" => "35"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The Hopkins Lupus Pregnancy Center&#58; ten key issues in management"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Rheum Dis Clin N Am"
                        "fecha" => "2007"
                        "volumen" => "33"
                        "paginaInicial" => "227"
                        "paginaFinal" => "235"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            35 => array:3 [
              "identificador" => "bib0510"
              "etiqueta" => "36"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The impact of increased lupus activity on obstetric outcomes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.20864"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2005"
                        "volumen" => "52"
                        "paginaInicial" => "514"
                        "paginaFinal" => "521"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            36 => array:3 [
              "identificador" => "bib0515"
              "etiqueta" => "37"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Rheumatology &#40;Oxford&#41;"
                        "fecha" => "2008"
                        "volumen" => "47"
                        "paginaInicial" => "646"
                        "paginaFinal" => "651"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            37 => array:3 [
              "identificador" => "bib0520"
              "etiqueta" => "38"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Flares of systemic lupus erythematosus during pregnancy and the puerperium&#58; prevention&#44; diagnosis and management"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1586/eci.12.36"
                      "Revista" => array:6 [
                        "tituloSerie" => "Expert Rev Clin Immunol"
                        "fecha" => "2012"
                        "volumen" => "8"
                        "paginaInicial" => "439"
                        "paginaFinal" => "453"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            38 => array:3 [
              "identificador" => "bib0525"
              "etiqueta" => "39"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [ …3]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3899/jrheum.100746"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Rheumatol"
                        "fecha" => "2011"
                        "volumen" => "38"
                        "paginaInicial" => "1012"
                        "paginaFinal" => "1016"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            39 => array:3 [
              "identificador" => "bib0530"
              "etiqueta" => "40"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1177/0961203310378669"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lupus"
                        "fecha" => "2010"
                        "volumen" => "19"
                        "paginaInicial" => "1665"
                        "paginaFinal" => "1673"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            40 => array:3 [
              "identificador" => "bib0535"
              "etiqueta" => "41"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Early risk factors for pregnancy loss in lupus"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/01.AOG.0000194205.95870.86"
                      "Revista" => array:6 [
                        "tituloSerie" => "Obstet Gynecol"
                        "fecha" => "2006"
                        "volumen" => "107"
                        "paginaInicial" => "293"
                        "paginaFinal" => "299"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            41 => array:3 [
              "identificador" => "bib0540"
              "etiqueta" => "42"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Obstetrical outcome of pregnancy in patients with systemic lupus erythematosus&#46; A study of 60 cases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur J Obstet Gynecol Reprod Biol"
                        "fecha" => "1999"
                        "volumen" => "83"
                        "paginaInicial" => "137"
                        "paginaFinal" => "142"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            42 => array:3 [
              "identificador" => "bib0545"
              "etiqueta" => "43"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pregnancy in women with pre-existing lupus nephritis&#58; predictors of fetal and maternal outcome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/ndt/gfn348"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nephrol Dial Transplant"
                        "fecha" => "2009"
                        "volumen" => "24"
                        "paginaInicial" => "519"
                        "paginaFinal" => "525"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            43 => array:3 [
              "identificador" => "bib0550"
              "etiqueta" => "44"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Lupus nephritis and renal disease in pregnancy lupus"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Lupus"
                        "fecha" => "2006"
                        "volumen" => "15"
                        "paginaInicial" => "148"
                        "paginaFinal" => "155"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            44 => array:3 [
              "identificador" => "bib0555"
              "etiqueta" => "45"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pregnancy in past or present lupus nephritis&#58; a study of 32 pregnancies from a single centre"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Rheum Dis"
                        "fecha" => "2001"
                        "volumen" => "60"
                        "paginaInicial" => "599"
                        "paginaFinal" => "604"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            45 => array:3 [
              "identificador" => "bib0560"
              "etiqueta" => "46"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pregnancy outcomes and appropriate timing of pregnancy in 183 pregnancies in Korean patients with SLE"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Med Sci"
                        "fecha" => "2011"
                        "volumen" => "8"
                        "paginaInicial" => "577"
                        "paginaFinal" => "583"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            46 => array:3 [
              "identificador" => "bib0565"
              "etiqueta" => "47"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Maternal and fetal outcome of lupus pregnancy&#58; a prospective study of 29 pregnancies"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Lupus"
                        "fecha" => "2005"
                        "volumen" => "14"
                        "paginaInicial" => "145"
                        "paginaFinal" => "151"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            47 => array:3 [
              "identificador" => "bib0570"
              "etiqueta" => "48"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3899/jrheum.100997"
                      "Revista" => array:7 [
                        "tituloSerie" => "J Rheumatol"
                        "fecha" => "2011"
                        "volumen" => "38"
                        "paginaInicial" => "1906"
                        "paginaFinal" => "1913"
                        "link" => array:1 [ …1]
                        "itemHostRev" => array:3 [ …3]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            48 => array:3 [
              "identificador" => "bib0575"
              "etiqueta" => "49"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Systemic lupus erythematosus and pregnancy"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.berh.2006.04.003"
                      "Revista" => array:6 [
                        "tituloSerie" => "Best Pract Res Clin Rheumatol"
                        "fecha" => "2006"
                        "volumen" => "20"
                        "paginaInicial" => "685"
                        "paginaFinal" => "694"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            49 => array:3 [
              "identificador" => "bib0580"
              "etiqueta" => "50"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Management of the high-risk lupus pregnant patient"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Rheum Dis Clin N Am"
                        "fecha" => "2007"
                        "volumen" => "33"
                        "paginaInicial" => "253"
                        "paginaFinal" => "265"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            50 => array:3 [
              "identificador" => "bib0585"
              "etiqueta" => "51"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Managing lupus patients during pregnancy"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.berh.2009.04.004"
                      "Revista" => array:6 [
                        "tituloSerie" => "Best Pract Res Clin Rheumatol"
                        "fecha" => "2009"
                        "volumen" => "23"
                        "paginaInicial" => "575"
                        "paginaFinal" => "582"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            51 => array:3 [
              "identificador" => "bib0590"
              "etiqueta" => "52"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Management of pregnancy in systemic lupus erythematosus"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/nrrheum.2012.133"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nat Rev Rheumatol"
                        "fecha" => "2012"
                        "volumen" => "8"
                        "paginaInicial" => "710"
                        "paginaFinal" => "718"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            52 => array:3 [
              "identificador" => "bib0595"
              "etiqueta" => "53"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk of congenital complete heart block in newborns of mothers with anti-Ro&#47;SSA antibodies detected by counterimmunoelectrophoresis&#58; a prospective study of 100 women"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2001"
                        "volumen" => "44"
                        "paginaInicial" => "1832"
                        "paginaFinal" => "1835"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            53 => array:3 [
              "identificador" => "bib0600"
              "etiqueta" => "54"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Utility of cardiac monitoring in fetuses at risk for congenital heart block&#58; the PR interval and dexamethasone evaluation &#40;PRIDE&#41; prospective study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/CIRCULATIONAHA.107.707661"
                      "Revista" => array:6 [
                        "tituloSerie" => "Circulation"
                        "fecha" => "2008"
                        "volumen" => "117"
                        "paginaInicial" => "485"
                        "paginaFinal" => "493"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            54 => array:3 [
              "identificador" => "bib0605"
              "etiqueta" => "55"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Anti-52<span class="elsevierStyleHsp" style=""></span>kDa Ro&#44; anti-60<span class="elsevierStyleHsp" style=""></span>kDa Ro&#44; and anti-La antibody profiles in neonatal lupus"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Rheumatol"
                        "fecha" => "2004"
                        "volumen" => "31"
                        "paginaInicial" => "2480"
                        "paginaFinal" => "2487"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            55 => array:3 [
              "identificador" => "bib0610"
              "etiqueta" => "56"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal&#47;fetal risk factors"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.24768"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2009"
                        "volumen" => "60"
                        "paginaInicial" => "3091"
                        "paginaFinal" => "3097"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            56 => array:3 [
              "identificador" => "bib0615"
              "etiqueta" => "57"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Maternal and fetal factors associated with mortality and morbidity in a multi-racial&#47;ethnic registry of anti-SSA&#47;Ro-associated cardiac neonatal lupus"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/CIRCULATIONAHA.111.033894"
                      "Revista" => array:6 [
                        "tituloSerie" => "Circulation"
                        "fecha" => "2011"
                        "volumen" => "124"
                        "paginaInicial" => "1927"
                        "paginaFinal" => "1935"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            57 => array:3 [
              "identificador" => "bib0620"
              "etiqueta" => "58"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevention of congenital heart block in children of SSA-positive mothers"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Rheumatology &#40;Oxford&#41;"
                        "fecha" => "2008"
                        "volumen" => "47"
                        "paginaInicial" => "i35"
                        "paginaFinal" => "i37"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            58 => array:3 [
              "identificador" => "bib0625"
              "etiqueta" => "59"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation &#40;PRIDE&#41; Study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.amjcard.2008.12.027"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Cardiol"
                        "fecha" => "2009"
                        "volumen" => "103"
                        "paginaInicial" => "1102"
                        "paginaFinal" => "1106"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            59 => array:3 [
              "identificador" => "bib0630"
              "etiqueta" => "60"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Isolated atrioventricular block in the fetus&#58; a retrospective&#44; multinational&#44; multicenter study of 175 patients"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/CIRCULATIONAHA.111.041970"
                      "Revista" => array:6 [
                        "tituloSerie" => "Circulation"
                        "fecha" => "2011"
                        "volumen" => "124"
                        "paginaInicial" => "1919"
                        "paginaFinal" => "1926"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            60 => array:3 [
              "identificador" => "bib0635"
              "etiqueta" => "61"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block&#58; Results of a multicenter&#44; prospective&#44; open-label clinical trial"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.27308"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2010"
                        "volumen" => "62"
                        "paginaInicial" => "1138"
                        "paginaFinal" => "1146"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            61 => array:3 [
              "identificador" => "bib0640"
              "etiqueta" => "62"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Failure of intravenous immunoglobulin to prevent congenital heart block&#58; findings of a multicenter&#44; prospective&#44; observational study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.27350"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2010"
                        "volumen" => "62"
                        "paginaInicial" => "1147"
                        "paginaFinal" => "1152"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            62 => array:3 [
              "identificador" => "bib0645"
              "etiqueta" => "63"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jacc.2010.09.044"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Coll Cardiol"
                        "fecha" => "2011"
                        "volumen" => "57"
                        "paginaInicial" => "715"
                        "paginaFinal" => "723"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            63 => array:3 [
              "identificador" => "bib0650"
              "etiqueta" => "64"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A combination therapy to treat second-degree anti-Ro&#47;La-related congenital heart block&#58; a strategy to avoid stable third-degree heart block"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1177/0961203311430969"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lupus"
                        "fecha" => "2011"
                        "volumen" => "21"
                        "paginaInicial" => "666"
                        "paginaFinal" => "671"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            64 => array:3 [
              "identificador" => "bib0655"
              "etiqueta" => "65"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Evaluation of the risk of anti-SSA&#47;Ro-SSB&#47;La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/ard.2009.119263"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Rheum Dis"
                        "fecha" => "2010"
                        "volumen" => "69"
                        "paginaInicial" => "1827"
                        "paginaFinal" => "1830"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            65 => array:3 [
              "identificador" => "bib0660"
              "etiqueta" => "66"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA&#47;Ro-antibody-associated cardiac manifestations of neonatal lupus"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/CIRCULATIONAHA.111.089268"
                      "Revista" => array:6 [
                        "tituloSerie" => "Circulation"
                        "fecha" => "2012"
                        "volumen" => "126"
                        "paginaInicial" => "76"
                        "paginaFinal" => "82"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21735743/0000001100000005/v1_201509041903/S2173574315000441/v1_201509041903/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "43294"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Original articles"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/21735743/0000001100000005/v1_201509041903/S2173574315000441/v1_201509041903/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574315000441?idApp=UINPBA00004M"
]

Article information

ISSN: 21735743
Original language: English

DOI:10.1016/j.reumae.2015.03.002

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 November	7	5	12
2024 October	50	63	113
2024 September	60	53	113
2024 August	81	78	159
2024 July	82	69	151
2024 June	106	55	161
2024 May	93	52	145
2024 April	79	62	141
2024 March	100	48	148
2024 February	76	47	123
2024 January	49	45	94
2023 December	130	44	174
2023 November	60	58	118
2023 October	97	39	136
2023 September	256	65	321
2023 August	58	21	79
2023 July	48	36	84
2023 June	51	47	98
2023 May	48	37	85
2023 April	44	27	71
2023 March	84	51	135
2023 February	72	39	111
2023 January	73	44	117
2022 December	124	58	182
2022 November	102	64	166
2022 October	124	49	173
2022 September	114	61	175
2022 August	119	47	166
2022 July	116	69	185
2022 June	92	56	148
2022 May	121	68	189
2022 April	182	63	245
2022 March	133	66	199
2022 February	111	67	178
2022 January	134	49	183
2021 December	127	54	181
2021 November	141	50	191
2021 October	150	83	233
2021 September	116	64	180
2021 August	88	71	159
2021 July	145	100	245
2021 June	109	57	166
2021 May	168	79	247
2021 April	222	110	332
2021 March	177	74	251
2021 February	79	30	109
2021 January	74	28	102
2020 December	74	28	102
2020 November	43	22	65
2020 October	38	19	57
2020 September	56	40	96
2020 August	70	45	115
2020 July	63	38	101
2020 June	68	41	109
2020 May	57	28	85
2020 April	57	27	84
2020 March	40	11	51
2020 February	1	1	2
2018 May	8	0	8
2018 April	46	12	58
2018 March	59	18	77
2018 February	41	8	49
2018 January	37	11	48
2017 December	47	10	57
2017 November	51	10	61
2017 October	49	18	67
2017 September	64	12	76
2017 August	39	20	59
2017 July	48	16	64
2017 June	78	29	107
2017 May	76	33	109
2017 April	59	20	79
2017 March	68	11	79
2017 February	97	21	118
2017 January	67	16	83
2016 December	116	27	143
2016 November	90	22	112
2016 October	133	22	155
2016 September	144	19	163
2016 August	100	14	114
2016 July	66	18	84
2015 December	4	48	52
2015 November	4	51	55
2015 October	17	66	83

Show all

Indexed in:

Follow us:

Subscribe:

Statistics

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter